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Summary 
Mastitis is the most important and expensive disease of the dairy industry. It results 
in severe economic losses from reduced milk production, treatment cost, increased labour, 
milk being withheld following treatment and premature culling. Streptococcus uberis is an 
important environmental pathogen causing bovine mastitis, resulting in reduced milk quality. 
The prevalence of S. uberis mastitis has increased worldwide, and S. uberis is the most 
common cause of mastitis in Australia. 
This thesis investigated three main aspects of mastitis due to S. uberis; (i) the 
epidemiology of clinical mastitis, including the relative importance of cow-to-cow 
transmission and acquisition from an environmental source as well as the occurrence of 
persistent infection and re-infection, (ii) factors affecting biofilm formation of S. uberis, and 
(iii) the virulence factors of S. uberis. 
Two hundred and twelve S. uberis isolates were obtained from clinical cases of 
mastitis in dairy cattle from different farms in Gippsland Victoria, Australia. Approximately 
28% (n=60) of isolates were from recurrent infections. Among these 60 S. uberis isolates 
from 27 cows, 34 different DNA restriction patterns were observed, indicating that a wide 
variety of S. uberis strains causing clinical mastitis. There were some examples of the same 
strain being isolated from different cows in the same herd, suggesting either cow-to-cow 
transmission at milking or acquisition from a common environmental source. It was not 
uncommon for the same PFGE type to be isolated from the same udder quarter on more than 
one occasion during one lactation period. It is likely that the initial clinical signs cleared 
following treatment but the organisms persisted, only to re-emerge and cause clinical mastitis 
later. In four cases strains persisted between lactations in a chronically infected quarter.  
There were three instances of the same PFGE type or subtype being isolated from cows with 
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clinical mastitis on different farms. The reasons for this are unclear as cows were not 
transported between these farms. These findings suggest that transmission patterns for 
clinical infections are similar to those for subclinical infection and that the same 
environmental reservoir exists for both types of mastitis.   
Twenty-seven S. uberis isolates were tested for their ability to form biofilms on a 
polystyrene surface, and to produce extracellular polysaccharide, assessed on Congo red agar. 
Biofilm production by S. uberis occurred in most isolates from cows with or without mastitis, 
but most produced lower amounts of biofilm than the control Staphylococcus epidermidis 
RP62A. The addition of milk markedly increased the amount of biofilm formation of S. 
uberis isolates. These results suggest that milk or its components could contribute to the 
pathogenesis of S. uberis mastitis by assisting in biofilm production. The roles the different 
milk components on biofilm formation were also assessed. Casein and β-lactoglobulin over a 
range of concentrations found in vivo, did not enhance biofilm formation. Lipids in milk are 
unlikely to contribute to biofilm formation as skim milk and whole milk behaved is a similar 
way. Lactoferrin (Lf) did not appear to play a major role in biofilm formation by most 
isolates of S. uberis. Biofilm formation increased with fructose, glucose or sucrose as a 
carbohydrate source, but when lactose was used as the carbohydrate source, biofilm produced 
significantly decreased. This could explain the detachment of S. uberis biofilms that was 
observed in the presence of raw milk, if lactose affected the attachment process. Iron 
limitation led to a concentration-dependent reduction in biofilm formation by the clinical 
isolates but not low cell counts. The indigenous flora of raw milk appears to contribute to 
biofilm formation by S. uberis since limited amounts of biofilm were produced when 
indigenous flora were removed from milk.  
 
A microarray assay was developed to analyse putative virulence factors among 
different S. uberis isolates. Suppressive subtractive hybridization, using a pool of isolates 
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from cases of clinical mastitis (tester pool) and a commensal pool from cows with low 
somatic cell counts in the milk (driver pool), was used to generate a library of tester-specific 
clones that were printed onto the array. Following hybridization with DNA from 29 S. uberis 
isolates, a dendogram showed five major clusters, which clearly differentiated between 20 
clinical isolates and nine low cell count isolates. The first cluster contained seven S. uberis 
isolates; among them just one isolate from a cow with clinical mastitis. This clearly indicated 
that these isolates lack statistically significant linkage with disease status and makes them 
unlikely candidates for S. uberis virulence-associated factors. The second cluster was mixed, 
consisting of seven isolates; four from cows with clinical mastitis and three from cows with 
low cell counts in their milk. These S. uberis isolates may represent opportunistic pathogens, 
possibly able to cause infections in particular groups of cows with increased susceptibility to 
infection, for example heifers or older animals. The third, fourth or fifth cluster contained 15 
S. uberis isolates from cows with clinical infection, but no low cell counts.   
The strain-specific features together with the fourteen features chosen by principal 
component analysis (PCA) were selected for sequencing. The probes that hybridized to most 
of the S. uberis isolates that were examined (from PCA analysis) had matches to metabolic 
genes in the streptococcal genomes compared. The correlation between the distributions of 
these DNA sequences and disease status could indicate their essential role in the growth or 
survival of S. uberis in diverse environments rather than their possible roles as virulence 
factors.  
In addition, probes W3-30 and W2-38 which were clinical isolate-specific 
sequences, encoded to a putative transposase virulence factor in S. salivarius. The occurrence 
of such a protein is indicative of an insertion sequence gained through horizontal gene 
transfer from other Streptococcus spp. 
Summary 
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The sequence of W3-21 was highly homologous to a hypothetical protein in 
Enterococcus faecalis, and it is unlikely to not represent a S. uberis virulence factors. 
Importantly, the sequence of the probe W2-17, which is specific for S. uberis clinical isolates, 
had no significant match in the database and therefore, this probe is potentially a novel 
virulence marker gene.   
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Chapter 1: Review of pertinent literature 
1.1 Background 
The genus Streptococcus is found in a large range of human, animal and plant 
environments. Streptococci are essential in the milk products market, but are also pathogens 
of humans and animals, including farm animals. Rosenbach first described the genus in 1884 
(cited in Jones, 1978).  Since that time, there have been several taxonomic revisions of the 
genus Streptococcus and related genera. The earliest classification was on the basis of 
cultural, biochemical and serological tests (Andrews and Horder, 1906; Lancefield, 1933; 
Orla-Jensen, 1919; Sherman, 1937).  
Streptococcus uberis, as a cause of bovine mastitis, was first described by 
Diernhofer (1932). That study found that S. uberis does not belong to the genus 
Enterococcus, but shows similarities with Streptococcus pyogenes. A comparison of 
physiological properties of S. uberis strains with those of seven other species in the same 
habitat found that S. uberis was a well-defined individual species (Roguinsky, 1977). 
Facklam (1977), also using physiological and serological characteristics, classified the genus 
Streptococcus into four significant groups: Streptococcus lactis, S. pyogenes, Streptococcus 
viridans and the related genus, Enterococcus. In that study, S. uberis was included with the 
“viridans” streptococci.   
A numerical taxonomic study of strains of the genus Streptococcus together with 
representatives of allied genera showed 28 reasonably distinct phenons (Bridge and Sneath, 
1983). S. uberis was classified under parapyogenic species, which also includes 
Streptococcus dysgalactiae and Lancefield groups R, S and T streptococci. Schleifer and 
Kilpper-Bälz (1984) and Schleifer (1985) later conducted a taxonomic revision of genus 
Streptococcus and re-classified this genus into three genera, i.e. Streptococcus sensu stricto, 
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Enterococcus and Lactococcus. Later Schleifer and Kilpper-Bälz (1987) further subdivided 
genus Streptococcus into three groups; pyogenic streptococci, oral streptococci and other 
streptococci. On the basis of cultural and biochemical characteristics as well as serological 
heterogeneity, S. uberis was classified under other streptococci.  
More recently, molecular studies have contributed to the taxonomic changes. 
Identification and differentiation of S. uberis from closely related species have been 
improved dramatically and become more frequent during in recent years. For instance, 
restriction fragment length polymorphism (RFLP) analysis was one of the first techniques 
used to differentiate S. uberis from Streptococcus parauberis on the basis of the 16S rRNA 
gene (Bentley et al., 1993 and Jayarao et al., 1991a). Furthermore, DNA hybridization-based 
methods have facilitated the discrimination of S. uberis from S. parauberis (Williams and 
Collins, 1990). Moreover, McDonald et al. (2005) reported that conventional identification 
methods for distinguishing these two species are inadequate, and that more reliable 
identification methods such as PCR–RFLP analysis and 16S–23S rRNA sequencing improve 
the accuracy of the identification of streptococcal mastitis pathogens. Another study was 
conducted by Tapp et al. (2003) on the mpB gene which was sequenced in 79 strains of the 
genus Streptococcus. Phylogenetic relationships were studied and phylogenetic inference was 
also studied for the 16S rRNA gene. They concluded that the rnpB gene is suitable for 
phylogenetic analysis of closely related taxa and has potential as a tool for species 
discrimination. 
1.2 Bovine mastitis 
Mastitis is the single most important cause of financial loss to the dairy industry 
worldwide (Beck et al., 1992; Petrovski et al., 2006). Subclinical and clinical mastitis can 
cause reduction in milk production, higher health care costs, increase in culling as well as 
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increase in the mortality rates (Brightling et al., 1998; Bradley, 2002; Kossaibati and 
Esslemont, 1997). Due to unpasteurised dairy products in the niche markets or improper 
pasteurisation, the possibility of transferring the zoonotic organisms through milk is still a 
concern. That is true especially when treatment with antibiotics is used extensively, and 
antibiotic resistant strains emerge leading to a higher risk of these strains entering the food 
chain (White and McDermott, 2001). Although human infections with S. uberis are 
uncommon, according to Facklam (1977) S. uberis was isolated from human cases of 
endocarditis and urogenital infections. In addition, Rabe et al. (1988) reported about the 
isolation of S. uberis from the human female genital tract.    
Bovine mastitis is an inflammation of the mammary gland, which can be caused by 
bacteria, including mycoplasma, or yeasts. Five species of bacteria (Escherichia coli, S. 
uberis, Staphylococcus aureus, S. dysgalactiae and S. agalactiae) are responsible for almost 
80% of all cases of mastitis (Field et al., 2003). 
 
Mastitis pathogens may be classified as either contagious or environmental (Blowey, 
1995). Contagious pathogens are spread from cow to cow during milking and are capable of 
surviving and resisting the immune defence of the host. They are able to cause clinically 
apparent infections, chronic mastitis and sub-clinical infections (usually revealed as an 
increase in the somatic cell count [SCC]). Cells contributing to the SCC include leukocytes 
(predominantly neutrophils) and epithelial cells (Radostits et al., 1994a). Environmental 
pathogens are best described as opportunistic pathogens that invade the mammary gland, and 
are not specifically adapted for survival in the host, for example, E. coli usually invades, 
multiplies, causing and immune response and is rapidly eliminated. The most important 
contagious pathogens include S. aureus, S. dysgalactiae and S. agalactiae; the main 
environmental pathogens include the Enterobacteriaceae (particularly E. coli) and S. uberis 
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(Bradley, 2002). Although S. uberis behaves predominantly as an environmental pathogen, 
there are numerous examples of probable cow to cow transmission (Baseggio et al., 1997; 
Khan et al., 2003; Phuektes et al., 2001; Rato et al., 2008; Wang et al., 1999). 
In the past mastitis was mainly caused by infection with contagious pathogens. 
However, during the 1960s, the implementation of antibiotic dry cow therapy, post-milking 
teat disinfection, and routine maintenance of milking machines, resulted in a reduction in the 
incidence of mastitis caused by these bacteria (Neave et al., 1969). Although these control 
programs were efficient in reducing the problem of contagious pathogens, they were not as 
effective against environmental pathogens (Schukken et al., 1990). The niche vacated by the 
contagious pathogens has become occupied by the environmental mastitis pathogens, in 
particular S. uberis (Jayarao et al., 1999; Ward et al., 2009). 
1.2.1 Subclinical mastitis 
Cows suffer from this type of mastitis do not show any clinical signs in terms of 
milk production or obvious visible changes to the milk, and udder palpation of these cows 
does not reveal inflammatory changes, such as hardness. Subclinical mastitis can progress to 
clinical mastitis or chronic infection (Harmon, 1994). The only definite sign of subclinical 
mastitis is an increase of SCC of milk. This can be assessed indirectly by conductivity testing 
or when these animals are tested by the California Mastitis Test (CMT) or directly by 
counting the number of somatic cells in the milk. The CMT test can be easily and quickly 
used for the detection of the presence of subclinical infections of a quarter at the beginning 
of, or during lactation period. This test indicates the number of SCC found in the milk. A 
small sample of milk is collected from each quarter in the paddle wells. An equal amount of 
CMT reagent is added before the content is mixed by swirling the paddle for 10 seconds and 
the result is read quickly since the reaction disappears within few seconds. The mix becomes 
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thicker and more viscous when the cow has a higher SCC in the milk. In addition, the colour 
change of the mix indicates the pH of the milk and therefore the level of udder inflammation 
(Schalm and Noorlander, 1957). Subclinical mastitis can be caused by different micro-
organisms in particular S. aureus and S. uberis. Due to their healthy appearance, cows 
infected with S. aureus can be a reservoir of infection and could easily spread the pathogens 
to the rest of the herd (Bradley, 2002; Radostits et al., 1994b). Furthermore, changes in milk 
composition especially milk proteins and fat may occur, affecting the bulk tank milk 
components which impacts on the price paid to farmers by milk companies (Harmon, 1994).  
The lactation cycle in the udder of dairy cows can be described briefly as follows; 
shortly after calving, milk is secreted into the udder to allow calf feeding immediately after 
birth. The cow then continues to produce milk until discontinuation of milking (generally 
after a period of ten months); this period is known as lactation period. For the two months 
prior to calving again, the cow is in the non-lactating period (dry period). A new lactation 
cycle begins with the birth of the calf. In the first two weeks after calving the cow produces 
milk which has a different composition and properties from normal milk; this milk is called 
colostrum (Bylund, 2003).       
A study was performed by Grommers et al. (1985) on the duration of subclinical 
infections due to several bovine mastitis pathogens including S. aureus, S. agalactiae, S. 
dysgalactiae and S. uberis, over a period of about four years. The duration of subclinical 
mastitis due to S. auerus, S. agalactiae, S. dysgalactiae and S. uberis was 12.8 weeks, 10.8 
weeks, 9.9 weeks, and 10.4 weeks respectively. Other studies; however, have reported that 
the duration of subclinical mastitis can be much shorter. In the early dry period the mammary 
gland is rested and absorbs retained milk including dead milk secreting cells which put the 
udder under extreme pressure. Almost half of new udder infections occur during the dry 
period, usually about three weeks before calving. One third of these new infections can be 
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prevented by dry cow therapy, given to all cows by the intramammary route on drying off 
(Smith et al., 1967).  
1.2.2 Clinical mastitis 
The common clinical signs of mastitis are swollen udder, one or more quarters 
showing signs of inflammation, and physical and chemical changes in milk such as presence 
of clots or blood or watery milk. Cows may appear healthy with no loss of appetite. A wide 
range of bacteria, including mycoplasmas and occasionally fungi can cause bovine clinical 
mastitis. This type of mastitis can usually be treated successfully with antibiotics in the form 
of intramammary preparations or intramuscular injections (Harmon, 1994; Leigh, 1999). 
However, cows infected with S. uberis often fail to respond to apparently appropriate 
treatment (Milne et al., 2005).  
Although clinical mastitis is generally accompanied by an increased level of somatic 
cell counts (SCCs), there is no clear relationship between SCC and severity of mastitis. This 
was confirmed by the work of Peeler et al. (2000) who reported clinical mastitis cases with 
SCCs <100.000 cells/mL. The authors concluded that cows with low SCCs can suffer a very 
low or very high occurrence of bovine clinical mastitis.  
1.2.3 Recurrent mastitis 
Sol et al. (1997) and Wilson et al. (1999) reported that bacteriological cure rates of 
mastitis after treatment using antimicrobial drugs ranges from 0% to 80% and are related to 
several factors including SCC, infected quarter, age, lactation stage and bacterial species. For 
instance, Owens et al. (2001) found that treatment of heifers just before parturition prevented 
the development of mastitis in 100% of cases, while the cure rates were about 50% in 
lactating cows. The cure rate for clinical mastitis caused by S. uberis may exceed 50%, but 
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persistence may occur, especially if the cows do not receive appropriate intramammary 
antibiotic for the required number of treatments (Morin et al., 1998). Generally, irrespective 
of bacterial species, treatment of older cows or high SCC cows with chronic infections was 
less successful or ineffective. When the therapy initially failed persistence of the infection is 
common (Hillerton and Kliem, 2002; Houben et al., 1993).  
1.2.4 Cost of mastitis 
The increased financial costs which could be associated with bovine mastitis include 
decrease in milk production, increased use of antibiotics, discarded milk, veterinary services, 
labour requirements, product quality, diagnostics, other diseases and culling (Halasa et al., 
2007). Although the costs can be different among countries, the same principles apply. 
The food industry sees mastitis as providing access of organisms to the product as it 
passes over a surface and as a result compromising product quality and safety. The dairy 
industry is of specific interest as it is a very significant industry in terms of product volume, 
and product range. For example, in Australia milk production during 2010/11 reached 9.1 
billion litres, and export returns increased 3.1% over the previous year. Moreover, in the local 
market, supermarket sales of dairy categories increased constantly in terms of volume and 
value and reached about $4 billion in 2010/11, with firm growth across all the major dairy 
products (Dairy Australia, 2012). The starting material for all dairy products is raw milk 
followed by pasteurized milk. Thus, if the microbiological quality of the these two materials 
is compromised, then not only are the consumers of pasteurized milk affected by shorter 
shelf-life product but other products, such as yoghurts, cheeses and dips, that use milk as a 
base are also compromised. 
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1.2.5 Effect of mastitis on milk composition 
In addition to increases in SCC, there are other changes in milk composition due to 
bovine mastitis (National Mastitis Council; Jones (2009) (Table 1). The major milk protein is 
casein, which decreases in mastitis and consequently the concentrations of whey proteins 
become higher. These changes impact on dairy product quality including yoghurt flavour and 
cheese yield.  
Changes in milk composition during bovine mastitis reflect the inflammation of the 
udder. Generally, milk from uninfected cows contains leukocytes, lymphocytes and 
polymorphonuclear leucocytes (PMNs) at levels below 150,000 cells /mL. In cows with 
mastitis, due to different chemotactic stimuli, neutrophil leukocytes migrate into the milk.  
Infiltration from the blood is increased and the first noticeable change is the presence in milk 
of plasma proteins, including transferrin, immunoglobulins, serum albumin and other serum 
proteins. Lactoferrin, the major antibacterial iron-binding protein in the bovine mammary 
gland secretions, increases in concentration. This is possibly due to increases in output from 
mammary host tissues. Bovine milk also contains proteolytic enzymes which break down 
milk proteins. Furthermore, electrolytes present in blood including sodium and chloride ions 
penetrate into milk and result in the milk pH being equal to that of blood; consequently, the 
gland syntheses capacity is reduced. These signs of the udder inflammation vary according to 
the host factors and invading pathogens (Schalm, 1977). 
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Table 1-1. Changes in milk constituents associated with high SCC (National Mastitis Counsel, 2009) 
Constituent Normal (%) Milk with high SCC (%) 
Fat 3.5 3.2 
Lactose 4.9 4.4 
Total protein 3.61 3.65 
Total casein 2.8 2.3 
Whey protein 0.8 1.3 
Serum albumin 0.02 0.07 
Lactoferrin 0.02 0.1 
Immunoglobulins 0.1 0.6 
Sodium 0.057 0.105 
Chloride 0.091 0.147 
Potassium 0.173 0.157 
Calcium 0.12 0.04 
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1.3 Control of mastitis    
Programs for the control of mastitis due to contagious and environmental pathogens 
require identification of the bovine mastitis pathogens and prevention of spread of infection 
by eliminating the reservoir. Control measures include teat dipping, providing a clean cow 
environment, and culling chronically infected cows. Awareness of mammary gland anatomy, 
physiology and its defence mechanisms, microorganism behaviour and virulence factors, 
milking machine function, and drugs is essential in establishing effective mastitis control 
(Hillerton and Berry, 2003). 
The United Kingdom developed a Five Point Plan in the 1960s from research at the 
National Institute for Research in Dairying (NIRD). The plan is called for a five pronged 
approach to the management of mastitis (Neave et al., 1969; Smith et al., 1967) and involves: 
(i) Treatment of clinically infected cows immediately with an effective agent to 
minimize exposure and reduce duration. 
(ii) Using antibiotics that have a longer action on all quarters at the end of the lactation to 
remove existing infection and protect the herd from any new infection in the dry 
period to reduce duration and limit exposure. 
(iii) Culling all cows that suffer from persisting infections. 
(iv) Teat dipping with an effective germicidal agent of all herds, after every milking to 
minimize exposure. 
(v) Routine maintenance of the milking machine.  
Despite the widespread implementation of these mastitis control techniques, dairy 
industries around the world are still challenged by mastitis. The incidence of mastitis was 
reduced sharply in the previous half century; however this was associated with a change in 
prevalence of infections due to S. uberis. Subclinical infections caused by E. coli and S. 
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uberis are problematic in low somatic cell count herds (Deluyker et al., 1993; Schrick et al., 
2001). 
For almost three decades some of these steps were not widely implemented on 
typical Australian farms for several reasons. One important reason was that the infection and 
transmission rates could not be reduced by Five Point Plans and therefore these steps were 
less successful in particular for mastitis caused by environmental pathogens such as S. uberis 
(Mein, 2011).     
The 1998 Countdown Downunder, Farm Guidelines for Mastitis Control was 
updated in early 2010 by Dairy Australia (Brightling et al., 2010). These set guidelines cover 
different periods through the milking year: calving, lactation, late lactation, drying off, dry 
period and review period. Mastitis control also provided management techniques to enhance 
animal hygiene, and minimize cow environment contamination due to mastitis pathogens. 
The Countdown Downunder program is aiming to keep the bulk tank somatic cell count 
(BTSCC) below 250,000 cells/ml in most Australian dairy farms and to decrease BTSCC to 
<400,000 cells/mL in all dairy farms around the country (Dairy Australia, 2012). 
1.3.1 Control of environmental mastitis including S. uberis  
The approaches to control bovine mastitis due to S. uberis must involve protection 
by either limited exposure to organisms or improved resistance of the dairy cattle. Controlling 
environmental organisms is more difficult than controlling contagious organisms. Some 
pathogens are transmitted in spite of teat dipping while some do not respond to dry cow 
therapy (Alvaro Garcia, 2004). The key to controlling environmental mastitis is the 
identification of the reservoir and reducing exposure to contaminated sources, such as ponds, 
mud and bedding. In addition, clipping the hair on the udder may reduce the amount of faecal 
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material clinging to the glands (Mein, 2011). Proper milking procedures should be practiced, 
for example, washing teats and milking only clean dry teats. Dipping teats with germicide 
prior to milking is advocated by some authorities. Cows should be kept standing post milking 
and offered feed if necessary. Furthermore, using sterile single-dose infusion products is 
essential (Daley et al., 1991). Post teat dipping or spraying is used in some countries 
including Australia. Dipping teats has the advantage over spraying as it covers the udder area, 
but uses less chemical than spraying. Although spraying techniques are faster, they require 
care; moreover the cost of equipment is higher than for the dipping method. Regular cleaning 
of the milking parlour and the container used for teat dipping is also essential as pathogens 
can survive in many disinfectants (Dairy Australia, 2012).  
1.3.2 Vaccination against mastitis 
Vaccination is an approach that aims to improve the resistance of the bovine 
mammary gland against new infection and decrease the severity of the clinical disease.  
Vaccines against Gram-negative pathogens, mainly E. coli and Salmonella spp, have been 
developed using mutant strains that have lost the ability to synthesize outer polysaccharide 
antigens, leading to exposure of the common Gram-negative lipopolysaccharide (LPS) 
antigens. It has been reported that clinical coliform mastitis decreased about 70% with 
reduced severity of clinical signs following vaccination (Hogan et al., 1992; Hogan et al., 
1995). 
Several attempts have been made to develop an effective S. aureus vaccine. One 
such vaccine, based on protein A, is injected either intramuscularly or into the 
supramammary lymph node. Vaccination failed to decrease the number of new infections, but 
there are reports that cure rates have been improved and the severity of the disease decreased 
by a few vaccines (Nickerson, 1999; Yancey, 1993). These vaccines lead to elevated 
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leukocytes in the mammary gland, and consequently enhancement of defence mechanisms. 
However, vaccination against S. aureus has been less successful than expected.  
There is some evidence that infection with S. uberis protects against future infection 
with homologous but not heterologous strains (Hill, 1988; Leigh et al., 1999).  
Fang et al. (1998) produced evidence that milk from mammary quarters challenged 
with S. uberis responded to the challenge by producing IgG, which together with 
complement, reduced the ability of the milk to support growth of homologous and 
heterologous strains of S. uberis. A week post challenge all mammary glands had become 
infected with S. uberis and the SCC count in milk increased. In milk collected from 
challenged quarters, in contrast to control quarters, there was a significant decrease in the 
growth of spiked homologous and heterologous strains of S. uberis. There was also an 
increase in total and specific IgG in challenged glands. Although the authors did not discuss 
the significance of their results in relation to vaccination, their findings suggest that the IgG 
response in milk could contribute to vaccine efficacy by reducing bacterial growth.   
  A review by (Leigh et al., 1999) revealed that several vaccines showed promise 
towards S. uberis bovine mastitis. In the last decade, several vaccines against S. uberis have 
been described. These vaccines include live bacteria, bacterial extracts or purified antigens; 
however, due to their cost and lack of efficacy, these vaccines are no longer in common use 
(Talbot and Lacasse, 2005). For instance, repeated immunization with a killed vaccine 
contributed to a decrease in the number of S. uberis present in milk after experimental 
challenge with the same strain of S. uberis used as a killed vaccine, but did not prevent 
recruitment of leucocytes. Killed vaccines prepared from killed S. uberis stimulated IgG1 
production but this was ineffective in providing protection (Leigh, 1999). In addition, 
combined intra-mammary and subcutaneous inoculation with a live vaccine or a vaccine was 
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prepared from the cell wall material, showed no effect towards heterologous strains but only 
protection against same strain (Hill et al., 1994; Leigh et al, 1999). The results indicated 
again no increase in phagocytosis, or intracellular killing in neutrophils. It appears that killing 
by neutrophils is not necessary for protecting against S. uberis mastitis. Possibly the decrease 
in colonization may be more important. Another vaccine developed from S. uberis 
plasminogen activator (PauA) gave approximately 60% protection against clinical infection 
and the number of SCCs did not exceed 300,000 cells/mL post challenge with different 
strains (Leigh et al., 1999; Yancey, 1999). The protection correlated with neutralizing 
antibody to PauA. Since PauA releases nutrients for growth, the mechanism of protection 
could be reduction of growth in the mammary gland.  
In 2010 Leigh and his team from United Kingdom discovered that S. uberis uses 
the enzyme sortase A (srtA) which anchors the proteins at the surface of S. uberis. The 
authors compared a wild type strain with a srtA mutant and found that, although their 
inflammatory response was same, cows challenged with the srtA mutant did not show any 
clinical signs. The results indicated that srtA plays a major role in S. uberis pathogenesis and 
the authors believe this discovery may lead to the production of a vaccine in the near future. 
Another research group from New Zealand (Denis et al., 2011) studied the presence and 
function of S. uberis-specific T cells in the blood and mammary gland secretions (MGS) of 
cattle, and established their phenotype. They purified MGS and incubated with blood 
monocytes as antigen presenting cells. Eighty percent of the T cell lines from MGS had 
significant direct killing activity against S. uberis in vitro. This finding suggested that MGS T 
cells play a major role in mediating resistance to mastitis. Therefore, they concluded that 
protection of mastitis due to S. uberis vaccines could be achieved by activating and 
expanding the T cells in the udder of cows.    
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In a more recent investigation Prado et al. (2011) vaccinated cows with 
recombinant S. uberis adhesion molecule (rSUAM) by subcutaneous route in the neck region 
at drying off, 28 days after drying off and 7 days after calving. This vaccination protocol 
demonstrated a significant increase in anti-rSUAM antibodies and the highest level was 
reached in the post parturient sampling period. Then the authors examined the adherence of 
two S. uberis strains, to bovine epithelial cells after coating of the bacteria with serum from 
vaccinated or untreated cows. Both strains were co-cultured with bovine epithelial cells and 
the adherence was measured. The adherence of treated S. uberis strains to mammary 
epithelial cells was significantly reduced compared to the untreated controls. The authors 
concluded that since the antibodies reduced the adherence of the pathogen to bovine 
epithelial cells in vitro, SUAM could be a potential important component in vaccine 
development.   
1.4 Characterisation of S. uberis 
Streptococcus uberis is found as a commensal on the mucosa of the tonsils and 
intestinal tract of cows and is responsible for approximately 20 – 30% of clinical mastitis 
cases in dairy cows in North America, Europe and Australia (Gyles et al., 2011). S. uberis is a 
Gram-positive coccus less than 2 μm in diameter that typically grows by cell division in one 
plane, so that nascent cells form a linear array. It is facultatively anaerobic and catalase 
negative with complex and variable nutritional requirements, which reflect its adaptation as a 
commensal or pathogen (Phuektes et al., 2001; Todhunter et al., 1985; Yamamoto et al., 
2005). Colonies are convex, moist with dense centres. On sheep blood agar, approximately 
15% of isolates produce beta-haemolysis. The key biochemical diagnostic characteristics of 
S. uberis are the hydrolysis of hippurate and esculin (Khan et al., 2003) and production of 
acid from inulin (Watts, 1988).  
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Streptococcus uberis is responsible for infection in subclinically and clinically 
infected cows and is the predominant organism isolated from the mammary gland of 
multiparous cows during the non-lactating period (Oliver, 1988; Todhunter et al., 1994). It 
causes subclinical mastitis, which progresses to clinical mastitis, as well as acute to chronic 
mastitis and may persist in the infected mammary gland for more than one lactation period 
(Oliver et al., 1998; Wilesmith et al., 1986).  The incidence of S. uberis mastitis is highest 
during early lactation and at the end of lactation (McDougall et al., 2004; Williamson et al., 
1995) and S. uberis mastitis is also common in the dry period just before calving. 
Approximately 20% of mastitis cases at calving were caused by S. uberis (Harmon and Crist, 
1994) and over 50% of quarters that were infected with S. uberis during the dry period 
subsequently developed clinical mastitis (Bradley, 2002; Bramley, 1984). 
Streptococcus uberis is distinguished from the phenotypically similar but less 
common S. parauberis by differences in its 16S and 23S rRNA genes, the absence of genes 
for pauA and the oligopeptide permease OppF. Analysis of the genomic sequence of S. uberis 
reveals a great variety of metabolic capabilities and nutritional flexibility but relatively few 
classical streptococcal virulence factors (Ward et al., 2009). Thus, it is well equipped to cope 
with a variety of environments, such as those encountered as a commensal of the bovine 
intestine, as an environmental contaminant, or a pathogen of the mammary gland. 
1.5 Reservoir and source of S. uberis infection 
Streptococcus uberis can be isolated from different areas of cow’s body such as the 
tonsils and intestinal tract and also from the farm environment including straw bedding, soil, 
faeces and water (Bramley, 1984; Leigh, 1999; Zadoks et al., 2005a). Zadoks et al. (2005a) 
isolated S. uberis from soil samples from herd-lying areas but not from non herd 
environments. These findings suggested that the environment is important source of S. uberis. 
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Several studies, using molecular techniques, have shown that S. uberis is generally 
acquired from the environment but there is evidence that cow-to-cow transmission may also 
occur (Douglas et al., 2000; McDougall et al., 2004; Phuektes et al., 2001; Pullinger et al., 
2007, and Zadoks et al., 2003). For example, Phuektes et al. (2001) and Zadoks et al. (2003) 
conducted a study on the transmission of S. uberis among herds from different farms and 
direct cow-to-cow transmission on the same farm, using various molecular typing techniques. 
These studies showed that a wide range of S. uberis strains are present on a single farm, and 
that strains appear to spread on the same farm or different farms. New infections due to a new 
type of S. uberis also occur. Although a predominant strain may be present on a farm, the 
predominant strain may differ between farms (Phuektes et al., 2001; Pullinger et al., 2007; 
Zadoks et al., 2003). A more detailed review of the transmission patterns of S. uberis is 
provided in Chapter 3.   
While most S. uberis infections are acquired from environmental sources, Zadoks 
et al. (2001) described an outbreak of S. uberis mastitis that also appeared to involve cow-to-
cow transmission. Milk samples were collected every three weeks from cows in the lactation 
period, from any clinically infected cows, from cows after drying off, before culling and at 
calving. All the samples were cultured bacteriologically and Poisson logistical analysis was 
applied to the data. The model supported both cow-to-cow transmission and an 
environmental source of S. uberis. The prevalence of infection at different points during the 
outbreak was able to predict the number of new infections occurring, and supported cow-to-
cow transmission. Moreover, the number of new infections decreased during periods in which 
post milking teat disinfection was used. Environmental transmission was also supported by 
the data, since new intramammary infections occurred in heifers, which had not been exposed 
to the milking process.   
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1.6 Pathogenesis of S. uberis 
In general, mastitis occurs when the organism passes through the teat duct and 
adheres before multiplying in mammary gland tissues and inducing an influx of PMNs into 
the secretory acini within 24 h. Later there are systemic signs such as septal edema, 
vacuolation of secretory cells, necrosis of alveoli, and infiltration of septa by lymphocytes 
(Timoney, 2004). As infection progresses, there are several physiological and systemic 
changes such as duct epithelial hypertrophy, involution of mammary gland tissue and 
fibrosis. Bacteria usually reside in lymphatic vessels and lymph nodes then adhere to the 
canal epithelial cells. Timoney (2004) has also reported that the main factors playing a central 
role in the severity of the infection can be strain virulence, bacterial number, season, host 
defence, age of the cow and lactation period.  
Streptococcus uberis has been described by some authors as an opportunistic 
invader of the mammary gland, not adapted to survival within the host. According to this 
theory, the potential of invasion is greatly increased by the organism residing inside the teat, 
i.e. contaminated teats increase the risk of infection (Oliver et al., 1998). Alternatively, others 
believe that adhesion to and internalization into host epithelial cells are promoted by 
virulence factors which contribute to avoiding the host immune response and persistence of 
the organism in the host mammary gland tissues (Leigh et al., 1999) (Fig. 1-1). 
 
 
 
 
 
 
 
Chapter 1. Review of pertinent literature 
Page 23 
   
 
 
 
 
 
   
 
 
 Fig. 1-1. Process of infection. Diagram adapted from (Jayarao, 2006). 
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Clinical and experimental studies support the view that the susceptibility of bovine mammary 
glands to new intra-mammary infection is very high during the gland physiological transition 
from lactation to involution and colostrogenesis. Involuted mammary gland secretions 
enhanced S. uberis growth in contrast to lactation secretions where S. uberis grew poorly 
(Eberhart, 1982; Smith et al., 1985; Oliver, 1988; Oliver and Sordillo, 1988). Bovine 
mammary glands are less susceptible to S. uberis infection at drying-off but become more 
susceptible at the advanced dry-stage (Leigh, 1999).  
This may be explained if, at the beginning of the dry period S. uberis invades the 
teat canal but is not able to remain there because the resistance of the teat canal increases 
(Bramley, 1984). Various authors have attempted to explain why susceptibility of the 
mammary gland increases during the dry period. Denis et al. (2006) examined the activity 
and the interactions of macrophages, with S. uberis during the mid-dry period and during 
lactation. Specifically, they attempted to determine whether S. uberis induced the release of 
the cytokine tumour necrosis alpha (TNF-) and the bactericidal moiety nitric oxide (NO). 
Their findings suggested that the bactericidal activity of macrophages against a virulent strain 
of S. uberis is low during the lactation period, and they concluded that during the drying off 
period S. uberis is not a strong inducer of NO and TNF- in macrophages from the milk or 
mammary gland secretions. Another group has shown that there is a clear relationship 
between the growth of S. uberis in the secretions of dry cattle and susceptibility to infection 
(Leigh, 1999). Essential nutrients for the growth of S. uberis have been described (Leigh, 
1993; Kitt and Leigh, 1997). Different strains of S. uberis are auxotrophic for between 10 and 
13 amino acids, while all strains require eight amino acids. These authors have also 
established that hydrolyses of host protein contributes to S. uberis growth in milk. 
Furthermore, when milk protein (alpha, beta and kappa casein) replaced essential amino acids 
in experimental media; this protein did not succeed in restoring bacterial growth. The authors 
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concluded that the growth of S. uberis can only be restored by the addition plasmin-
hydrolysed caseins when essential amino acids are omitted.  Finally, complex interactions 
between actoperoxidase (LP), hypothiocyanite thiocyanate (SCN) and free sulphur-
containing amino acids may contribute to the increased prevalence of S. uberis in the dry 
period. Concentrations of LP increase in infected cattle during the dry period. This enzyme 
hampers S. uberis growth by production of hypothiocyanite thiocyanate (SCN) and hydrogen 
peroxide; however, this activity does not completely prevent the growth of bacteria. The 
reason could be related to the presence in secretions of free sulphur-containing amino acids, 
which could counteract the LP, SCN and hydrogen peroxide inhibitory system by increasing 
the concentration of cystine in bovine milk (Brown and Mickelson, 1979).      
1.7 Virulence factors of S. uberis 
Several virulence factors have been proposed for S. uberis by different groups, but 
there is no consensus as to the most important factors responsible for mammary glans 
infection. The ability to grow in milk has been proposed as an important virulence factor of S. 
uberis. S. uberis has the ability to activate bovine plasminogen to the serine protease plasmin 
with a specific activator, PauA, and bind plasmin to its surface (Leigh, 1993; Leigh, 1994; 
Leigh and Lincoln, 1997; Rosey et al., 1999). The proteolytic activity of plasmin derives 
peptides from milk casein and provides amino acids which are proposed to support growth of 
S. uberis in the early stages of mammary gland colonization.   
Resistance to phagocytosis and the bactericidal activity of neutrophils is a hallmark 
of S. uberis infection (Hill et al., 1994). During infection, the inflammatory response of 
bovine mammary gland results in an increasing the number of PMNs, which engulf and kill 
most potential pathogens. Bovine mastitis due to S. uberis is not controlled by this defence 
mechanism while E. coli infections can be easily eliminated. A hyaluronic acid capsule, 
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protective against phagocytosis and intracellular killing in vitro, is expressed by a small 
percentage of isolates; the majority of isolates do not produce mucoid colonies indicative of 
capsule presence, thus the capsule is not believed to be an essential virulence factor. 
Furthermore, hasA or C gene deletion mutants (encoding capsule producing ability), although 
less resistant to phagocytosis by bovine neutrophils (Ward et al., 2001), are nevertheless 
pathogenic following entry into the mammary gland. In a study by Leigh (2003) it was shown 
that the hasABC gene is the only gene required for capsule production. One study found that 
a capsular strain of S. uberis (0140J) was more capable of establishing an infection in the 
lactating gland than a noncapsular strain (EF20) (Leigh, 2003). These two strains differed in 
their ability to resist uptake and killing by neutrophils in vitro however; both organisms were 
equally able to resist uptake and killing by neutrophils in vivo (Leigh et al., 2004). This was 
explained by the ability of S. uberis to inhibit neutrophil function by the release of an effector 
molecule on cultivation in bovine milk (Leigh and Field, 1994). Pullinger et al. (2006) 
showed that capsulated bacteria isolated from New Zealand and the United Kingdom, were 
mainly associated with subclinical mastitis while, for isolates from Denmark, carrying hasA 
correlated with clinical mastitis. The role of capsule in the pathogenesis of mastitis due to S. 
uberis therefore is still a mystery in spite of extensive research in this area.  
Other potential virulence factors have been described that enhance attachment to 
bovine mammary gland tissues facilitating the pathogen to avoid the immune response and 
persist in the bovine gland (Almeida et al., 2006). Potential virulence factors include 
hyaluronidase, a 28 - kDa S. uberis factor similar to the CAMP factor of S. agalactiae, an 
adhesion specific for cubic mammary gland cells (Jiang et al., 1996), the plasminogen 
activator, PauA (Rosey et al., 1999), and the manganese scavenger lipoprotein, MtuA. 
Activation of plasmin, in addition to its importance in the generation of essential amino acids 
from casein, also may uncover target sites for adhesions expressed on the bacterial surface A 
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novel adhesion molecule, SUAM (112 kDa), with Lf binding abilities, is proposed to 
contribute to attachment to cells by serving as a bridge between epithelial receptors and the 
bacterium. The SUAM protein has an affinity for Lf and is involved in the adherence of S. 
uberis to a bovine mammary epithelial cell line in vitro and therefore may be important 
during the initial stages of infection and colonisation (Ward et al., 2009). Antibodies to this 
protein inhibit bacterial attachment and internalization. Similar molecules have been reported 
on other streptococcal mastitis pathogens. Certain strains of S. uberis have the ability to 
attach to extra-cellular matrix and to host cell surface in the presence of fibronectin (Almeida 
et al., 2006; Almeida et al., 2011). S. uberis also has the ability to enter and survive within 
mammary epithelial cells for extended periods (Oliver et al., 1998). 
The previous discussion indicates that the pathogenic mechanisms and virulence 
factors of S. uberis are poorly understood; however there is evidence that some multilocus 
sequence typing (MLST) types are associated with clinical infection while others behave 
mainly as low cell count (Tomita et al., 2008). Subtractive hybridization has been 
successfully used for the identification of genomic differences including possible virulence 
factors, between closely related strains of several microorganisms, for instance C. jejuni 
(Hepworth et al., 2007), Bacillus cereus (Sergeev, 2006) and Burkholderia pseudomallei 
(Brown et al., 2000). Subtractive hybridization for virulence factor evaluation is based on the 
assumption that if a certain gene sequence is only present in isolates associated with disease 
and absent in non-disease isolates, it is most likely that the gene sequence may represents a 
virulence factor (Brown et al., 2000). Microarray technology has recently shown increased 
importance and potential in rapidly determining a genetic profile in pathogenic bacteria. 
Microarray technology has also been used for simple and efficient genotyping of many 
organisms or their genes such as Listeria spp, S. aureus enterotoxin genes, and Clostridium 
perfringens toxin genes in a single hybridization experiment (Myers, 2006). Microarrays can 
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be used to analyse many samples simultaneously. This method is an efficient and valuable 
tool for identification and characterization of bacterial pathogenic microorganisms and other 
bacteria (Sergeev, 2006). A recent study identified gene differences between S. uberis strains, 
using oligonucleotide microarray (Lang et al., 2009).  More recently, Egan et al. (2012) 
analysied and identified transcriptional differences in gene expression in a wild type strain of 
S. uberis and its mutant lacking the gene, Vru. They found that Vru coordinates the 
expression of putative virulence-associated genes in S. uberis and affects the ability of to 
cause mastitis.   
1.8 Biofilms 
Bovine mastitis organisms are generally susceptible to antibacterial agents used to 
treat or prevent mastitis; however treatment of recurrent mastitis is very difficult. One 
possible reason for failure to respond to treatment is the capability of bacteria to produce 
biofilms (Melchior et al., 2006).  
In general, micro-organisms are studied as broth cultures. Research based on broth 
studies has produced significant information on the behavioural characteristics of micro-
organisms. Broth cultures, which allow organisms to be free flowing agents, have been 
regarded as representing the dominant environment (physical and chemical) in which 
organisms reside. Consequently, bacterial trends observed in broth cultures were viewed as 
characterising an organism’s growth and behavioural patterns (Oosthuizen et al., 2002). 
Over a number of years, the thought has been growing that the free-flowing 
environment is only a ‘means to an end’; the end being the biofilm. Cells residing in biofilms 
are referred to as sessile cells, there has been a paradigm shift in scientific thinking that 
suggests that the main environment for micro-organisms is the biofilm, and consequently they 
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live as sessile cells. For most organisms the free flowing environment (the broth), and 
consequently the planktonic cell, is only a means of allowing the organisms to move from 
one biofilm to another (Parsek and Fuqua, 2004). 
The question has to be asked as to why would organisms form biofilms at all. What 
is the advantage to the organism in a biofilm environment? Various authors have suggested 
possible reasons for biofilm formation and these reasons range from a means of increasing 
antimicrobial resistance (Dodds et al., 2000), improving chances of survival in a nutrient-
limited environment (Parsek and Fuqua, 2004) to the concept that organisms within the 
biofilm form a community and can signal one another, referred to as quorum sensing, and 
thus gain the benefits of a multi-cellular organism (Waters and Bassler, 2005). 
Biofilms are defined as a community of micro-organisms attached to a surface, 
producing extracellular polymeric substances (EPS) and interacting with each other (Lindsay 
and Holly, 2006). How biofilms are formed is generally accepted as being a 3 to 4 stage event 
involving: (Kumar and Anand, 1998; Zottola and Sasahara, 1994) (Fig. 1-2):  
 
(i) The formation of a conditioned surface which involves the coating of a surface 
with organic molecules with which bacteria may interact. This step may not 
be necessary if the biofilm is to be formed on an organic surface such as 
epithelium.  
(ii) Reversible bacterial attachment to the surface through weak interactions such 
as Van der Wals or hydrophobic interactions. A hydrophilic surface results 
from the presence of lipopolysacchride (LPS) of Gram-negative bacteria, 
whereas lipoteichoic acid of the Gram-positive bacteria extends from the cell 
externally, leading to a hydrophobic surface.  
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(iii) Irreversible bacterial attachment to the surface which requires specific 
interactions between macromolecules on the bacterial surface such as surface 
proteins, carbohydrates, and pili or fimbriate with material on the 
conditioned surface. 
(iv) The final stage in biofilm establishment is a combination of colonization and 
growth of micro-organisms. The colonisation of a surface by one bacterial 
genus often affects attachment of other genera to the same surface. Then 
detachment occurs when biofilm cells present in outer surface of biofilm are 
released into the environment, back to planktonic stage and attach to another 
surface for a new biofilm cycle (Lindsay and Holly, 2006). 
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Fig. 1-2. Biofilm formation and maturation: attachment of planktonic bacteria, cellular 
aggregation, clumping and exopolysaccharide production, mature biofilm with detachment of 
planktonic cells (modified from Melchior et al., 2006). 
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There is considerable evidence that the two forms (planktonic and biofilm) are not 
identical. For example, Costerton et al. (1995) showed biofilm bacteria can be physically and 
morphologically different from their planktonic counterparts. Furthermore, Trachoo (2003) 
stated that biofilm bacteria are up to 500 times more resistant to antimicrobial agents than 
their planktonic counterparts. Another factor that makes this area of research important is that 
biofilm formation is very widespread and affects a very wide range of health and industrial 
environments. Biofilm formation is associated with problems in areas as diverse as cystic 
fibrosis (Costerton et al., 1999), dental caries (Parsek and Fuqua, 2004) and corrosion 
(Sreekumari et al., 2000). Biofilm formation in food processing has been associated with 
increased cost of cleaning (Criado et al., 1994), reduced processing efficiency (Wong, 1998.), 
decrease in product shelf-life (Criado et al., 1994) and most importantly, food safety (Zottola 
and Sasahara, 1994).  
Biofilms cause considerable problems in the food processing industry. Since 1994, 
there have been some 20 articles examining biofilms associated with the dairy / milk industry. 
These studies have, for example focused on effective cleaning (Reinemann, 2002), including 
the removal of B. stearothermophilus (Parkar et al., 2004), and characterisation of organisms 
surviving cleaning (Bore and Langsrud, 2005) in a Norwegian dairy plant. However, the 
specific issues stated in the research objectives and questions were not reported. The 
relationship between pathogens and background microflora in biofilm formation of any 
relevance to the dairy industry has been examined to a limited extent with the study by 
Carpentier and Chassaing (2004). Yet enhancement / inhibition of pathogens residing in 
biofilms by background microflora could affect the approach taken to monitoring and 
eradicating these biofilms in a dairy environment. In a similar way, there is some but limited 
information on the effect of dairy proteins, as conditioning film, on biofilm formation (Al-
Makhlafi et al., 1995; Barnes et al., 1999; Wong, 1998). From studies on the effect of 
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processing parameters and nutrient content on biofilm formation, it will be possible to 
identify conditions that enhance / inhibit biofilm formation within a dairy processing 
environment.  
Many microbial pathogens use biofilm formation as a means to meet their 
requirements.  To generate clinical mastitis, the bovine mastitis bacteria must resist the host 
defence mechanisms, specifically antibacterial action of phagocytic cells existing in the 
mammary gland secretions. Residing within biofilm could be one way of achieving these 
requirements (Hodgkinson et al., 2007). There have been a few studies that examined biofilm 
production of S. uberis bovine mastitis. S. uberis strains that do not produce a protective 
capsule; are capable of using host factors such as; fibrinogen, Lf, collagen, and 
glycosaminoglycans for adherence to host cells (Almeida et al., 1999, 2006; Almeida and 
Oliver 2001; Fang et al., 2000; Patel et al., 2009). Since adhesion is a prerequisite for biofilm 
formation, these factors could be useful in establishing biofilms. A recent in vitro study has 
shown that alpha and beta-casein enhances biofilm formation of S. uberis in a biofilm assay 
(Varhimo et al., 2011). As a consequence, further studies are needed for more understanding 
of the possible role of biofilms in the pathogensis of bovine mastitis due to S. uberis.  
1.9 Lactoferrin-binding proteins 
The mammary gland is capable of reacting against bacterial invasion through a 
complex network of specific and nonspecific defence mechanisms (Sordillo and Streicher, 
2002). Nonspecific mechanisms are characterised by the recognition of structural motives 
that are common to many pathogenic bacteria such as peptidoglycan, LPS, and lipoteichoic 
acid. These defence mechanisms are predominant during the early stages of infection and 
consist of anatomical, cellular, and soluble factors that act in a tightly coordinated fashion 
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(Chaneton et al., 2008). Soluble factors involved in innate immunity are mainly peptides and 
proteins including, among others, lysozyme, lactoperoxidase, and Lf. 
Bovine Lf is a 92.l-kDa, acute phase, iron-binding protein occurring in milk, 
various biological secretions, and PMNs (Naidu et al., 1991). Lf concentrations vary in the 
range of 0.1 to 0.3, 2 to 5, and 20 to 30 mg/ml in normal milk, colostrum, and during 
glandular involution, respectively, depending on the physiologic status of the bovine 
mammary gland (Smith et al., 1985). During acute bovine mastitis, Lf concentration in the 
lacteal secretions increases up to 30-fold, corresponding to the severity of infection. The 
biological role of Lf includes the amplification of the inflammatory response by promoting 
the adhesion and aggregation of PMNs to the endothelial surface. Lf stimulates the 
phagocytic and cytotoxic property of macrophages and regulates myelopoiesis by causing a 
feedback inhibition of granulocyte-monocyte colony-stimulating factor (Naidu et al., 1991). 
Due to the role of iron as a prosthetic group in key proteins including 
ribonucleotide reductase, oxidases, cytochromes, and catalases, it is required by most 
pathogenic bacteria (Yu and Schryvers, 2002). Iron is present in oxygenated haemoglobin 
within the intracellular compartment or stored as ferritin. Free extracellular iron is bound by 
the iron binding proteins, transferrin (Tf) and Lf, thus the available aqueous iron in tissues is 
significantly reduced to below the requirement for bacterial growth (Chaneton et al., 2008). 
Streptococci, including S. uberis, are resistant to the antimicrobial action of Lf, because 
streptococci do not require a high level of iron (Oliver, 1999).  
Lactoferrin reduces cellular multiplication of a clonal bovine mammary epithelial 
cell line (MAC-T) (Fang et al., 2000), and binds to MAC-T cells and their crude cellular 
membranes (Fang and Oliver, 1999). It has been reported that Lf may directly kill certain 
bacteria or may lessen bacterial resistance to host defence by attachment to the bacterial 
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surface (Kawai et al., 1999). Lf in milk seems to play a key role in the defence mechanisms 
in the bovine mammary gland of dairy cows; however, the influence of Lf in preventing 
mastitis has not yet been fully studied (Moshynskyy et al., 2003; Patel et al., 2009). 
The effect of Lf on S. uberis attachment to bovine mammary gland tissues has been 
determined recently (Almeida et al., 2010; Fang et al., 2000). The authors found that Lf may 
play a bridging molecule role between the host cell and Lf-binding proteins on the surface of 
S. uberis, and enhance S. uberis attachment to the epithelial cells. Thus, although S. uberis is 
resistant to its antimicrobial action, Lf may contribute to adherence of S. uberis to mammary 
gland tissue.   
1.10 Techniques for subtyping S. uberis 
Bacterial subtyping is useful for a number of epidemiological and infection control 
purposes including tracking the spread of strains of interest, determining isolates involved in 
outbreaks, monitoring trends in endemic isolates, and source tracking. Earlier techniques for 
subtyping S. uberis were phenotypic and biochemical in nature but many of these have been 
replaced with genomic techniques that have higher discriminatory power. One of the earliest, 
DNA-based methods, ‘ribotyping’, is a method used to compare both the size and the number 
of DNA fragments by conventional electrophoresis after the genomic DNA is cut by frequent 
cutting endonucleases, followed by hybridisation with DNA from E. coli. The limitation of 
this method is its high requirement of labour (Zarrilli et al., 2005); although rapid automated 
methods are now available. Although a randomly amplified polymorphic DNA (RAPD) assay 
provides discrete DNA fingerprint patterns for S. uberis isolates, it is very difficult to 
standardize and agarose gels are difficult to compare, leading to making interpreting complex 
patterns difficult (Zadoks et al., 2003 and Gillespie et al., 1998). Pulsed field gel 
electrophoresis (PFGE) has been used extensively to study S. uberis epidemiology. This 
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method is based on cleaving the bacterial DNA with an infrequent cutting restriction 
endonuclease (mainly Sma1), and then the fragments are separated by electrophoresis. 
Because of its high discrimination and reproducibility, PFGE has been regarded as the gold 
standard method for typing S. uberis (Baseggio et al., 1997; Douglas et al., 2000; Gillespie et 
al., 1998; Khan et al., 2003; Phuektes et al., 2001; Rato et al., 2008; Wang et al., 1999).  
Multilocus sequence typing (MLST) is useful for biogenetic studies and provides 
sequence data which could contribute in prediction of evolutionary development. Isolates of 
S. uberis vary in MLST and in PFGE type between and within infected herds, although 
persisting infections in individual cows are usually caused by a single genotype (Pullinger et 
al., 2007; Zadoks et al., 2005b). Unlike ribotyping, PFGE and RAPD, MLST does not rely on 
the use of agarose gels; thereby reproducibility problems due to gel-to-gel variation are 
eliminated. Zadoks et al. (2005b) developed the initial MLST scheme for S. uberis typing but 
used virulence genes (which show variability) as well as housekeeping genes. The latter are 
more highly conserved. An MLST scheme has also been designed by Coffey et al. (2006) 
however they found that inclusion of virulence genes rendered the method unsuitable for the 
analysis of population structure and evolutionary relationships. Those two schemes led to 
high level of strain discrimination which related to the epidemiological origin of isolates. 
However, it has been noted that isolates with the same MLST type behaved differently in an 
infection model, indicating possible genetic differences, undetected by MLST but affecting 
the phenotype. This might be related to the fact that MLST focuses just on the core genome, 
not the accessory genes involved in virulence (Turner and Feil, 2007). Thus limitations of 
MLST could be its suitability only for understanding global epidemiology not for short-term 
epidemiological studies (Enright and Spratt, 1999). Also the sequencing of multiple PCR 
products for typing every single isolate makes MLST expensive (Gilbert et al., 2006) and 
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therefore this assay does not lend itself to large high-throughput S. uberis epidemiology 
studies.  
PFGE has significant advantages over the other methods. First, it takes advantage 
of its high discriminatory power. Second, PFGE provides patterns consistent within and 
between laboratories. Third, PFGE generally yields a high amount of pattern diversity. 
Another advantage of PFGE is that it is easily applied to different species (Vimont et al., 
2008). Consequently, it has been widely used and was therefore chosen for this study. 
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1.11 Specific objectives 
The experimental design of this study is outlined in the following specific aims 
with hypotheses: 
1. To investigate the molecular epidemiology of S. uberis in bovine mastitis, in 
particular isolates from cows with clinical mastitis, using PFGE. 
 
 To determine whether recurrent clinical mastitis is caused by 
the same strain or different strains of S. uberis. 
 
2. To investigate the ability of S. uberis to form biofilm using microtiter plate assay: 
 To examine the role of factors that might contribute to biofilm 
production by S. uberis.  
 To examine milk and milk components and their roles in 
enhancement of biofilm formation by S. uberis.  
 
 To establish whether there is interdependence between 
organisms present in milk to form biofilms. Particularly, to 
establish whether biofilm formation by selected S. uberis 
isolates is affected by the background microflora of milk. 
 
3. To investigate whether there were any differences in putative virulence factor genes 
between isolates of S. uberis from cows with clinical mastitis and those from 
cases of low cell counts in their milk. 
 
 To identify novel virulence-associated genes of S. uberis by 
subtractive hybridization followed by microarray technology. 
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1.12 Justification and specific objectives 
Controlling the bovine mastitis pathogen S. uberis requires sensitive and 
epidemiologically meaningful subtyping methods which provide a vision into this pathogen’s 
epidemiology and evolution (Zadoks et al., 2005a). PFGE procedures are used to examine S. 
uberis isolates and to investigate any cow-to-cow transmission and recurrent infections.  
Biofilms are ubiquitous and are of great importance in disease. If biofilm forms on 
the surface of microtitre plates, it may also form on mammary gland epithelial cells during S. 
uberis infection, and this may contribute to the development of recurrent mastitis. 
Determining the factors affecting biofilm formation of S. uberis may have significant 
implications in veterinary medicine and industrial processes.     
Microarray technology combined with subtractive hybridization enables us to 
detect genes present in isolates from clinical mastitis cases but absent in presumed low cell 
counts. Knowledge of the genes expressed by isolates from cows with clinical mastitis may 
contribute to the development of vaccines against S. uberis.    
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1.13 Importance of this research 
The knowledge gained from this project will have both scientific and commercial 
benefits. Commercial and environmental advantages of this project include identification of 
strains that cause persistent infection or produce biofilm. This information will allow 
veterinarians to more effectively monitor and target these organisms.  
Successful vaccine for S. uberis mastitis should be capable of causing an immune 
response to natural infection which protects, eliminates or efficiently controls the subsequent 
infection without stimulating a marked inflammatory response. This work may contribute to 
vaccine development by identifying bacterial capabilities and molecules which have an 
important role in the establishment of infection and to induce an inhibitory immune response. 
Scientific contribution of this project: 
(i) Identification of strains associated with recurrent clinical mastitis and 
biofilm formation as well as the virulence factors of S. uberis will contribute 
to the scientific body of knowledge.  
(ii) The possibility of using the scientific information derived from (i) to 
examine effective ways of eliminating these biofilm-forming strains from 
mammary gland cells surfaces, should biofilm formation prove to be 
important in vivo.  
(iii) An extension in our understanding of the virulence factors, including the 
possible role of biofilm in the pathogenesis of mastitis. This in turn could 
help our understanding of the epidemiology of recurrent infections. This 
information can also be usefully targeted at identification of candidates for 
inclusion in effective vaccines.                                 
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Chapter 2: Materials and Chemicals 
 
2.1 Materials                                                                 Manufacturers 
Adaptor 1 and Adaptor 2R                                          Clontech Laboratories, Inc., Mountain 
                                                                                      View, CA, USA 
Adhesive PCR film                                                       Thermo Fisher Scientific, Scoresby, VIC,  
                                                                                      AU                           
Agar No.1                                                                     Oxoid Ltd., Basingstoke, UK 
 
Agarose (Molecular biology grade)                              Bioline, Alexandra, NSW, AU 
 
Ampicillin                                                                     Sigma-Aldrich Co., St. Louis, MO, USA 
 
Biotin DecaLabel™ DNA Labelling                Quantum Scientific, Murarrie, QLD, AU 
Kit            
Boric acid                                                                      Sigma-Aldrich Co., St. Louis, MO, US 
 
Bovine serum albumin (BSA)                                       Sigma-Aldrich Co., St. Louis, MO, USA 
 
Brain heart infusion (BHI)                                            Oxoid Ltd., Basingstoke, Hampshire, UK 
 
Buffer EB                                                                      QIAGEN, Hilden, Germany 
 
Buffer PB                                                                      QIAGEN, Hilden, Germany 
 
Buffer PE                                                                      QIAGEN, Hilden, Germany 
 
Corning® GAPS II coated slide                                   Corning Incorporated, Lowell, MA, USA                     
CY3-Streptavidin                                                          Crown Scientific, Minto, NSW, AU 
Deoxynucleotide triphosphate                                      Promega, Madison, WI, USA 
(dNTP)     
Dilution buffer                                                              Clontech Laboratories, Inc., Mountain  
                                                                                      View, CA, USA 
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DNeasy
®
 Blood & Tissue Mini Kit                              QIAGEN, Hilden, Germany 
 
Edward’s agar                                                               Oxoid Ltd., Basingstoke, UK 
 
Ethidium bromide                                                         BDH. Laboratory Supplies, Poole, UK 
 
Ethylenediaminetetraacetic acid                                   Sigma-Aldrich Co., St. Louis, MO, USA 
  (EDTA)  
Ethanol                                                                          BDH. Laboratory Supplies, Poole, UK 
 
Full cream milk                                                             Pasteurised milk obtained from a           
                                                                                      Supermarket, VIC, AU 
Glycerol                                                                         Research Organics, Cleveland, Ohio, USA 
 
Human Cot-1DNA                                                        Invitrogen, Carlsbad, CA, USA 
 
Humidified hybridization chamber                               Corning Incorporated, Lowell, MA, USA 
 
Hybridization buffer (4×)                                             Clontech Laboratories, Inc., Mountain  
                                                                                       View, CA, USA 
Isopropanol                                                                    Sigma-Aldrich Co., St. Louis, MO, USA 
 
IPTG                                                                              Bioline, Alexandra, NSW, AU 
 
Lactoferrin from bovine milk                                        Sigma Genosys, Castle Hill NSW, AU 
Lambda Ladder PFG Marker                                        New England Biolabs, Beverly, MA, USA 
 
Lifter slips                                                                      Thermo Fisher Scientific, Scoresby,  
                                                                                       VIC, AU 
Ligation buffer (5 X)                                                     Clontech Laboratories, Inc., Mountain  
                                                                                       View, CA, USA 
Low melting point, molecular                                        Progen Industries, Darra, AU 
biology grade  
Lysozyme                                                                       Boehringer, Mannheim, Germany 
 
MassRuler™ DNA Ladder,                                           Fermentas, Hanover, MD, USA     
Low Range MBI  
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MassRuler™ DNA Loading                                          Fermentas, Hanover, MD, USA 
Dye (6 x) MBI  
Magnesium chloride (MgCl2)                                         QIAGEN, Hilden, Germany 
 
Microplate, 96 Well Clear V-Bottom,                            Corning Incorporated, Lowell, MA, USA                   
tissue culture treated 
Microplate, 96 Well Flat bottom,                                    Iwaki, Tokyo, Japan 
tissue culture treated                               
Molecular grade water                                                    Sigma-Aldrich Co., St. Louis, MO, USA 
Nested PCR primer1 and                                            Clontech Laboratories, Inc., Mountain        
primer 2R                                                                        View, CA, USA   
Nuclei lysis solution                                                       Promega, Madison, WI, US 
PCR-Select™ Bacterial                                             Clontech Laboratories, Inc., Mountain     
Genome Subtraction Kit                                                 View, CA, USA              
PCR buffer (10 x)                                                           QIAGEN, Hilden, Germany 
PCR plate-96 well                                                           Thermo Fisher Scientific, Scoresby,  
                                                                                         VIC, AU 
PCR reaction tubes (0.5 ml)                                            ABgene, Epsom, UK 
PCR tube, thermo tubes (0.2ml)                                      ABgene, Epsom, UK 
PGEM-T Easy Vector                                                     Promega, Madison, WI, USA 
Phenylmethylsulfonylflouride                                         Sigma-Aldrich Co., St. Louis, MO, US             
(PMSF)                 
Plug mould                                                                      Bio-Rad Laboratories, Hercules, CA, USA 
Primers (S. uberis species-specific PCRs)                      Sigma Genosys, Castle Hill NSW, AU 
Primer1                                                                            Clontech Laboratories, Inc., Mountain  
                                                                                         View, CA,   USA 
Proteinase K                                                                    Sigma-Aldrich Co., St. Louis, MO, US 
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Protein precipitation solution                                          Promega, Madison, WI, USA 
QIAquick column                                                           QIAGEN, Hilden, Germany 
QIAquick Gel Extraction Kit                                         QIAGEN, Hilden, Germany 
QIAquick PCR Purification Kit                                     QIAGEN, Hilden, Germany 
Raw milk                                                                         Unpasteurised milk obtained a health                     
                                                                               store, VIC, AU 
Restriction enzyme, Rsa I                                               Promega, Madison, WI, USA  
Restriction enzyme, Sma I MBI                                      Fermentas, Hanover, MD, USA 
Restriction enzyme buffer C                                           Promega, Madison, WI, USA 
Restriction buffer, Tango buffer                                     Fermentas, Hanover, MD, USA 
(10 x) MBI  
RNAse solution                                                               Promega, Madison, WI, USA 
Salmon sperm DNA                                                        Sigma-Aldrich Co., St. Louis, MO, USA 
Sarkosyl (N-Lauroylsarcosine)                                        Sigma-Aldrich Co., St. Louis, MO, USA 
Skim milk                                           Pasteurised milk obtained from a           
                                                                                         Supermarket, VIC, AU 
Sheep blood                                                                     Oxoid Ltd., Basingstoke, UK 
Sodium acetate                                                                Sigma Chemical Co., St. Louis., Mo., USA 
Sodium chloride (NaCl)                                                  Fluka Chemical Corp., Ronkonkoma, NY,   
                                                                                         USA 
Sodium citric acid                                                           BDH. Laboratory Supplies, Poole, UK 
Sodium dodecylsulphate (SDS)                                      BDH. Laboratory Supplies, Poole, UK                     
Sodium deoxycholate                                                      BDH. Laboratory Supplies, Poole, UK 
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Sodium hydroxide (NaOH)                                            BDH. Laboratory Supplies, Poole, UK 
Taq DNA polymerase                                                     QIAGEN, Hilden, Germany 
T4 DNA ligase                                                                Clontech Laboratories, Inc., Mountain 
                                                                                         View, CA, USA 
Todd-Hewitt broth (THB)                                               Oxoid Ltd., Basingstoke, UK 
Tris HCl                                                                           Progen, Darra, QLD, AU 
Trizma
®
 Base                                                                   Sigma-Aldrich Co., St. Louis, MO,     
                                                                                         USA 
Wizard
®
 Genomic DNA Purification                             Promega, Madison, WI, USA             
Kit            
X-Gal                                                                               Bioline, Alexandra, NSW, AU  
2.2 Equipment                                                                         Manufacturers 
 
BioRobotics
®
 MicroGrid II                                             Genomics Solutions, Ann Arbor, MI 
Compact arrayer 
CHEF DR-II chamber                                                     Bio-Rad, Hercules, CA, USA 
ELISA plate reader, Wallac VICTOR 3                         PerkinElmer, Waltham, USA 
Eppendof biophotometer                                                Barkhausenweg, Hamburg, Germany 
Filter, 0.2 μm syringe filter “Acrodisc”                          Gelman Science, Ann Arbor, MI, USA 
Filter, 0.45 μm syringe filter “Acrodisc”                        Gelman Science, Ann Arbor, MI, USA 
Gel Doc 2000 imaging system                                        Bio-Rad, Hercules, CA, USA 
Hybaid PCR Express thermocycler                                 Hybaid Ltd., Teddington, UK 
Hybaid Shake 'n' Stack Hybridization                            Hybaid Ltd., Teddington, UK 
Oven  
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Microcentrifuge (5415C)                                                 Eppendorf, Hamburg, Germany 
Power PAC, POWER PAC 300                                     Bio-Rad, Hercules, CA, USA 
ScanArray Gx                                                                  PerkinElmer Life and Analytical  
                                                                                         Sciences, Downers Grove, IL 
Submerged horizontal electrophoresis                            Bio-Rad, Hercules, CA, USA 
 
 
2.3 Chemicals 
2.3.1 General chemicals 
DNA rehydration solution: 10 mM Tris-HCl (pH 7.4), 1 mM EDTA (pH 8.0) 
Lysozyme: (6 μg/μl) 
NaOH/SDS: 0.2 M NaOH, 1% (w/v) SDS 
Potassium acetate solution: 3 M potassium acetate, 2 M glacial acetic acid 
Tris EDTA (TE) buffer: 10 mM Tris-HCl (pH 7.6), 1 mM EDTA (pH 8.0) 
Tris-acetate-EDTA (TAE) buffer pH 8.3: 40 mM Tris acetate, 1 mM EDTA 
2.3.2 Chemicals for PFGE 
2.3.2.1 ESP buffer (10mL, for 10-15 samples):  
Premixed ESP buffer (9 mL)                                                    final concentration 
5 mL of 1 M EDTA (pH 8.6)                                                             0.5 M   
1 mL of 10% N-lauroylsarcosine                                                         1% 
3 mL of ddH2O 
1 mL of Proteinase K (10 mg/mL)                                                   1 mg/mL 
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Final volume was10 mL, however 1 mL of Proteinase K (10 mg/mL) was added prior to the 
assay.  
2.3.2.2 Lysis buffer (10 mL, for 10-15 samples):  
The buffer was prepared by combining the following ingredients: 
Premixed lysis buffer (9 mL)                                                    final concentration 
0.06 mL of 1 M Tris-HCl (pH 7.6)                                                      6 mM 
1 mL of 1 M EDTA (pH 7.6)                                                              0.1 M 
5 mL of 2 M NaCl                                                                                 1 M 
1 mL of 2% sodium deoxycholate                                                        0.2% 
0.5 mL of 10% sodium lauroylsarcosine                                              0.5% 
1.5 mL of ddH2O 
1 ml of lysozyme (10 mg/ml)                                                            1 mg/ml 
9 mL of lysis buffer was kept in – 20oC until use, and 1 mL of lysozyme (10 mg/mL) was 
added to the buffer prior use. 
2.3.2.3 Pett IV buffer:  
1 litre of this buffer was prepared as follows                                                 final concentration 
10 mL of 1 M Tris-HCl (pH 7.6),                                                                            10 mM 
500 mL of 2 M NaCl                                                                                                 1 M 
490 mL of ddH2O 
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2.3.2.4 5× TBE buffer (pH 8.3): 
1 litre of this buffer was prepared as follows                                                final concentration 
54 g of tris base                                                                                                     0.445 M 
27.5 g of boric acid                                                                                               0.445 M 
 25 mL of 0.5 M EDTA                                                                                       12.5 mM 
The ddH2O was added up to 1 litre. 
2.3.2.5 1mM of PMSF (0.175 mg/mL): 
0.0175 g of PMSF was dispensed and placed in a bottle. 1 mL of isopropanol was 
added to dissolve PMSF completely. Then 100 mL of TE buffer was added. The 
concentration of PMSF varies between workers; the concentration used for this study was 
1mM PMSF (0.175mg/mL). 
2.3.3 Chemicals for subtractive hybridization and microarray  
2.3.3.1 Denaturation solution: 
0.5 M NaOH and 1.5 M NaCl were added and mixed. 
2.3.3.2 20× saline sodium phosphate EDTA (SSPE) buffer (pH 7.4): 
The buffer was prepared as follows: 
NaCl                                                                              175.3 g 
NaH2PO4.2H2O                                                              27.6 g 
EDTA                                                                                7.4 g 
MilliQ H2O was added up to                                        1000 mL 
The ingredients were well mixed and sterilised by autoclaving.  
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2.3.3.3 20× standard saline citrate (SSC) buffer (pH 7.0):  
The following was dissolved in 750 mL sterile water: 
Sodium chloride                                                             175.3 g 
Sodium citrate                                                                  88.2 g 
MilliQ H2O was added up to                                       1000 mL 
The solution was well mixed and sterilised by autoclaving. 
2.3.3.4 6× SSPE-T buffer: 
20× SSPE                                                                       300 mL 
100× Triton                                                                    0.05 mL 
Sterile MilliQ H2O was added up to                             1000 mL 
2.3.3.5 Pre- hybridization buffer: 
25% 20 x SSC, 50% MilliQ H2O, 0.1% BSA, 0.1% (w/v) SDS, and 25% 
formamide was mixed in a falcon tube and filter sterilised.  
2.3.3.6 2× Hybridization buffer:  
The buffer was prepared fresh: 500 µL formamide, 250 µL 20 x SCC, 250 µL 
MilliQ H2O, and 20 µL 10% SDS. 
2.3.3.7 Detection solution:  
In an Eppendorf tube the following was added and well mixed: 6 x SSPE-T, 0.5% 
BSA, and 0.3% Cy3.  
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2.3.3.8 Neutralization solution (pH 7.5):  
0.5 M Tris and 3 M NaCl were added and mixed. 
2.4 Growth media used in this research 
2.4.1 Todd-Hewitt Broth (THB) 
Cultivation of the bacteria in fluid media was performed in Todd-Hewitt broth. The 
composition of the media was as follows: 
Tryptone                                                                                                  20.0 g 
Infusion from 450 g fat-free minced meat                                              10.0 g 
Sodium bicarbonate                                                                                  2.0 g 
Sodium chloride                                                                                        2.0 g 
Disodium phosphate                                                                                  0.4 g 
Glucose                                                                                                      2.0 g 
Distilled water                                                                                       1000 mL 
pH 7.8 ± 0.2 
 
The media was prepared according to the manufacturer’s instructions; incubation of the 
bacteria was carried out for 18-24 h at 37°C under aerobic conditions with or without using a 
shaker. 
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2.4.2 Brain heart infusion (BHI) broth / agar 
Cultivation of the bacteria in agar was performed in brain heart infusion agar. The 
basic ingredients were as follows: 
Brain, heart extract and peptone                                                      27.5 g (Nutrient substrate) 
Glucose                                                                                               2.0 g 
Sodium chloride                                                                                  5.0 g 
Disodium hydrogen phosphate                                                           2.5 g 
Distilled water                                                                               1000 mL 
pH 6.8 ± 0.2 at 25°C 
This medium was prepared according to the manufacturer’s instructions. The broth was 
mixed with 1% agar then autoclaved. 
2.4.3 Sheep blood agar (SBA) 
Columbia agar base was autoclaved (15 min at 121°C) and cooled at approximately 
50°C. Finally 5% aseptically collected sheep blood was added and gently mixed. The plates 
were poured and kept at 4°C until used. 
2.4.4 Luria Bertoli (LB) agar with ampicillin 
The composition of the media was as follows: 
Tryptone                                                                                                10.0 g 
Yeast extract                                                                                            5.0 g 
Sodium chloride                                                                                      5.0 g 
Agar No.1                                                                                              10.0 g 
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Distilled water                                                                                       1000 mL 
pH 7.0  
The medium was sterilized by autoclaving at 121°C for 15 min. Following cooling to 50°C, 
ampicillin was filter-sterilized before adding to the agar at the final concentration of 100 μg 
/mL. 
2.4.5 Luria Bertoli (LB) broth with ampicillin 
The composition of the media was as follows: 
Tryptone                                                                                                10.0 g 
Yeast extract                                                                                            5.0 g 
Sodium chloride                                                                                      5.0 g 
Distilled water                                                                                       1000 mL 
pH 7.0  
The broth was sterilized by autoclaving at 121°C for 15 min. Following cooling to 50°C, 
ampicillin was filter-sterilized and adding to the broth at the final concentration of 100 μg 
/mL. 
2.4.6 SOC Medium 
The composition of the media was as follows: 
Tryptone                                                                                                    2.0 g 
Yeast extract                                                                                              0.5 g 
Sodium bicarbonate                                                                                   2.0 g 
1M NaCl                                                                                                  1.0 mL 
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1M KCl                                                                                                  0.25 mL 
2M Glucose, filter-sterilized                                                                    1.0 mL 
Sterile distilled water                                                                             1000 mL 
pH 6.8 ± 0.2 at 25
o
C 
According to the manufacturer’s instructions tryptone, yeast extract, NaCl and KCl were 
added to 97 mL distilled water. The mixture was properly mixed with a magnetic stirrer to 
dissolve, then autoclaved and cooled to room temperature. Then 2 M Mg
2+
 stock and 2 M 
glucose added, each to a final concentration of 20 mM.  
2 M Mg
2+
 stock 
20.33 g MgCl2.6H2O 
24.65 g MgSO4.7H2O 
The distilled water then was added to 100 mL before filter-sterilized.  
2.5 Milk samples and bacterial isolates 
2.5.1 Collection of milk samples 
For PFGE analysis, bovine quarter milk samples from dairy cows with clinical 
mastitis previously obtained from six different farms in Gippsland Victoria, Australia during 
field research and veterinary investigation were used (Runciman et al., 2010). The milk 
samples were frozen and sent to RMIT University, when they arrived, still in a frozen state. S. 
uberis was isolated as described below. Isolates were stored at -80
o
C as a part of the 
microbiology research laboratory culture collection.  
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For the biofilm assays and microarray analysis, frozen samples (-80 
o
C) that had 
previously been analysed by MLST (Tomita et al., 2008) were used. These isolates were 
collected in 2007 and earlier from cows with clinical mastitis, sub clinical, recurrent clinical 
mastitis and from cows with low milk cells counts. 
2.5.2 Bacterial strains used as a control in biofilm study 
Two ATCC strains were used as controls: biofilm-positive control strain was S. 
epidermidis ATCC 35984 (RP62a) and S. hominis ATCC 3598 (SP2) was used as biofilm-
negative control strain. 
2.5.3 Streptococcus uberis isolation 
All isolates were originally isolated from milk for other studies as follows: Milk 
samples were cultured immediately on arrival at the laboratory by spreading 50 μl on the 
surface of SBA plates and Edward’s agar plates followed by incubation at 37°C for 48 hrs. 
Bacterial colonies resembling Streptococcus spp. were subcultured onto BHI agar and 
incubated at 37°C for 24 hrs. If multiple morphologically different colonies grew on a 
primary culture plate, each of these was subcultured to BHI agar. 
2.5.4 Identification  
On retrieval from storage, all of the subcultured isolates were Gram stained and 
examined for catalase activity, hydrolysis of esculin and hippurate, or by API 20 Strep. Gram 
positive cocci that were catalase negative and hydrolyzed hippurate and esculin were 
biochemically identified as S. uberis, and molecular analysis was performed, as described 
below. 
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2.5.4.1 Biochemical characterisation 
2.5.4.1.1 Carbohydrate fermentation test 
Inulin - phenol-red broth was prepared in 5 mL volumes to serve as the basic medium. 
Inulin was added to a final concentration of 1%, then the medium was sterilised by 
autoclaving at 121
o
C for 10 minutes. After inoculating part of a colony and incubation at 37 
o
C for 24-48 h, a positive reaction was indicated by a colour change from red to yellow.  
2.5.4.1.2 Aesculin hydrolysis 
      The test was conducted by inoculating part of colony in prepared 0.1% aesculin broth 
and incubating for 24-48 h at 37
o
C. Formation of black pigment was recorded as positive 
reaction for aesculin hydrolysis.   
2.5.4.1.3 Hippurate hydrolysis 
The test was performed by making a heavy suspension of the test isolate in 400µL of 
1% sodium hippurate solution (1 g of sodium hippurate [C
9
H
8
NNaO
3
] and 99 mL of PBS), and 
incubating at 37
o
C for 2 h. Then 200 µL of 3.5 % ninhydrin, 50 mL of acetone and 50 mL of 
butanol reagent were added and mixed. Following incubation for a further 15 minutes at 
37
o
C, a positive reaction was indicated when the solution changing from yellow to purple.  
2.5.4.2 Molecular characterization   
2.5.4.2.1 DNA extraction 
The isolates from cows with clinical mastitis which were used for PFGE and biofilm 
studies were molecularly confirmed. S. uberis ATCC 700407 was used as a positive control 
for PCRs. Details of DNA template preparation are given in section 5.2.2.  The isolates used 
in the biofilm and microarray studies had been previously identified using a range of 
molecular techniques.  
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2.5.4.2.2 16S and 23S rRNA gene PCRs 
The isolates were further examined by S. uberis species-specific PCRs described by 
Hassan et al. (2001) with minor modification (Table 2-1). Both 16S and 23S rRNA genes 
were amplified in a 50 µL reaction with 1 x PCR buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.2 
mM of either the 16S or 23S rRNA gene primers, 0.625 U of Taq DNA polymerase and 
template genomic DNA (50 ng). The primers used are listed in Table 2-1. The cycling 
conditions were one cycle of 95
o
C for 5 min, 28 cycles of 95
o
C for 30 s, 58
o
C for 30 s and 
72
o
C for 2 min, and a final extension of 72
o
C for 5 min. All amplification reactions were 
performed using a Hybaid PCR Express thermocycler.    
2.5.4.2.3 hasA and hasC gene PCRs 
The capsular genes, hasA and hasC, were amplified using a method described by 
Field et al., (2003) with modification. The hasA or hasC gene was PCR amplified in a 50 µL 
reaction with 1 x PCR buffer, 1.5 mM MgCl2, 0.2 mM each dNTPs, 0.3 μM of each primer 
(Table 2-1), 1.25 U of Taq DNA polymerase and template genomic DNA( 50 ng). The PCR 
cycling conditions are same as in the previous section 2.5.4.1.2. The primers used are listed in 
Table 2-1. 
2.5.4.2.4 PauA gene PCRs 
The gene was amplified using a method modified from the methods described by 
Field et al. (2003) and Zadoks et al. (2005b). The pauA gene was PCR amplified in a 50 µL 
reaction with 1 x PCR buffer, 1.5 mM MgCl2, 0.3 mM each dNTPs, 0.5 μM of each primer 
(Table 2-1), 1.25 U of Taq DNA polymerase and template genomic DNA( 50 ng). The 
primers used are listed in Table 2-1. The PCR cycling conditions were one cycle of 95
o
C for 
5 min, 35 cycles of 94
o
C for 30 s, 55
o
C for 1 min and 72
o
C for 1 min, and a final extension of 
72
o
C for 5 min.   
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         Table 2-1. List of primers used for molecular characterisation of S. uberis 
Target 
rRNA 
gene 
Oligonucleotide 
primer 
Primer sequence 
Size of 
PCR 
product 
(bp) 
 
 
Reference 
16S rRNA 
Ub-I  
Ub-II 
5'-CGCATGACAATAGGGTACA-3' 
 
5'-GCCTTTAACTTCAGACTTATCA-3' 
445 
    
 
(Hassan et al., 2001) 
23S rRNA 
Ub-23S-I  
Ub-23S-II 
5'-CGTATTTAAAATTGACTTTAGCC-3' 
 
5'-AATTTCTCCGCTACCCAC-3' 
451 
    
 
(Hassan et al., 2001) 
hasA 
HasA-for  
HasA-rev 
5'-GAAAGGTCTGATGCTGATG-3' 
 
5'-TCATCCCCTATGCTTACAG-3' 
319 
 
 
  (Field et al., 2003) 
hasC 
HasC-for  
HasC-rev 
5'-TGCTTGGTGACGATTTGATG-3' 
 
5'-GTCCAATGATAGCAAGGTCAC-3' 
225 
 
 
  (Field et al., 2003) 
pauA 
PauA-for  
PauA-rev 
5'-TTC ACT GCT GTT ACA TAA CTT TGT G-3' 
 
5'-CCT TTG AAA GTG ATG CTC GTG-3' 
976 
    
 
(Zadoks et al., 2005b) 
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Chapter 3: Strain differentiation of Streptococcus uberis from cows with   
repeated episodes of clinical mastitis 
 
3.1. Introduction 
     Streptococcus uberis is an important cause of bovine mastitis which is 
inadequately controlled by existing procedures (Hill and Leigh, 1989; Talbot; Lacasse, 
2005). Although many potential infection sources have been identified, the relative 
importance of the different means of transmission of infection particularly of strains causing 
clinical infections still remains a mystery. Moreover, as S. uberis is very difficult to control, 
sensitive and epidemiologically meaningful subtyping methods which provide insight into 
this pathogen's epidemiology and evolution are required (Hill and Leigh, 1989; Zadoks et 
al., 2005a). An ideal typing scheme would have the following characteristics; type ability, 
reproducibility, discriminatory power, ease of interpretation, ease of use, speed and cost 
(Struelens, 2006).  
Different typing methods have been developed to differentiate subtypes of S. 
uberis. These methods are classified into two distinct typing systems: phenotyping and 
genotyping. Determination of bacterial phenotypes carried out by the morphology of 
colonies on different culture media, biochemical tests, serology, killer toxin susceptibility, 
pathogenicity, and antibiotic susceptibility, are not sufficiently variable for discriminating 
between closely related strains and often lack reproducibility (Jayarao et al., 1991c; Li et al., 
2009). For example, since about half of S. uberis isolates are serologically ungroupable, 
serological tests are of little value for the differentiation of S. uberis subtypes (Roguinsky, 
1971).  Classical typing methods, such as serotyping (Groschup et al., 1991; Jayarao et al., 
1991b; Khan et al., 2003; Lämmler et al., 1991), biotyping (Jayarao et al., 1991b; Jayarao et 
al., 1991c; Lammler, 1991), and antibiotic resistance typing (Jayarao et al., 1991c), and 
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phage typing (Hill and Brady 1989; Phuektes et al., 2001), have been replaced by molecular 
methods such as restriction fragment length polymorphism (RFLP), PFGE and MLST.  
Molecular typing offers high reproducibility and almost absolute typing ability (Maslow et 
al., 1993; Tenover et al., 1994). The genetic profile of a given strain generated by a specific 
genotyping method can be as unique as a fingerprint. Therefore, genotyping is also referred 
to as DNA fingerprinting (Li et al., 2009). 
Restriction fragment length polymorphism was one of the first techniques used to 
detect variations in homologous DNA sequences. It measures the length of restriction 
fragments separated by gel electrophoresis (Hill and Leigh, 1989; Jayarao et al., 1991c; 
Jayarao et al., 1993; Li et al., 2009). Although RFLP has high discriminatory power, it has 
several disadvantages. It requires extracted DNA of high purity and physical integrity as 
degradation or incomplete digestion of the genomic DNA can lead to inconclusive results 
(Bai and Wong, 2004; Jayarao et al., 1993). Ribotyping is a variation of RFLP in which 
restriction fragments are first hybridized with ribosomal DNA from E. coli. Ribotyping can 
be automated, which is an advantage. Previous information of DNA sequences are not 
needed with this analysis due to the universal nature of rRNA operons. Because not many 
fragments are produced, ribotyping results are not difficult to interpret. Ribotyping is 
available with Riboprinter and Ribobank for microbial characterisation and bacterial 
database (Harvey and Minter, 2005; Li et al., 2009).    
One of the modern methods used for molecular typing for S. uberis is MLST. 
MLST is a molecular technique which relies on DNA sequencing of the internal fragments 
of multiple housekeeping genes. Distinct sequences of each gene (alleles) are given 
numbers and the combinations of numbers assigned to each strain denote the sequence type 
(Enright and Spratt, 1999; Feil and Enright, 2004). A review by Li et al. (2009) indicated 
that MLST can be used to examine bacterial structures for long-term phylogenetic analysis, 
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especially for subtyping species that have a high degree of genetic recombination, for 
instance, E. faecalis and S. pneumoniae. However, MLST techniques have disadvantages. 
The requirement to sequence multiple housekeeping genes makes the method expensive and 
time consuming. Also, MLST is frequently unsuccessful in differentiating closely related 
subtypes of recent origin. Moreover, the phylogenetic analysis of tested strains may not be 
reliable as the gene sequences used represent only partial alleles which are assigned to a 
numbering system (Li et al., 2009).   
Pulsed field gel electrophoresis is an electrophoretic technique used to separate large 
DNA molecules (10 kb–10 Mb). In conventional gel electrophoresis, the large DNA 
molecules greater than 420 kb are unable to move and so they remain in the well. By 
applying alternating electric fields at different angles, however, PFGE can separate the large 
DNA molecules, up to 1,000,000 base pairs in length, in a flat agarose gel (Herschleb et al., 
2007; Li et al., 2009). PFGE is recognised as the ‘gold standard’ for subtyping many 
bacterial species, as it provides a high-resolution, macro-restriction analysis at the genomic 
level (Tenover et al., 1995). 
Pulsed field gel electrophoresis has several advantages over RFLP. As the whole 
bacterial chromosome is subject to analysis by PFGE it has higher discriminatory power 
than RFLP. Its capability to differentiate at subspecies level with high reproducibility and 
relative cost-effectiveness also justify why PFGE is often considered favourably over RFLP 
(Agvald-Öhman et al., 2004; Bert et al., 1997; Tenover et al., 1995). For these reasons, 
PFGE has been applied extensively in many bacterial epidemiological studies. 
Some limitations of PFGE have been demonstrated by Tenover (1991). Phage 
integration into the genome might result in PFGE pattern differences among isolates of the 
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same strain. Consequently, it is important that the patterns of epidemiologically related 
isolates are analysed carefully. Moreover PFGE is time consuming.  
Tenover et al. (1994) reported that on occasions, the interpretation of PFGE results 
may be difficult, if PFGE generated more than 15 bands that sometimes included partial 
restriction products, double bands representing two or more fragments of almost the same 
size, and faintly stained bands of low molecular size. Standardization of running conditions 
and preparation of samples is essential in PFGE analysis of multiple isolates. These 
problems make the interpretation of PFGE fragment patterns more subjective than 
interpretation of RFLP fragment patterns which contains of fewer bands, especially when a 
large number of samples need to be compared on multiple gel electrophoresis images. 
However, in contrast of other molecular typing methods, the discrimination capability of 
PFGE was clearly superior (Gillespie and Oliver, 2004). 
    To better analyse and cluster PFGE profiles, GelCompar II software (Applied 
Maths, Kortrijk, Belgium) can be used for the analysis of the banding patterns. The 
standardization of gel electrophoresis images is facilitated in GelCompar II using different 
numbers of lanes containing molecular size markers on the gel, and editing distortion. In 
addition, GelCompar II allows the comparison of PFGE patterns from multiple images with 
minimum operator subjectivity, has automatic band-finding options as well as molecular 
size estimation, similarity calculation, and cluster analysis features (Gerner-Smidt et al., 
1998).  
Several studies on the epidemiology of S. uberis have used PFGE typing 
(Baseggio et al., 1997; Douglas et al., 2000; Gillespie et al., 1998; Khan et al., 2003; 
McDougall et al., 2004; Phuektes et al., 2001; Rato et al., 2008; Wang et al., 1999) (Table 
3-1). Rato et al. (2008) described the molecular epidemiology and population structure of 30 
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bovine subclinical mastitis isolates of S. uberis, collected from six Portuguese herds. The 
isolates clustered into 18 PFGE types. In addition, Douglas et al. (2000) identified 330 
PFGE types from a total of 342 S. uberis isolates collected from cows with subclinical and 
clinical mastitis from 15 farming regions in New Zealand over a 1-2 year period, and a 
single isolate from the US. Due to high dissimilarity of patterns between isolates, the 
authors suggested that bovine mastitis was generally an opportunistic infection with 
different strains acquired from the cow’s environment. There were very few cases in which 
identical or similar strains were found in quarters of the same cow or isolated from different 
cows on the same farm. This finding indicated that infection with the same strain could arise 
from a common environmental reservoir, by transmission from one quarter to another of the 
same cow or between cows. More recently, Rato et al. (2008) reported on 30 subclinical 
isolates from 12 different farms. Unrelated PFGE types accounted for more than the half of 
the S. uberis isolates from different herds. Their finding suggested infection from 
environmental reservoirs with a variety of S. uberis strains as well as within cow or direct 
cow to cow transmission.  
A study on sources of infection performed by Zadoks et al. (2005a) compared 
environmental and faecal isolates of S. uberis obtained during the dry period with those 
present in milk, using PvuII ribotyping. The results indicated 48 ribotypes among 266 
isolates. The distribution of ribotypes could not discriminate between environmental, faecal 
and milk samples. They drew a conclusion that ribotyping is not sensitive enough to pick up 
differences between isolates. The level of S. uberis in faecal samples was greater in 
summer, suggesting that faecal shedding of bacteria could enhance the persistence of S. 
uberis in dairy herds. Another study was carried out by Zadoks et al. (2003) to investigate 
epidemiological and molecular characteristics of subclinical mastitis due to S. uberis using 
random amplified polymorphic DNA (RAPD)-fingerprinting. One predominant RAPD-type 
was identified. They found instances of isolates belonging to the same type being found in 
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different cows in the same herd, indicating that these isolates are capable of persisting in a 
herd and supporting cow-cow transmission of S. uberis infections. An althernative 
explanation of the data could be that the method used was insufficiently sensitive to detect 
different types of S. uberis. 
Other studies on the epidemiology of S. uberis mastitis are summarized in Table 
3.1. Most of these studies used milk samples from cows with subclinical mastitis or both 
clinical and subclinical mastitis.  No studies have looked at cows with repeated episodes of 
clinical infections only.  
The PFGE technique was chosen as the method of choice for this study because it 
can separate large DNA molecules in a flat agarose gel, it is recognised as an 
electrophoretic technique for strain discrimination of bacterial species, it provides a high 
resolution, macro-restriction analysis at the genome level, resulting in high discriminatory 
power for subtyping different bacteria. Moreover, PFGE is more useful than MLST for 
examining recent genetic changes.    
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3.1.1 Specific objective  
      The main purpose of this study was to determine whether recurrent cases of 
clinical mastitis from which S. uberis was isolated were associated with the same strain of S. 
uberis (possibly indicating treatment failure) or were associated with different strains, 
indicating new infections. Pulsed field gel electrophoresis was used to type 60 Australian 
isolates of S. uberis from cows with more than one episode of clinical mastitis.     
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3.2 Methods 
3.2.1 Streptococcus uberis isolates 
    In total, 212 S. uberis isolates were used for this study. They had been cultured 
previously from quarter milk samples from 153 cows with evidence of clinical mastitis (Fig. 
3-1). The samples have been collected over a 12-month period from 6 different farms in 
Gippsland Victoria, Australia, as follows: of the 212 isolates, 22 were from 16 cows from T 
dairy farm; 41 isolates from 37 cows in J farm; 37 isolates were from 22 cows of D dairy 
farm; 25 isolates were from 23 cows from R farm; 37 isolates were from 20 cows in M farm 
and 50 isolates from 35 cows from P dairy farm. The isolates were collected as part of a 
large field study on the management of S. uberis mastitis and stored in 1 mL of glycerol 
broth at – 80oC, until required (Runciman et al., 2010). Approximately 28% of the isolates 
were from 27 cows with recurrent clinical mastitis. For this study, isolates were retrieved 
from storage then speciated using selected cultural, biochemical tests (carbohydrate 
fermentation, aesculin hydrolysis, and hippurate hydrolysis) and serological tests 
(streptococcal agglutination system containing A. B, C, D. F. and G group-specific 
antibodies).  
3.2.2 Pulsed field gel electrophoresis (PFGE) 
  Pulsed field gel electrophoresis was performed by a modification of methods 
described previously by (Phuektes et al., 2001; Smith and Cantor, 1987). S. uberis isolates 
were grown on HBA or Columbia HBA overnight at 37
o
C. A single colony was transferred 
to 10 ml of THB and incubated overnight at 37°C with gentle shaking. The isolates in THB 
were harvested by centrifugation for 15 min at 5500 rpm and the pellet was resuspended in 
1 ml Pett IV buffer. The suspension of cells was transferred into a microcentrifuge tube. The 
suspension was washed by PIV buffer twice. To remove the supernatant, the solution was 
spun at a maximum speed (13000 rpm) for 3 minutes each time. The bacterial suspension in 
PIV was adjusted at OD600 between 1.5 to 1.6 (McFarland 4-5) (10 x 10
8
 cfu/mL, based on a 
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standard curve). An aliquot of the S. uberis suspension was then mixed with an equal 
volume of 2.4% (w/v) low melting point agarose in Pett IV buffer and dispensed to plug 
moulds. Before and after using the plug mould, it was carefully washed to remove any 
inhibitors or contamination.  
 
Plugs were incubated overnight at 37°C in lysis solution to lyse the bacterial cells 
and release the genomic DNA. The plugs were subsequently incubated in ESP buffer with 
Proteinase K overnight at 50°C to inactivate cellular proteins, and then incubated in TE 
buffer with 1 mM phenylmethylsulfonyl fluoride (PMSF) for 2 hrs at 37°C with shaking to 
inactivate Proteinase K. The gel plug is washed in TE buffer for 2 hrs at room temperature 
with gentle shaking, followed by four 20 minutes washes under the same conditions.  
 
 
After PMSF treatment, the plugs were cut into an appropriate size, and washed in 
the restriction buffer twice for thirty minutes. Afterwards the plugs containing S. uberis 
genomic DNA were digested with 40 U of Sma I enzyme at 30°C in a water bath overnight. 
The plugs were then placed at 4
o
C for fifteen minutes before loading into a 1% (w/v) 
agarose gel. The Sma I digested DNA fragments were separated by PFGE using a CHEF 
DR-II chamber at 14°C in TBE buffer with pulse times of 5 s to 15 s for 7.7 h and 15 s to 45 
s for 9.5 h at 6 V/cm. A Lambda Ladder PFG Marker was used as a molecular weight 
marker in the range 50 to 1000 kb and each gel contained 4 marker loaded at every fifth 
well starting with first well. Gels were stained with ethidium bromide (0.5μg/ml) and the 
DNA bands were visualized using the Gel Doc imaging system. 
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Table 3-1. Examples of molecular epidemiology studies used in discriminating S. ubeis 
isolates. 
Country 
Typing 
method 
Number of 
isolates 
examined 
Source 
(milk 
from) 
Number of 
different 
types 
Number 
of types 
from 
more than 
one cow 
Number 
from 
recurrences 
Author's 
conclusions re 
transmission 
Reference 
USA   RFLP 42 
Clinical 
and 
subclinical 
17 7 0 
RFLP can be used 
to identify S. 
uberis subtypes 
and to draw 
epidemiological 
inferences. 
Jayarao et 
al., 1991 
USA RFLP 50 
Clinical 
and 
subclinical 
35 5 0 
Clonal diversity 
some types 
confined to one 
geographical area. 
Jayarao et 
al., 1993 
Australia PFGE 21 
Clinical 
and 
subclinical 
17 4 0 
Environmental 
Cow-to-cow               
Baseggio et 
al., 1997 
Australia PFGE 130 
Low cell 
count 
20 5 2 
Occasional  cow 
to cow  
Wang et al., 
1999 
USA and 
New 
Zealand  
PFGE 343 
Clinical 
and 
subclinical 
330 6 0 
Environmental 
Cow-to-cow  
Douglas et 
al., 2000 
Australia PFGE 62 
Clinical 
and 
subclinical 
26 6 
One 
predominant 
strain 
Environmental 
Cow-to-cow               
Phuektes et 
al., 2001 
Germany PFGE 69 
Clinical 
and 
subclinical 
55 9 0 
Environmental 
Cow-to-cow               
Khan et al., 
2003 
USA and 
New 
Zealand  
Ripotypi
ng, PFGE 
and 
RAPD 
46 
Low cell 
count 
29 isolated by 
ribotyping, 35 
by PFGE and 
14 by RAPD  
    
PFGE detected S. 
uberis isolates 
more patterns 
types than the 
other two 
methods 
Gillespie 
and Oliver, 
2004 
New 
Zealand  
PFGE 234 
Clinical 
and 
subclinical  
173 3 0 
Environmental 
Cow-to-cow               
McDougall 
et al., 2004 
Potugal PFGE 30 Subclinical 18 3 0 
Environmental 
Cow-to-cow               
Rato et al., 
2008 
Argentina PFGE 32 Subclinical 18 6 0 Environmental 
Lasagno et 
al., 2011 
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22 (16 cows)
41 (37 cows)
37 (22 cows)
25 (23 cows)
37 (20 cows)
50 (35 cows)
T J D R M P
 
 
 
 
 
 
 
 
 
 
 
Fig 3-1. The total number (n=212) of isolates obtained from milk samples collected 
from 153 clinical cases of S. uberis mastitis, from 6 farms (T, J, D, R, M, and P) in 
Gippsland Victoria, Australia.  
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3.2.3 Strain classification 
The images obtained by PFGE were analysed by GelCompar II. They were also 
examined and interpreted manually based on the criteria developed by Tenover et al. (1995). 
According to these criteria, isolates are considered epidemiologically related if PFGE 
patterns are indistinguishable. PFGE patterns that differed by up to three bands were 
considered as genetically and epidemiologically related and assigned as subtypes. PFGE 
patterns with more than three band differences are considered as unrelated isolates. 
Pulsed-field gel electrophoresis profiles obtained were converted to TIFF files and 
subjected to cluster analysis with use of GelCompar II version 6·0 software package 
(Applied Maths, Sint-Martens-Latem, Belgium). The calculation of the molecular sizes of 
each PFGE profile band was performed by comparing their migration to those of lambda 
molecular weight marker run on a standard gel. In one gel, the standard lambda molecular 
weight marker was used as reference pattern to normalize subsequent gels containing lanes 
with the same reference pattern. Clustering was based on the unweighted pair group method 
with arithmetic averages (UPGMA). The similarities of the banding patterns were analysed 
by using the Dice correlation coefficient (Fang et al., 2008; Liebana et al., 2004 and Zarrilli 
et al., 2005). The tolerance position was 1%. Interpretation of chromosomal DNA 
restriction patterns was based on the criteria of Tenover et al. (1995) as well as analysis by 
GelCompar II. Isolates indicating more than three DNA fragment differences and a 
similarity of < 80% at dendogram analysis were recognised to represent different PFGE 
types, while fragment variations and a similarity of > 80% upon dendogram analysis were 
recognised to represent PFGE pattern subtypes. Isolates showing identical patterns and a 
similarity index of > 80% were interpreted as belonging to the same PFGE type. 
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Recurrent clinical mastitis caused by the strain that caused the original episode was 
defined as persistent infection, while recurrent infections with a different strain were 
defined as re-infections (Döpfer et al., 1999).   
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3. 3 Results 
Two hundred and twelve single isolates of S. uberis, collected over a period of 12 
months from 153 cows with clinical mastitis, were obtained. The majority of isolates (n = 
152) were from 126 cows with single infections but 60 were from 27 cows with more than 
one infection over the period of the study (Table 3-2). This study focussed on the 60 isolates 
from cows with more than one infection over the 12-months period.  
Of the 27 cows with more than one episode of clinical mastitis with S. uberis, 22 
cows had two episodes, four cows had three episodes and one had four episodes over the 
study period.  The duration between the first and second episode ranged from 10 days to 
more than one year (into a new lactation period).  Based on PFGE analysis, most recurrent 
episodes of clinical mastitis were new infections (caused by a new strain), but some were 
persistent infections due to the original strain. The second episode was with a different 
PFGE type in the same or a different quarter (re-infection) in the case of 20 cows, 
suggesting environmental acquisition. A recurrence of clinical mastitis in the same quarter 
and due to the initial PFGE type (persistence) occurred in five cows (Table 3-3).  For the 
two remaining cows, the second episode occurred in a different quarter, but with the same 
PFGE type as the initial episode, indicating spread between quarters.  Third episodes of 
clinical mastitis were all due to new PFGE types.  One cow (No. 3599) had four episodes of 
clinical mastitis; two due to different PFGE types from the original isolate.  The fourth 
episode was considered to be due to persistence (possibly associated with treatment failure) 
as it occurred in the same quarter only two weeks after the third episode and was caused by 
a new subtype of the third strain. All persistent infections or examples of spread to a 
different quarter occurred within one to eight weeks of the first infection.  A representative 
gel showing PFGE profiles of isolates from three different farms is presented in Fig. 3-2. 
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Analysis of the 60 isolates from cows with one or more episodes of clinical mastitis 
revealed 47 major PFGE types (including subtypes), clustered into six major groups at the 
80% similarity level (Fig. 3-3). Thirty-seven PFGE patterns were represented by single 
isolates, but 10 PFGE types, which were distributed over all but one of the six clusters, 
appeared in two (7 types) or three (3 types) different isolates. Eight paired isolates of the 
same PFGE type were associated with persistence or probable persistence. There were five 
examples of the same type being isolated from different cows on the same farm (2 
instances) or different farms (3 instances) (Fig. 3-4). Two of the latter involved different 
subtypes of S. uberis and the third was due to an identical type.    
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   1       2      3       4       5       6       7      8       9      10     11     12     13    14     15  
Fig 3-2 A representative PFGE gel showing Sma I digested chromosomal 
DNA from S. uberis isolates from 8 cows (3 farms represented). Lane 1, 
lambda ladder PFGE marker. Lanes 2, 3, 4, PFGE type 47 [isolates 3551(2), 
3668(1), 3668(2)]. Lanes 5, 6, PFGE type 45 [isolates 3885(1), 3885(2)]; 
Lane 7, PFGE type 17 [isolate 5851(1)]; Lane 8, PFGE type 41 [isolate 
5851(2)]; Lane 9, PFGE type 38b [2905(2)]; Lanes 10, 11, PFGE type 38a 
[isolates 3706(1), 3706(2)]; Lanes 12, 13, PFGE type 24 [isolates 3386(1), 
3386(2]; Lanes 14, 15, PFGE type 35 [isolates 4707(1), 4707(2)].  Kb = 
kilobases.  
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Table 3-2. Cows with single and multiple episodes of S. uberis clinical mastitis.               
Type of infection No. of cows 
Single infection 126 
Second infection  
 New PFGE type (new infection)   20 
 
 Identical PFGE type, same quarter (persistence)    5 
 Identical PFGE type, different quarter (spread)    2 
Third infection  
 New PFGE type (re-infection)    5 
Fourth infection  
 Different subtype, same quarter (probable persistence)    1 
All cows  153 
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Table 3-3. Relationship between time and the occurrence of new and persistent episodes of clinical mastitis due to S. uberis. 
Cow 
ID 
Farm Udder 
quarter
1
 
2
nd
 infection Classification Udder 
quarter 
3
rd
 or 4
th
 infection Classification 
   Time since 
first 
infection 
(weeks) 
New or same type 
or subtype 
  Time 
since 
previous 
infection 
(weeks) 
New or same 
type or subtype 
as previous 
infection 
 
6232 R LF 
RH 
 
6 
 
Different type 
 
Environmental 
  
- 
 
 
 
3446 
 
P RH 
LF 
 
 
52 
 
Different type 
 
Environmental 
 -   
3551 P LF 
RH 
 
12 
 
Different type 
 
Environmental 
 -   
    
3860 
 
P LH 
RH 
 
4 
 
Different type 
 
Environmental 
 
 -   
3668 P LH 
LF 
1-2 Same type Quarter spread 
RF 53 Different type Environmental 
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3885 P LH 
LH 
 
3 
 
Same type 
 
Persistence 
 -   
5851 P LH 
RH 
 
5 
 
Different type 
 
Environmental 
 -   
4016 P RH 
RH 
 
7 
 
Same type 
 
Persistence 
 -   
3085 
 
D LH 
RF 
 
10 
 
Different type 
 
Environmental 
LF 38 Different type Environmental 
3321 D LF 
LF 
 
50 
 
Different type 
 
Environmental 
 - 
 
 
3413 D RH 
LH  
 
5 
 
Same type 
 
Quarter spread 
 - 
 
 
3440 D LF 
LH 
 
37 
 
Different type 
 
Environmental 
 - 
 
 
3519 D RH 
RH 
50 
 
Different type 
 
Environmental 
LF 12 Different Type 
 
Environmental 
3531 D LF     -   
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RF 
 
8 Different type Environmental 
3557 D RF  
34 
 
Different type 
  - 
 
 
LH Environmental   
581 M RF 
RF 
 
2 
 
Different type 
 
Environmental 
 - 
 
 
2989 M LF  
2 
 
Different type  
  - 
 
 
RF Environmental   
3116 M LF 
RH 
 
4 
 
Different type 
 
Environmental 
 - 
 
 
3481 
 
M RF 
LF 
 
45 
 
Different type 
 
Environmental 
 - 
3571 M LF  
56 
 
Different type 
  - 
 
 
RF Environmental   
3599 M LF 
LF 
 
44 
 
Different type 
 
Environmental 
LF/LF 20/2 Different type 
/different 
subtype 
Environmental/probable 
persistence 
3677 M LH 1   RF 5 Different type Environmental 
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1
LF left front, RH right hind; LH left hind; RF right front; environmental, different type; quarter spread, new quarter infected with same strain; 
persistence, subsequent episode in the same quarter as the first episode. 
 
 
RF Different type  Environmental 
2905 T RF  
7 
 
Different type  
  - 
 
 
RF Environmental   
3386 
 
T RF 
RF 
 
1-2 
 
Same type 
 
Persistence 
 - 
 
 
3706 T 
 
LF  
8 
 
Same type 
  - 
 
 
LF Persistence   
4707 J LF  
3 
 
Same type 
  - 
 
 
LF Persistence   
7218 J LF 
LF 
 
5 
 
Different type 
 
Environmental 
 -  
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Isolate ID 
3519 (1) 
3321 (1) 
3085 (1) 
2989 (2) 
3519 (2) 
3413 (1) 
3413 (2) 
3557 (1) 
3677 (1) 
3557 (2) 
3571 (1) 
3519 (3) 
2905 (1) 
3599 (1) 
3677 (3) 
4016 (1) 
4016 (2) 
6232 (1) 
5851 (1) 
2989 (1) 
581 (1) 
3599 (4) 
3599 (3) 
3599 (2) 
7218 (2) 
3116 (1) 
6232 (2) 
3386 (2) 
3386 (1) 
7218 (1) 
3531 (1) 
581 (2) 
3440 (1) 
3446 (2) 
3571 (2) 
3116 (2) 
3531 (2) 
3481 (1) 
3481 (2) 
3668 (3) 
4707 (1) 
4707 (2) 
3860 (2) 
3551 (1) 
3706 (1) 
3706 (2) 
2905 (2) 
3085 (2) 
3085 (3) 
5851 (2) 
3440 (2) 
3860 (1) 
3677 (2) 
3885 (1) 
3885 (2) 
3321 (2) 
3446 (1) 
3668 (1) 
3668 (2) 
3551 (2) 
PFGE 
type/subtype 
1 
2 
3 
4 
5 
6a 
6a 
7 
8 
9 
10 
11 
12 
13 
14 
15a 
15a 
16 
17b 
17c 
18 
19b 
19c 
20 
21 
22 
23 
24a 
24a 
25 
26 
27 
28 
29a 
29a 
30 
31 
32 
33 
34 
35a 
35a 
36 
37 
38a 
38a 
38b 
39 
40 
41 
42 
43 
44 
45a 
45a 
45b 
46 
47a 
47a 
47a 
Farm  
D      
D 
D 
M 
D 
D 
D 
D 
M 
D 
M 
D 
T 
M 
M 
P 
P 
R 
P 
M 
M 
M 
M 
M 
J 
M 
R 
T 
T 
J 
D 
M 
D 
P 
M 
M 
D 
M 
M 
P 
J 
J 
P 
P 
T 
T 
T 
D 
D 
P 
D 
P 
M 
P 
P 
D 
P 
P 
P 
P 
% Similarity 
 6 
15 
19 
17 
24 
29 
35 
38 
45 
47 
    
 Fig. 3-3. Dendogram of 60 Australian S. uberis isolates from cows with more than one 
episode of clinical mastitis. Farms are represented by letters; D, M, T, P, R, and J. PFGE 
types are indicated by numbers (type) and letters (subtype). Isolate identification, second 
infection is denoted by number (2) next to the isolate. Repeatedly isolated PFGE types are 
indicated by rectangles. 
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       Fig. 3-4. Two cows on different farms with identical PFGE profiles 
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3.4 Discussion and Conclusion  
The PFGE technique was chosen for strain discrimination of S. uberis because it 
provides high resolution and discrimination at the genome level (Li et al., 2009). PFGE 
has been applied extensively in many epidemiological studies for subtyping different 
species of bacteria, including S. uberis (Table 3-1) (Li et al., 2009). In contrast to MLST, 
which relies on DNA sequencing of the internal fragments of multiple housekeeping 
genes to examine slowly accumulating genetic changes (Coffey et al., 2006; Li et al., 
2009), PFGE depends on macro-restriction analysis of the entire bacterial genome and 
can therefore identify more rapidly evolving genetic changes (Smith and Cantor 1987; Li 
et al., 2009). Earlier techniques, RFLF and its variation, ribotyping, have high 
discriminatory power, but results can be inconclusive unless the extracted DNA is of 
high purity and quality (Li et al., 2009).  
The PFGE restriction patterns obtained from 60 S. uberis isolates revealed 47 
different DNA restriction patterns, indicating a wide variety of S. uberis strains causing 
clinical mastitis. Most types (n = 37) were represented by only one isolate. Other 
studies from several different countries examined isolates from collections of both 
clinical and sub-clinical mastitis (Table 3-1). All of these studies found a high degree of 
heterogeneity among isolates, suggesting that most S. uberis mastitis is acquired from 
the cow’s environment.  Isolates from environmental samples also show great diversity, 
supporting an environmental source (Zadoks et al., 2005a).   
The finding of examples of the same type or subtype of S. uberis being isolated 
from different cows in the same farm is also consistent with studies using collections 
consisting of both clinical and subclinical isolates (Table 3-1). There are two possible 
reasons for these findings. Either cow-to-cow transmission occurred at milking or there 
was a common environmental source of S. uberis. Since it is the practice in the herds in 
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this study to graze cattle on pasture, rather than use feedpads or cow barns, the first 
explanations seems most likely, although infection through muddy sleeping areas 
cannot be ruled out. Cow to cow transmission might be influenced by several 
management factors, in particular milking management. It is possible that strains 
infecting more than one cow might possess enhanced transmission potential, be 
relatively stable over time in the environment, and have a greater capacity to attach and 
become established in the host epithelial cells (Hill and Brady, 1989; Leigh et al., 1990) 
or to establish biofilm-mediated infection compared with the other isolates. It is well 
known that organisms growing within biofilms (Crowley et al., 2011), growing 
intracellularly (Hall-Stoodley and Stoodley, 2009; Leigh et al., 2010) or protected by 
fibrous tissue (McDougall et al., 2004) respond poorly to antimicrobial chemotherapy.   
Most second and subsequent cases of S. uberis clinical mastitis (~73%) were 
caused by a different PFGE type from the strain causing the initial infection, generally 
in a different quarter, indicating that treatment of the initial infection was usually 
effective.  These recurrent cases associated with different strains may be due to chance, 
or may be associated with some anatomical damage to the teat end, or to compromised 
host immune mechanisms in that animal. In these cows, a more effective antimicrobial 
treatment program is unlikely to be beneficial.   
In the case of six cows (five second infections and one fourth infection), the same 
or a closely related PFGE type was isolated a second time from the same udder quarter 
within eight weeks of the previous infection. It is most likely that the initial clinical 
signs resolved following treatment but the organisms persisted, only to re-emerge later 
as clinical mastitis. The existence of a small subgroup of cows in which the same PFGE 
S. uberis is isolated in initial and then recurring cases of clinical mastitis in the same 
quarter indicates that the currently used treatments will not always result in a 
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bacteriological cure. The two instances of the same PFGE type being isolated from 
different quarters of the same cow after periods of 10 days to five weeks suggest that 
treatment of the initial infection was successful, but there was spread of S. uberis 
between quarters. It is also possible that these apparent persistent infections were re-
infections from a common environmental source. This possibility is considered 
unlikely, since cows are not housed indoors in Australia. Other studies that examined 
isolates from cases of both clinical and subclinical mastitis using PFGE or MLST also 
identified identical or closely related strains from second infections occurring in the 
same or different quarters of the same cow (Jayarao et al., 1993; Wang et al., 1999; 
Douglas et al., 2000; Phuektes et al., 2001; Khan et al. 2003; McDougall et al., 2004; 
Pullinger et al., 2007). For example, in a New Zealand study of pasture-fed cows, an 
average of 55% of paired isolates from the same cow had the same PFGE type, 
although this percentage varied considerably between farms, from 16% to 100% 
(McDougall et al., 2004). Pullinger et al. (2007), using isolates collected for a 
longitudinal study from cows that received no antimicrobials during the study period, 
found that 73% of paired isolates from recurrent infections belonged to the same 
sequence type, while 27% were of different sequence types. These differences in the 
proportion of persistent and new infections probably reflect differences in treatment 
protocols and the proportion of clinical cases (treated) and subclinical cases (untreated) 
included in the samples.   
In agreement with Pullinger et al. (2007) we found no evidence of particular 
strains having a greater propensity to persist than others, since the PFGE types that 
caused persistent infections were distributed across all but one of the major clusters. It 
is therefore likely that host factors, rather than strain determine whether persistence 
occurs. These persistent infections are important as they may play a major role as 
reservoirs of infection in a herd (Phuektes et al., 2001).   
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The reasons for the three instances of identical or closely related PFGE types of 
S. uberis being isolated from clinical cases of mastitis on different farms are not clear.  
Although isolates used in the present study were from cows in the Maffra district of 
Gippsland, Australia, cows were not transported between these farms. Other studies 
have also reported isolating the same or closely related PFGE types from cows on 
different farms (Douglas et al., 2000; Lasagno et al., 2011). It is possible that these 
strains are more prevalent in the environment than other strains. Alternatively, since 
members of three of the four pairs of isolates from different farms were subtypes rather 
than identical PFGE types, it is also possible that they may in fact be different strains, 
not identified by PFGE.       
It is concluded that second and subsequent episodes of S. uberis clinical mastitis 
are commonly (20 out of 27 cows in this study) caused by new strains, acquired from 
the cow’s environment. However, in a small but significant number of recurrent cases 
(5 of 33 recurrent cases, ~18%) the same or closely related PFGE type was isolated 
subsequently from the same udder or quarter within eight weeks of the previous 
infection. It is likely that the initial clinical signs resolved, but the organisms persisted, 
only to re-emerge later as a recurrent case of clinical mastitis. There was also evidence 
of either direct transmission between cows or possibly infection from a common 
environmental source. These findings are in agreement with other studies that included 
isolates from both clinical and subclinical cases of mastitis, although the proportion of 
types infecting more than one cow differed between studies. These observations 
suggest that relative importance of an environmental source and cow-to-cow 
transmission in the occurrence of mastitis may depend on different management 
practices, geographical factors as well as the transmissibility and disease potential of 
the particular strains circulating in the cow’s environment. Attention to possible 
environmental sources of infection, good standards of milking hygiene and proper 
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treatment of S. uberis mastitis remain important measures in attempts to control 
transmission of S. uberis.  
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Chapter 4: Factors involved in biofilm formation by Streptococcus uberis 
4.1 Introduction 
The ability of bacteria to colonise host epithelial cells is an essential stage particularly 
during the initiation of infection. The colonization of the lactating mammary gland by 
pathogenic organisms can only occur if bacteria are protected from elimination during 
milking either by adhering to host tissues or multiplying at a sufficient rate to overcome 
their elimination (Leigh, 1999). One of the mechanisms that might enable pathogenic 
bacteria to evade elimination is to grow within a biofilm.   
4.1.1 Biofilm 
Biofilms are defined as communities of micro-organisms attached to an inert or 
living surface, producing extracellular polymeric substances (EPS) and interacting with 
each other (Costerton et al, 1999; Lindsay and Holy, 2006; Sutherland, 2001). Biofilm 
formation involves the following stages: bacterial attachment with or without prior surface 
conditioning, colonization, growth of micro-organisms, and exopolysaccharide slime 
production (Zottola and Sasahara, 1994). After the initial attachment of free-swimming (or 
planktonic) cells to a surface, surface motility and binary division result in aggregation of 
attached cells (Stoodley et al., 2002). Cell wall associated adhesions, which are products of 
various genes, may play a role in cells adherence to a surface (Mack, 1999). Moreover, 
host matrix proteins promote the attachment to native polymeric surfaces.         
Biofilms are responsible for many persistent and recurrent infections, including 
bovine mastitis. It has been reporte that up to 65% of the mastitis due to S. aureus is 
associated with biofilm formation (Melchior et al., 2006). Within the biofilm bacteria are 
protected from host immune mechanisms and antibiotics; making biofilm-related 
infections difficult treat (Melchior et al., 2006). Although most mastitis pathogens remain 
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susceptible to most antimicrobial agents if examined by conventional methods, recurrent 
infections frequently fail to respond to treatment. This has been related to the ability of 
pathogens to form biofilm (Melchior et al., 2006). In spite of the importance of biofilm-
related infections, there is very little information on the contribution of biofilms to the 
pathogenesis of mastitis due to S. uberis. There is; however, a large body of work on initial 
step in biofilm formation: adhesion to host tissues.    
4.1.2 Adhesion 
Direct attachment of bacteria to the epithelial tissue of the host mammary gland is 
the most important step in the pathogenesis of most organisms (Almeida et al., 1996; Frost 
et al., 1977; Harper et al., 1978; Jones and Rutter, 1972; Thomas et al., 1992) and is the 
first step in biofilm formation (Zottola and Sasahara, 1994).  Several authors have reported 
the adherence capability of S. uberis to bovine mammary epithelial cells. Opdebeek et al. 
(1988) used cells derived by enzymatic digestion or mechanical disruption of the tissue, 
while others have used immortalized lines (Mathews et al., 1994).  
In contrast, work by Thomas et al. (1994) reported that the adhesion of S. uberis 
occurs to alveolar exudates, with very little adhesion to the luminal surface of ductular or 
secretory epithelium. The ability of S. uberis to adhere to almost every single cell or tissue 
of the mammary gland other than infected epithelium was not supported by these studies.    
Evidence of the importance of adhesion has been provided by a series of studies by 
Rogunsky (1977). The authors inoculated two different species of Streptococcus; S. uberis 
and S. infrequens (a Group E streptococcus, closely related to S. uberis, probably what is 
now known as S. pseudoporcinis) (Bekal et al., 2006; Bridge and Sneath, 1983; 
Shewmaker et al., 2012) by the intra-mammary route during the dry period. The results 
revealed that the udder was infected equally by both species, but only S. uberis was able to 
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cause mastitis. When different strains of S. uberis were used, there was a clear difference 
between strains in their ability to cause intramammary infection, which correlated with 
their ability to adhere to the host cells in vitro.  S. infrequens strains were unable to adhere 
to the epithelium tissues. These studies support the hypothesis that adhesion is an 
important first step in infection of the bovine mastitis with S. uberis.   
 Bacterial adhesion assays were performed by Ditcham et al. (1996) using 
monolayers of epithelial cells isolated from the secretory alveoli of the mammary gland.  
Epithelial cells with microvilli or without microvilli were tested. Two different strains of S. 
uberis (highly virulent and less virulent) were used and their adherence capability was 
examined. The less virulent strain adhered readily and in higher number to the cells 
without microvilli while the highly virulent strain adhered equally to the both types of 
cells. These results suggested that there was no significant difference between virulent and 
non virulent S. uberis strains in terms of adhesion to the cultured cells. These authors 
concluded that the virulence of the strains could not be related to the adhesion ability to the 
host mammary gland (Ditcham et al., 1996). 
4.1.3 Role of milk components in adherence of S. uberis 
Apart from direct adhesion to surfaces, bacteria can adhere indirectly by attaching 
to conditioning films, usually protein nature (Almeida et al., 2003; Christensen et al., 
1985; Crowley et al., 2011). Milk is a complex protein-rich exosecretion, which contains 
different components that could affect the initial adherence step of biofilm formation. 
Therefore, it is important to examine the relationship between S. uberis and milk 
components, especially proteins, including the role of such interactions, if any, in the 
ability to adhere and produce biofilms (Arnold et al., 1977; Fang and Oliver, 1999; Smith 
and Oliver, 1981). 
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Some studies have suggested that extracellular matrix proteins such as laminin, 
collagen and fibronectin can mediate adhesion of S. uberis epithelial cells (Almeida et al., 
1996; Almeida et al., 2006).  In contrast, other studies (Lammers et al., 2001) reported that 
S. uberis behaves differently in terms of adhesion to bovine mammary gland tissues than 
other pathogenic organisms, in having very weak binding capacity to fibronectin. Thomas 
et al. (1994), using of explant cultures of mammary gland cells, determined that S. uberis 
bound to endothelium coated with fibrin (Thomas et al., 1994). 
 One of the nonspecific antibacterial factors in bovine milk is Lf.  Lf plays a role in 
host defence, by depletion of free iron, thus depriving the organism of iron for growth 
(Patel et al., 2009; Smith and Oliver, 1981). Furthermore, mitogen- and alloantigen-
induced lymphocyte proliferation are inhibited by Lf and cellular proliferation of the 
bovine mammary epithelial cell line MAC-T was lowered by Lf (Rejman et al., 1992a; 
Rejman et al., 1992b). When the host mammary gland is infected, the concentration of Lf 
increases dramatically. Gram-positive bacteria, in particular streptococci including S. 
uberis, are more resistant to the antibacterial effect of Lf than Gram-negative bacteria 
(Todhunter et al., 1985), probably because streptococci do not have a high requirement for 
iron (Ward et al., 2009).  Since Lf is an important antibacterial factor in bovine milk, the 
ability of bacteria to bind Lf could contribute to their virulence.    
Lactoferrin-binding proteins of S. uberis were investigated by (Almeida et al., 
2006; Fang and Oliver, 1999; Fang et al., 2000; Patel et al., 2009; Rejman et al., 1994).  In 
a study by Chaneton et al., (2008), polyacrylamide gel electrophoresis and Western 
blotting were used to determine whether S. uberis was capable of binding Lf in milk. Fang 
and Oliver (1999) reported interaction between the S. uberis and host tissues through Lf, 
which acted as a bridging molecule. These findings were supported by observations that 
addition of Lf to the media caused enhancement of adhesion of S. uberis strains to host 
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cells (Fang et al., 2000). A recent study (Patel et al., 2009) demonstrated interaction 
between S. uberis adhesion molecule (SUAM), bovine Lf, and a putative Lf receptor on 
the bovine mammary gland cell surface. Their results suggested that Lf serves as a 
bridging molecule between S. uberis SUAM proteins and the epithelial cell surface where 
Lf receptors are located. Since adhesion is the first step in biofilm formation, it is possible 
that Lf contributes to that process.   
Many pathogenic organisms express some of their virulence factors in conditions 
of iron stress (Ling and Shryvers, 2006; Mey et al., 2005).  Research from our laboratory 
showed that biofilm production by S. epidermidis increased with increasing levels of iron 
stress (Deighton and Borland, 1993). Moreover, growth in low-iron conditions enhanced 
biofilm production in S. capitis isolates similar to studies with S. epidermidis (unpublished 
data). Only a few studies have examined the relationship between iron availability and the 
physiology or virulence of streptococci (Almeida et al., 2010). Iron-restricted growth 
conditions have been shown to enhance and play an important role in biofilm formation in 
other organisms such as S. aureus and S. epidermidis (Lyte et al., 2003; Weinberg, 2004).   
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4.1.3 Objectives 
The main objective of this study was to investigate a possible contribution of 
biofilm formation to the pathogenesis of intramammary infection caused by S. uberis in 
vitro. The effect of milk and various milk components, in particular proteins, on the 
amount of biofilm produced by S. uberis in vitro was also investigated, as was the effect of 
iron limitation and the presence of indigenous flora on the amount of biofilm produced by 
S. uberis.   
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4.2 Methods 
4.2.1 Bacterial isolates 
The isolates used in this study had been isolated and identified previously 
(Runicman et al., 2010; Tomita et al., 2008) and stored a- -80 
o
C. They consisted of twenty 
- seven isolates of S. uberis (8 isolates were from 5 cows with clinical mastitis, 9 isolates 
were from 6 cows with low cell counts in their milk (< 250,000/mL) (contaminating flora) 
and 10 isolates were from 10 cows with high cell counts in their milk but no clinical signs 
of mastitis (> 250,000/mL) (subclinical mastitis)). All isolates belonged to different PFGE 
types and thus were epidemiologically distinct (Tomita et al., 2008; Tomita et al., 
unpublished; Chapter 3). Most of these isolates had been characterised previously by 
MLST (Tomita et al., 2008). As a control, S. epidermidis RP62A was included as a known 
biofilm-producing organism and S. hominis SP2 as a known non – biofilm – producing 
bacteria (Christensen et al., 1985) (Table 4-1). 
4.2.2 Media preparation 
Details with regard to preparation of the following media TSB, THB, HBA, 
Edward’s agar, nutrient agar and BHI agar have been described in Chapter 2.   
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Table 4-1. Isolates used in the study. 
     Isolate number   Disease status 
2917.2 Uninfected  
2945.3 Uninfected 
3068.5 Uninfected 
3133.3 Uninfected 
3147.1 Uninfected 
3147.5 Uninfected 
3217.2 Uninfected 
3217.3 Uninfected 
3217.5 Uninfected 
   684.6   Subclinical mastitis  
686.5   Subclinical mastitis  
796.2   Subclinical mastitis  
796.3   Subclinical mastitis  
816.2   Subclinical mastitis  
868.4   Subclinical mastitis  
2407.7   Subclinical mastitis  
2581.2   Subclinical mastitis  
2655.5   Subclinical mastitis  
2690.2   Subclinical mastitis  
3551(1)   Clinical mastitis  
3551(2)   Clinical mastitis  
3668(1)   Clinical mastitis  
3860(1)   Clinical mastitis  
3860(2)   Clinical mastitis  
3885(1)   Clinical mastitis  
5851(1)   Clinical mastitis  
5851(2)   Clinical mastitis  
S. epidermidis RP62A    Positive control 
S. hominis SP2        Negative control 
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4.2.3 Preparation of milk, milk components, and chemicals 
4.2.3.1 Commercial milk 
Three different types of milk were used; ultrahigh-temperature-treated (UHT) 
(skim milk, full cream milk) purchased from a supermarket, and raw milk purchased from 
a health food store. Milk was added to test media within 3 hours of purchase. Different 
percentages (12.5%, 25%, and 50%) were added into test media.           
4.2.3.2 Methylene blue reductase (MBR) test 
Methylene blue reductase (MBR) test was performed to assess the quality of the 
milk. The test was performed by transferring 10 mL of milk sample into test tube, and 1 
mL of MB dye was added. Then the stopper was inserted before the test tube was gently 
inverted about four times and incubated in water bath at 37
o
C. The samples for MB 
reduction were obsereved every 30 minutes for 3 h. Reduction was indicated by a change 
in the colour of the sample to white. A good quality of the milk sample was indicated 
when the reduction occurred within 3 h or more.  
4.2.3.3 Milk proteins 
4.2.3.3.1 β-Lactoglobulin from bovine milk (β-Lg) 
A stock solution of β-lactoglobulin (equivalent to 10 mg of β-Lg per mL) was 
prepared by first dissolving in 0.01 M phosphate buffer (pH 7.0) while stirring for 20 min. 
The solution was then filtered through a Millipore filter (pore size, 0.2 µm). This solution 
was prepared fresh. Concentrations used were 0, 0.2, 1, or 5 mg/mL were used, to relate to 
3 mg/ml present in milk (Bylund, 2003). 
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4.2.3.3.2 Casein from bovine milk (50 mg/mL) 
A stock solution was made by dissolving the mixture of α, β, and Kapa casein 
powder in 1 M sodium hydroxide solution to a final concentration (50 mg/mL). Another 
solution used was a mixture of α, β, and Kapa casein at concentrations of 0, 1, 5, and 10 
mg/mL. This product is hydrolysed and partially dephosphylated.    
4.2.3.4 Lactoferrin bovine milk (20 mg/mL)  
A stock solution was prepared by dissolving bovine Lf (50 mg/mL) in MilliQ 
water and mixing well until totally dissolved. The solution was stored at -20 C until use. 
The final concentrations of 0, 0.2, 1, or 5 mg/mL were used which is related to about 0.2 
mg/ml present in infected milk (Bylund, 2003). 
4.2.3.5 Removal of indigenous flora from milk samples  
To investigate the role that indigenous microflora of raw milk play in the 
formation of biofilms, milk samples were defatted by centrifugation at 1,400 × g for 30 
minutes.  After removal of the fat layer, the defatted milk was centrifuged at 5,400 × g for 
3 hours, and then filter sterilized (pore size 0.45 µm) to remove the normal flora. Removal 
of normal flors was confirmed by standard culture.  Isolates from a cow with low cell 
counts in the milk (3217.2) and an isolate from cow with clinical mastitis (3885(1)) were 
used and the experiment was performed in triplicate.  
4.2.3.6 Ethylenediamine-di-o-hydroxyphenol acetic acid (EDDA) solution (1 mg/mL) 
10 mg of EDDA powder was dissolved in 10 mL of MilliQ water and mixed well 
by vortexing. Then the solution was sterilised by filtration using a 0.45 µm Millipore filter. 
The solution was always freshly prepared before use. EDDA is a ferric ion (Fe3+) chelator 
and it was used to reduce the iron availability in the media.   
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4.2.3.7 Ferric chloride solution (1 mg/mL) 
10 mg of anhydrous ferric chloride powder was dissolved in 10 mL of MilliQ 
water then filtered using a 0.45 µm Millipore filter. This solution was also prepared fresh. 
 4. 2.3.8 Preparation of Hucker crystal violet for staining biofilms 
For this purpose, 2 g of crystal violet was dissolved in 20 mL of alcohol and 0.8 g 
of ammonium oxalate was dissolved in 80 mL of distilled water. The two solutions were 
mixed, left to stand at room temperature for 24 h, and then filtered. The stain was checked 
for precipitate and refiltered again if necessary before each use.  
4.2.4 Biofilm assays 
4.2.4.1 Standard biofilm assay 
The biofilm assay was performed as described by Deighton et al. (2001) with 
modifications. This assay is based on the adherence of biofilm-positive cells to polystyrene 
and to each other, developing a biofilm whose density is measured spectroscopically after 
staining. Three colonies of S. uberis from freshly streaked BHI agar plates were inoculated 
into Todd Hewitt broth (THB) and colonies from controls of S. epidermidis and S. hominis 
were inoculated into tryptone soya broth (TSB) and incubated at 37°C to stationary phase 
with gentle shaking overnight. Bacterial suspensions of ~ 10
8
 CFU/mL were diluted 1:100 
into different broth mixtures with supplements or without supplements (see section 
4.2.5.10 below) (Christensen et al., 1985; Courtney et al., 2009; Grenier et al., 2009; 
Merritt et al., 2005). For each strain, 100 µl of cell suspension was dispensed per well into 
four wells of sterile, flat-bottomed, 96-well polystyrene microtitre plates and incubated at 
37
o
C for 18 – 24 h without shaking. Following this incubation, the wells were washed and 
stained with Hucker crystal violet.  Media controls consisted of un-inoculated broth.   
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4.2.4.2 Staining and reading biofilms  
Washing the plates and staining the biofilms were conducted as described by 
Deighton et al. (2001), with slight modifications. Briefly, after incubation for 18 – 24 h at 
37 
o
C, the optical density of the cell suspension within each well was measured using plate 
reader at 590 or 600 nm (OD600) to confirm growth of each strain in the medium. To 
visualize the biofilm, the planktonic cells were removed by aspiration, then the plates were 
submerged in a tank filled with water and gently shaken to empty the water inside the 
wells and to avoid washing-off any biofilms at the same time. This was followed by 
incubation of the plates at 55 
o
C for one hour. This process kills the bacteria in the biofilms 
by heat fixation. Thereafter, the plates were stained with Hucker crystal violet (about 50 
µL) for one minute, the crystal violet solution was removed by aspiration, and then wells 
were washed well in plastic tanks to remove unbound crystal violet dye. Afterwards, the 
plates were blotted dry and placed upside down at room temperature overnight. Then 
OD600 was read using a plate reader. 
All biofilm assays were run with three independent repeats of four replicates and 
the means and standard deviations were calculated. According to Deighton et al. (2001) the 
isolates producing OD value of ≥ 0.24 were deemed biofilm positive, whereas values of 
0.12 to 0.24 were considered as weak biofilm production and values of < 0.12 as biofilm 
negative.  
In order to examine the effect of milk and different milk components on biofilm 
production, various supplements were added to the basic medium, (section 4.2.4.4 to 
4.2.4.8). 
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4.2.4.3 Viable Counts 
Determination of the amount of growth in biofilms produced in microtitre plates 
containing broth with three different percentages (12.5 %, 25%, and 50 %) of the three 
types of milk (skim, whole, and raw) was by standard surface viable count after overnight 
incubation. This was done to assess whether growth differed in milk-supplemented media. 
The number of bacteria present in biofilms in all four wells was counted and the mean 
value was taken to represent all biofilms (Gualtieri et al., 2006). This was achieved by 
addition of 100 µL of THB into microwells containing biofilm. A sterile tip was used to 
scrape the biofilm matrix before sonication (Branson 450 sonifier with a microtip) for 8 
seconds at 11% of the maximum amplitude. Serial dilutions of the biofilm cell suspension 
were prepared in PBS, and then aliquots were streaked onto the surface of NA plates.  The 
colonies were counted after 37°C incubation for 24 h and the viable count of the original 
suspension determined. 
4.2.4.4 Effect of milk compounds on biofilm formation 
The effect of milk on biofilm production was determined by a modification of the 
method used previously by Fang et al. (2000). The isolates were cultured in THB at 37 
o
C 
overnight and bacterial density was calibrated to about 10
8
 colony-forming units (CFU) 
per mL. After diluting 1 in 100 in milk-THB mixtures, 100 µL aliquots were added to 
wells of a 96-well tissue culture plate. Final concentrations of milk in THB were 0, 12.5, 
25, and 50%. Each concentration was tested in quadruplicate on three separate occasions, 
and skim milk, full cream milk, and raw milk were used. After incubation for 24 h at 37 
o
C, the wells were washed and stained. Controls consisted of 12.5, 25, and 50% 
concentrations of milk in THB with no added S. uberis and negative and positive controls 
of S. hominis and S. epidermidis respectively.  
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4.2.4.5 Effect of carbohydrates on biofilm formation in S. uberis 
Streptococcus uberis isolates were cultured in THB broth containing 1%, 2% 
sugars (fructose or glucose or lactose or sucrose) to test the effect of different 
carbohydrates on biofilm production by S. uberis. Biofilm formation was assessed as 
described in section 4.2.4.4.  
4.2.4.6 Effect of β-Lactoglobulin (β-Lg) on biofilm formation in S. uberis 
THB media with different concentrations (0, 0.2, 1 and 5 mg/mL) of whey protein 
(β-Lg) were used to test the effect of β-Lg on biofilm production, as described in section 
4.2.4.4. 
4.2.4.7 Effect of casein on biofilm formation in S. uberis 
The effects of total caseins on biofilm formation on polystyrene microtitre plates 
were tested by supplementing all cultures with 0, 1, 5 and 10 mg/mL of casein. The 
biofilm assay was performed as described in section 4.2.4.4. 
4.2.4.8 Effect of lactoferrin on biofilm formation in S. uberis  
To test the effect of Lf on biofilm formation, strains of S. uberis were grown in 
THB overnight at 37
o
C, and then cultures in THB were prepared with different 
concentrations of Lf (0.2 mg/mL, 1 mg/mL and 5 mg/mL). The remainder of the procedure 
was the same as the biofilm assay described in a section 4.2.4.4. 
4.2.4.9 Preparation of THB with different EDDA and iron concentrations 
THB media with different concentrations of EDDA and iron were prepared. 
Concentrations of EDDA used were 12.5, 25, 50, and 100 µg/ mL. To complement iron, 
media was prepared at the molar ratio of 2:1 (FeCl3: EDDA). The molecular weight of 
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EDDA is 360.4 where FeCl3 is 162.21. Therefore, required concentrations of EDDA and 
FeCl3 were calculated before being added into THB. For every run, nine different media 
were prepared and labelled as follows: THB, THB/E12.5 (THB + 12.5 µg/mL of EDDA), 
THB/E25, THB/E50, THB/E100, THB/Fe12.5 (THB + 12.5 µg/ml of EDDA + equivalent 
iron at molar ratio of 2:1 with EDDA i.e., 11.25 µg/ml), THB/Fe25 (FeCl3 22.5 µg/ml), 
THB/Fe50 (FeCl3 45 µg/mL), THB/Fe100 (FeCl3 90 µg/mL). Before running each 
experiment media were prepared freshly.     
4.2.4.10 Identification of the effect of iron on biofilm formation in S. uberis 
This study attempted to study the relationship between iron status and biofilm 
formation by S. uberis. Six isolates from cows with low cell milk counts and six isolates 
from cows with clinical mastitis were chosen for this study. S. uberis isolates and reference 
strains (S. epidermidis and S. hominis) stored at -70 
o
C were thawed, plated on BHI agar 
and NA respectively. Overnight cultures were made in THB, and the reference strains were 
subcultured in TSB and incubated at 37 
o
C. At the same time, THB media with different 
EDDA and iron concentrations were prepared (section 4.2.4.9). Nine different media with 
different chemical compositions were prepared (section 4.2.4.9) and bacterial suspensions 
of ~ 10
8
 CFU/mL were diluted 1:100 into different diluents. 100 µL from each dilution 
tube was added to wells of a 96-well microtitre plate. The first three wells were used as 
controls; THB as blank, negative control and positive control using reference strains 
respectively. The plates were incubated overnight at 37 
o
C.  
4.2.5 Congo red agar method 
A method described in 1989 by Freeman et al. was followed to examine the 
ability of S. uberis isolates to produce extracellular polysaccharide (slime). In brief, S. 
uberis isolates were cultured on brain heart infusion (BHI) agar plates containing 5% 
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sucrose and Congo red stain (0.8g/L). Plates were then incubated at 37ºC for 24 to 72 
hours. A positive result was indicated by black colonies with a dry crystalline consistency. 
Colonies that remained pink or darkened at the centers were considered non-biofilm 
producers. Indeterminate results were indicated by a darkening of the colonies but without 
the dry crystalline colonial morphology. Reference strains (S. epidermidis and S. hominis) 
were used as a positive and negative control respectively. 
4.2.6 Statistical analysis 
Assays to determine biofilm formation of bacteria after adding different 
concentrations of milk were carried out in three repeated triplicates (12 assays). Initially 
one way analysis of variance (ANOVA) was used to look for any differences between 
repeats that performed independently. Further, two and three ways ANOVA were used to 
compare the three types of milk at different percentages on three different disease stages. If 
homogeneity of variances could not be confirmed, a nonparametric variant of Tukey’s 
post-hoc test that does not assume equal variances was used for pairwise comparison at α = 
0.05. The statistical analysis was performed with SPSS software (version 18).  
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4.3. Results  
4.3.1 Bacteria identification 
The isolates from cows with low cell count and with subclinical mastitis had been 
identified as S. uberis previously in the microbiology research laboratory at RMIT 
university using Gram stain, biochemical tests (esculin, hippurate and inulin test) and 
molecular methods (S. uberis species-specific PCRs). However, identification in this study 
was confirmed by Gram stain and biochemical tests. All isolates including clinical isolates 
were Gram positive cocci, and the biochemical characteristics showed that all isolates 
hydrolysed esculin and sodium hippurate. All isolates fermented inulin and were catalase 
negative. In addition, clinical isolates were further characterised using S. uberis species-
specific PCRs.  
4.3.2 Biofilm formation 
To determine the conditions for biofilm formation, this study tested the ability of 
streptococci to grow and form biofilms in THB containing different milk types and milk 
components (Table 4-2). One way ANOVA analysis showed no significant difference 
between repeats done in different days and consequently a three way ANOVA was 
conducted to analyse the other three factors; milk type, percentage and mastitis type.  
4.3.2.1 Standard biofilm assay 
        Most isolates from cows (low cell counts, subclinical and clinical isolates) failed to 
produce biofilm (n=14) or were weak biofilm producers (n=12). One isolate from a cow 
with a low cell count (3217.5) was considered to be as a biofilm producer (OD ≥ 0.24) 
(Table 4-2 and Table 4-3). A single-factor between-subject ANOVA was performed in 
order to analyse biofilm formation by S. uberis in THB with regard to the mastitis type. 
The means and standard deviations for biofilm formation by S. uberis isolates from cows 
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with three types of mastitis are presented in Table 4-3. It was found that the mastitis type 
had a significant effect on biofilm production result, F (2,352) = 2956.629, P ˂ 0.001. The 
mastitis type main effect indicated that clinical isolates were stronger biofilm producers 
than other two mastitis types in particular isolates from cows with subclinical mastitis.  
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Table 4-2. Amount of biofilm produced by 27 S. uberis isolates from cows with low cell counts, 
subclinical and clinical mastitis. 
  
Masti
tis 
  Isolates     THB 
Milk THB* 
THB 
iron 
limited 
THB 
lactoferrin 
THB β-
lactoglobuline 
THB 
Casein 
THB 
various 
sugars 
Skim milk THB 
  Raw  
Whole         
pasteurised 
Skim 
pasteurised 
Indigenous 
flora 
No 
indigenous 
flora 
    Milk 
no S. 
uberis 
ND ND +++ + + ND ND ND ND ND + ± 
L
o
w
 C
el
l 
C
o
u
n
t 
  3217.5 + ++ +++ +++ + + ± ± 
+ F 
+ S 
ND ND 
3217.2 ± ++ ++ ++ ± + ± ± ND +++ + 
3217.3 ± ++ +++ +++ + + ± ± 
+ F 
+ S 
ND ND 
3147.5 ‒ ‒** +++ +++ ± ± ± ± ND ND ND 
3147.1 ± ± ++ ++ ND ‒ ± ‒ ND ND ND 
3068.2 ‒ ‒** +++ ++ ND ‒ ± ‒ ND ND ND 
2945.3 ‒ + +++ +++ ± ‒ ± ‒ ND ND ND 
2917.2 ‒ ‒** ++ +++ ND ‒ ± ‒ ND ND ND 
3133.3 ± ‒** ++ ++ ± ± ± ‒ 
+ F 
+ S 
ND ND 
S
u
b
-c
li
n
ic
al
 
684.6 ‒ ‒** + +  ND ND  ND ND ‒ ND ND 
796.3 ‒ + ++ +  ND ND  ND ND ND ND ND 
2655.5 ± ‒** + +  ND ND  ND ND ‒ ND ND 
2407.7 ‒ + + ++  ND ND  ND ND ND ND ND 
2690.2 ‒ ‒** + +  ND ND  ND ND ND ND ND 
2581.2 ‒ ‒** + +  ND ND  ND ND ND ND ND 
686.5 ± ‒** + +++  ND ND  ND ND ‒ ND ND 
796.2 ‒ ‒** + +  ND ND  ND ND ND ND ND 
868.4 ‒ ‒** + ++  ND ND  ND ND ND ND ND 
816.2 ‒ ‒** + ++  ND ND  ND ND ND ND ND 
C
li
n
ic
al
 
3885(1) ± + ++ + ± ‒ ‒ ± 
+ G 
+ F 
+ S 
++ + 
5851(1) ± ‒** ++ ++ ± ‒ ‒ ± 
+ G 
+ F 
+ S 
ND ND 
5851(2) ± ‒** ++ ++  ND ‒ ‒ ± ND ND ND 
3551(1) ‒ ‒** + ++ ‒ ‒ ‒ ± ND ND ND 
3551(2) ‒ ‒** ++ ++  ND ‒ ‒ ± ND ND ND 
3668(1) ± ‒** ++ +++  ± ‒ ‒ ± 
+ G 
+ F 
+ S 
ND ND 
3860(1) ± ‒** + ++  ND ‒ ‒ ± ND ND ND 
3860(2) ± ‒** ++ ++ ± ‒ ‒ ± ND ND ND 
 
 
* Increasing amount with increasing amount of milk 
** Visible loss of biofilm (greatest loss in 12.5% milk in THB, least in 50% milk THB 
F, Fructose; G, Glucose; L, Lactose; S, Sucrose 
ND, Not Determined 
- Negative ≤ 0.12, ± Weak ≈ 0.12 – 0.24, + Positive ≥ 0.24, ++ greater biofilm producer, 
+++ strongest biofilm producer 
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Table 4-3. Biofilm formation by S. uberis in THB.   
Isolates Mastitis type 
No of 
replicates 
Mean (OD) 
Standard Deviation 
(OD) 
Control         No added bacteria 36 0.017 0.01 
      2917.2 Low cell count 12 0.09 0.01 
  2945.3 Low cell count 12 0.09 0.01 
  3068.2 Low cell count 12 0.08 0.01 
  3133.3 Low cell count 12 0.16 0.01 
      3147.1 Low cell count 12 0.17 0.01 
      3147.5 Low cell count 12 0.11 0.01 
  3217.2 Low cell count 12 0.15 0.01 
  3217.3 Low cell count 12 0.18 0.01 
  3217.5 Low cell count 12 0.35 0.02 
684.6 Sub-clinical 12 0.11 0.01 
686.5 Sub-clinical 12 0.16 0.01 
796.2   Sub-clinical 12 0.09 0.01 
796.3   Sub-clinical 12 0.08 0.01 
816.2 Sub-clinical 12 0.09 0.01 
868.4 Sub-clinical 12 0.11 0.01 
  2407.7 Sub-clinical 12 0.11 0.01 
 2581.2   Sub-clinical 12 0.08 0.01 
 2655.5 Sub-clinical 12 0.18 0.01 
 2690.2 Sub-clinical 12 0.09 0.01 
      3551(1)   Clinical 12 0.09 0.01 
  3551(2)   Clinical 12 0.11 0.01 
  3668(1)   Clinical 12 0.11 0.01 
  3860(1)   Clinical 12 0.19 0.01 
 3860(2)   Clinical 12 0.16 0.01 
  3885(1)   Clinical 12 0.18 0.01 
 5851(1)   Clinical 12 0.17 0.01 
 5851(2)   Clinical 12 0.18 0.01 
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4.3.2.2 Growth in milk 
Milk cultures grew to levels of ~ 10
8
 cfu/mL regardless of the amount of milk 
present in the broth or the milk type. 
4.3.2.3 Effect of different types of milk on biofilm formation 
According to crystal violet staining, when raw milk was examined in THB, large 
amounts of biofilm were produced in the absence of S. uberis (Table 4-4-a). In the 
presence of S. uberis, less biofilm was formed (Table 4-4-b); however, large amounts were 
visibly lost during washing. Skim and whole heat-treated milk produced a small amount of 
biofilm in the absence of S. uberis (Table 4-4-a), but the amount produced by most isolates 
increased when S. uberis was added (Table 4-4-b). The amount of biofilm produced was 
comparable to that formed by S. epidermidis RP62A in TSB (Table 4-2, and refer to the 
Appendix 2).  
A 3 x 3 x 3 ANOVA was conducted to evaluate the effects of three different 
mastitis types, in media containing different amounts of milk, and three types of milk on 
biofilm formation by S. uberis. The means and standard deviations of OD values 
representing biofilm formation by S. uberis as a function of the three factors are presented 
in Table 4-4-b. Although there were considerable variation between individual isolates the 
results indicated a significant main effect for percentage of milk, F (2, 2889) = 1951.567, p 
< 0.001, types of mastitis, F (2, 2889) = 214.284, p < 0.001, and milk type, F (2, 2889) = 
28.305, p < 0.001.  
In the presence of S. uberis THB with 50% milk displayed the highest amount of 
biofilm formation while 12.5% was lowest, a finding that was consistent across all milk 
types and mastitis groups. For mastitis types, the amount of biofilm produced was 
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significantly greater for isolates from cows with low cell counts (M = 1.95, SD = 1.32), 
followed by isolates from cows with clinical mastitis (M = 1.37, SD = 1.12) (Table 4-4-b).   
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Table 4-4-a. Biofilm formation by controls (no S. uberis) for milk type and percentage.   
Milk 
Type 
Percentage 
of milk  
No of 
replicates 
Mean 
(OD) 
Standard Deviation 
(OD) 
Skim 
milk 
  
12.5% 
    
 
36 0.12 0.01 
    
25% 
     
 
36 0.15 0.02 
    
50% 
     
 
36 0.18 0.01 
    
Whole 
milk 
  
12.5% 
    
  
 
36 0.12 0.01 
    
25% 
      
 
36 0.15 0.01 
    
50% 
    
 
36 0.17 0.01 
    
Raw 
milk 
  
12.5% 
    
 
36 1.54 0.05 
    
25% 
    
 
36 2.72 0.04 
    
50% 
    
 
36 3.78 0.06 
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Table 4-4-b. Biofilm formation by S. uberis for milk type, percentage, and mastitis types.   
Milk 
Type 
Percentage of 
milk 
Mastitis 
type 
No of 
replicates 
Mean 
(OD) 
Standard 
Deviation (OD) 
Skim 
milk 
  
  12.5% 
Low Cell Count 108 0.81 0.59 
Sub clinical 120 0.32 0.11 
Clinical 96 0.69 0.51 
25% 
Low Cell Count 108 1.52 0.89 
Sub clinical 120 1.06 0.80 
Clinical 96 1.25 0.58 
50% 
Low Cell Count 108 3.38 0.45 
Sub clinical 120 2.21 1.46 
Clinical 96 2.62 0.86 
Whole 
milk 
  
12.5% 
Low Cell Count 108 0.67 0.44 
Sub clinical 120 0.31 0.19 
Clinical 96 0.48 0.27 
 25% 
Low Cell Count 108 1.51 0.87 
Sub clinical 120 0.68 0.40 
Clinical 96 0.91 0.48 
  50% 
Low Cell Count 108 3.16 1.09 
Sub clinical 120 2.09 0.98 
Clinical 96 2.05 0.97 
Raw milk   
     12.5% 
Low Cell Count 108 0.97 0.78 
Sub clinical 120 0.49 0.32 
Clinical 96 0.51 0.23 
  25% 
Low Cell Count 108 1.99 1.07 
Sub clinical 120 1.19 0.64 
Clinical 96 1.31 0.57 
  50% 
Low Cell Count 108 3.56 0.09 
Sub clinical 120 2.38 1.35 
Clinical 96 3.13 0.92 
   
Low Cell Count 972 1.95 1.32 
Total 
 
total Sub clinical 1080 1.28 1.19 
   
Clinical 864 1.37 1.12 
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4.3.2.3.1 The effect of raw milk on biofilm formation by S. uberis 
        The results of the ANOVA indicated a significant main affect for raw milk 
compared with the other milk types on the amount of biofilm produced in media with or 
without added S. uberis. Adding raw milk to the media generally greatly enhanced biofilm 
formation in a dose-dependent fashion, but there were some examples in which the amount 
of biofilm produced in raw milk was lower than in other milk types. The low levels of 
biofilm produced by some isolates in raw milk could be caused by loss of biofilm during 
processing, as visible loss was sometimes observed. This occurred mainly in cultures 
containing 50% raw milk.  The addition of S. uberis to media containing raw milk either 
had no effect, reduced or enhanced biofilm formation (Table 4-2, 4-4-a and 4-4-b, and 
refer to the Appendix 2).    
Fig. 4-1 provides more detailed data on the effect of raw milk on biofilm 
formation by clinical isolates of S. uberis in the presence of media containing 50% milk.  
There was much individual variation in the response of different isolates to the three types 
of milk. For most isolates, the same amount of biofilm was produced in the control 
containing raw milk, but without added S. uberis as in raw milk cultures containing S. 
uberis.  The total amount of biofilm produced by individual isolates was generally greater 
in raw milk than in other milk types; however, a few isolates, for example, isolate 5851(1) 
produced the lowest levels of biofilm in raw milk. The observation that larger amounts of 
biofilm were produced by most isolates in raw milk alone or with added S. uberis, 
compared with other milk types supports the hypothesis that indigenous bacteria in raw 
milk contribute to biofilm formation.   
Although the amount of biofilm was affected by adding raw milk to the culture 
media at different concentrations, growth was not affected, as viable counts of culture 
media in all wells contained approximately 10
8
 cfu/mL despite differences in the amount 
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of milk in the broth. These results showed that the amount of bacterial growth was not 
responsible for individual differences in biofilm formation in raw milk. Therefore, the 
question had to be asked what caused the bacterial biofilm to be washed off in the presence 
of raw milk. In an attempt to answer this question, a series of experiments were carried 
out. 
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Fig. 4-1.  An example of the effect of milk type on biofilm formation by S. uberis (clinical 
isolates) in media containing 50% raw milk (a), whole milk (b) and skim milk (c) determined 
by the polystyrene microtitre plate assay. Data points are represent the average of three 
biological replicates and the error bars show standard deviation for each isolate tested.  
 
a) 
b) 
c) 
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4.3.2.3.2 The effect of whole milk on biofilm formation by S. uberis 
By comparing biofilm formation in the presence of UHT-treated full cream milk 
and raw milk, may shed light on the effect of background microflora and other milk 
components on the amount of biofilm produced.  
In contrast to the observation that biofilms formed in the presence of raw milk were 
easily washed off, biofilms remained intact in the presence of UHT milk. The amount of 
biofilm produced was dose – dependent, with the densest biofilms produced in 50 % milk, 
for example see Fig. 4-1b, Fig. 4-2b and Fig. 4-3b.   
In whole milk, only a small amount of biofilm was produced in the absence of S. 
uberis, but the amount of biofilm produced by most isolates increased when S. uberis was 
added.  In contrast, large amounts of biofilm were produced in THB containing raw milk 
in the absence of S. uberis. With the addition S. uberis, less biofilm was recorded on 
average; however, there were differences between individual isolates, isolate source and 
milk types. For example, two clinical isolates [3885(1) and 5851(2)] produced very dense 
biofilm in 50 % milk (OD >3), while other isolates produced less biofilm (OD 1 to 2.5) in 
50 % whole milk. This is in contrast to the amount of biofilm produced in milk without 
added bacteria, with OD value ~0.5 (Fig. 4-1).  
4.3.2.3.3 The effect of skim milk on biofilm formation by S. uberis 
Skim milk has a reduced fat content compared with whole milk and raw milk. In 
general there were no major differences between the amount of biofilm produced in whole 
and skim milk (table 4-4-b), but examination of individual responses showed that some 
isolates produced more biofilm in whole milk, while others produced more in skim milk  
(Fig. 4-1, Fig. 4-2, Fig. 4-3 and Fig. A2-2 in Appendix 2). For example isolate 3885 (1) 
produced more biofilm in whole milk, whereas isolates 5851 (1), 3668 (1) and 3860 (1) 
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produced more in skim milk (Fig. 4-1). These results suggest that the observed biofilm 
formation by S. uberis was not affected by fat globules in milk, but appeared to be due to 
another milk compound interaction. 
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Fig. 4-2.  An example of the effect of milk type on biofilm formation by S. uberis (subclinical 
isolates) in media containing 50% raw milk (a), whole milk (b) and skim milk (c) determined 
by the polystyrene microtitre plate assay. Data points are represent the average of three 
biological replicates and the error bars show standard deviation for each isolate tested.  
a) 
b) 
c) 
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Fig. 4-3.  An example of the effect of milk type on biofilm formation by S. uberis (low cell 
count isolates) in media containing 50% raw milk (a), whole milk (b) and skim milk (c) 
determined by the polystyrene microtitre plate assay. Data points are represent the average of 
three biological replicates and the error bars show standard deviation for each isolate tested.  
a) 
b) 
c) 
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4.3.2.3.4 The effect of iron on biofilm formation in S. uberis 
A 2 x 5 x 2 ANOVA was conducted to evaluate the effects of two types of mastitis, 
in media containing different amounts of EDDA and FeCl3 and two iron conditions 
(depletion and complemented) on biofilm formation by S. uberis. The means and standard 
deviations of OD values representing biofilm production by S. uberis as a function of the 
three factors are presented in Fig. 4-4. Although there was considerable variation between 
individual isolates and biofilm production was low, even in medium supplemented with 
EDDA, some significant differences were observed. There was a significant effect for type 
of mastitis, F (1, 1360) = 78.032, p < 0.001, concentration of iron, F (4, 1360) = 48.046, 
and iron condition, F (1, 1360) = 126.988, p < 0.001, on the amount of biofilm produced. 
For the six isolates from cows with low cell counts, adding iron chelators to the biofilm 
assay medium enhanced biofilm formation at lowest iron levels. This was followed by a 
decrease of biofilm in a dose-dependent manner. Complementation with FeCl3 partially 
restored biofilm at the highest level of EDDA for all isolates (Fig. 4-4-a and Fig. 4-5-a).  
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Fig. 4-4.  The effects of EDDA concentrations on biofilm formation by six S. uberis 
isolates from cows with low cell counts and five clinical mastitis. Biofilm levels 
(OD600) indices after growth overnight in THB containing EDDA (concentrations 
ranging from 0 to 100 µg/ml) are shown. Bacterial cultures were grown in (a) iron-
depleted media (plus EDDA; low iron) or in (b) iron-replete (plus EDDA + FeCl3; 
high iron). The data represent the averages of three independent experiments. 
Standard deiviations are indicated by the error bars. 
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Fig. 4-5. A representative example of effects of EDDA concentrations on biofilm 
formation by S. uberis isolates from cows with low cell counts. Biofilm levels 
(OD600) after growth overnight in THB containing EDDA (concentrations ranging 
from 0 to 100 µg/ml) are shown. Bacterial cultures were grown in (a) iron-depleted 
media (plus EDDA; low iron) or in (b) iron-replete (plus EDDA + FeCl3; high iron). 
The data represent the averages of three independent experiments. Standard 
diviations are indicated by the error bars. 
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For isolates from cows with clinical mastitis, the ANOVA indicated a significant 
concentration effect with means decreasing in iron-depleted media (plus EDDA; low iron) 
(Fig. 4-4 and Fig. 4-6). Addition of iron to the biofilm assay medium restored biofilm 
formation in clinical isolates to the same levels as the controls. 
There was no difference in the amount of growth in iron-depleted media and iron-
replete media; indicating that the observed effects were not due to differences in growth.  
4.3.2.3.5 The effect of lactoferrin and other milk proteins on biofilm formation in S. 
uberis 
To determine the potential role of Lf in biofilm production by S. uberis, the effect 
of bovine Lf (0, 0.2, 1, 5 mg/mL) on biofilm formation was evaluated by conducting 4 x 2 
ANOVA. The results indicated a significant effect for isolates from cows with low cell 
counts, F (3, 808) = 20.85, p < 0.01; however, these results reflected the strong response of 
three isolates. There was no significant response to Lf for isolates from cows with clinical 
mastitis. The means and standard deviations of biofilm formation by S. uberis for Lf are 
presented in Table 4-5. There was little change in biofilm formation in concentration of 0.2 
and 1 mg/ml Lf, but isolates from three cows with low cell counts responded strongly to 
higher levels of Lf (5 mg/mL) (Fig. 4-7).  
Addition of other milk proteins such as bovine casein and β-lactoglobulin to the 
culture media did not greatly enhance biofilm formation in the any S. uberis isolates (Table 
4-2).  
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Fig. 4-6. An example of effects of EDDA concentrations on biofilm formation by S. 
uberis isolate from cow with clinical mastitis. Biofilm indices after growth for 
overnight in THB containing EDDA (concentrations ranging from 0 to 100 µg/ml) 
are shown. Bacterial cultures were grown in (a) iron-depleted media (plus EDDA; 
low iron) or in (b) iron-replete (plus EDDA; high iron). The data represent the 
averages of three independent experiments. Standard diviations are indicated by the 
error bars. 
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 Table 4-5. Biofilm formation by S. uberis for lactoferrin, concentration, and mastitis 
types. 
  Concentration Mastitis N Mean Standard Deviation 
L
a
c
to
fe
r
r
in
 
0 mg/ml 
Low cell count 108 0.13 0.06 
Clinical 96 0.15 0.04 
0.2 mg/ml 
Low cell count 108 0.15 0.06 
Clinical 96 0.12 0.02 
1 mg/ml 
Low cell count 108 0.19 0.11 
Clinical 96 0.10 0.01 
5 mg/ml 
Low cell count 108 0.38 0.37 
Clinical 96 0.09 0.01 
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Fig. 4-7. Effect of lactoferrin on biofilm formation by S. uberis isolates from low cell 
counts cows (a) and clinical mastitis (b). 
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4.3.2.3.6 The effect of carbohydrates on biofilm formation in S. uberis 
Three isolates from cows with low cell counts (3217.5, 3217.3 and 3133.3), three 
from cows with subclinical mastitis (684.6, 2655.5 and 686.5) and three from cows with 
clinical mastitis (3885(1), 5851(1) and 3668(1)) were tested for their ability to form 
biofilms in the presence of different type of carbohydrate. A 4 x 3 x 3 ANOVA was 
conducted to evaluate the effects of three different mastitis types, in media containing 
different amounts of carbohydrate, and four types of carbohydrate on biofilm production 
by S. uberis. The means and standard deviations of OD values representing biofilm 
formation by S. uberis as a function of the three factors are presented in Table 4-7. The 
results indicated a significant main effect for types of mastitis, F (2, 1260) = 396.189, p < 
0.001, and carbohydrate type, F (3, 1260) = 455.597, p < 0.001. Addition of fructose, 
glucose, or sucrose to THB as the carbohydrate source promoted biofilm formation by S. 
uberis (Table 4-6 and Fig. 4-8); however lactose markedly reduced biofilm formation, 
despite having no effect on growth. The difference in carbohydrate concentration (1% or 
2%) had a similar effect on biofilm formation for all four types of carbohydrate and for all 
mastitis types.  
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              Table 4-6. Biofilm formation by S.uberis for carbohydrate, percentage and mastitis   
types. 
Carbohydrate Percentage Mastitis N Mean 
Standard  
Deviation 
  
Fructose   
0% 
Low cell count 36 0.23 0.08 
Subclinical 36 0.15 0.03 
Clinical 36 0.19 0.01 
1% 
Low cell count 36 0.34 0.08 
Subclinical 36 0.19 0.06 
Clinical 36 0.33 0.03 
2% 
Low cell count 36 0.45 0.08 
Subclinical 36 0.24 0.10 
Clinical 36 0.45 0.03 
Glucose   
0% 
Low cell count 36 0.23 0.08 
Subclinical 36 0.15 0.03 
Clinical 36 0.19 0.01 
1% 
Low cell count 36 0.31 0.08 
Subclinical 36 0.19 0.05 
Clinical 36 0.29 0.04 
2% 
Low cell count 36 0.41 0.08 
Subclinical 36 0.23 0.09 
Clinical 36 0.40 0.05 
Lactose   
0% 
Low cell count 36 0.23 0.08 
Subclinical 36 0.15 0.03 
Clinical 36 0.19 0.01 
1% 
Low cell count 36 0.14 0.05 
Subclinical 36 0.11 0.01 
Clinical 36 0.14 0.01 
2% 
Low cell count 36 0.10 0.04 
Subclinical 36 0.07 0.01 
Clinical 36 0.08 0.01 
Sucrose   
0% 
Low cell count 36 0.23 0.08 
Subclinical 36 0.15 0.03 
Clinical 36 0.19 0.01 
1% 
Low cell count 36 0.30 0.11 
Subclinical 36 0.19 0.02 
Clinical 36 0.24 0.01 
2% 
Low cell count 36 0.35 0.10 
Subclinical 36 0.24 0.03 
Clinical 36 0.28 0.02 
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            Fig. 4-8. An example of the effect of carbohydrates on biofilm formation by S. uberis, 
isolate from cow with low cell count (3217.3), isolate from cow with subclinical mastitis 
(686.5) and isolate from cow with clinical mastitis (5851(1)). 
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4.3.2.3.7 The effect of indigenous flora in raw milk on biofilm formation in S. uberis 
Results reported in section 4.3.2.3.3 showed that biofilm formation in the 
presence of skim milk was generally similar to that produced in the presence of whole 
milk, suggesting that fat globules in milk do not affect biofilm formation. However, the 
comparison of raw milk with whole and skim milk suggested that there might be a 
relationship between S. uberis and background microorganisms that reside in milk.  
Two isolates of S. uberis were selected and a study was undertaken to examine the 
effect of indigenous flora present in raw milk on biofilm formation. Indigenous flora and 
fat were removed from raw milk by centrifugation and filtration, and then biofilm 
formation by S. uberis was assessed in the presence of different percentages of milk 
(12.5%, 25% or 50%) in THB. Controls consisted of defatted unfiltered milk. At each 
concentration of milk in THB, there was a significant difference in the amount of biofilm 
produced in defatted milk without indigenous flora compared with defatted milk with 
indigenous flora (Fig. 4-9). The enhanced biofilm production could be due to either (i) 
indigenous flora enhancing biofilm production by S. uberis or (ii) both S. uberis and 
indigenous flora forming a multi-species biofilm.   
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  Fig. 4-9. An example of the effect of indigenous flora on biofilm formation by S. uberis 
isolates from cows with low cell counts (3217.2) and clinical mastitis (3885(2)). Biofilm 
levels (OD600) after growth in media containing 12.5%, 25% and 50% defatted milk with 
or without indigenous flora. The data represent the average of three biological replicates 
and the error bars show standard deviation for each isolate tested.    
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4.3.2.3.8 Congo red agar method to demonstrate slime production 
Phenotypic production of extracellular polysaccharides (slime) was assessed by 
culturing all isolates on CRA (Fig. 4-10). Plates were examined at 48 h, however the 
classification of two isolates at 48 h was uncertain (almost black) and the incubation was 
extended to 72 h, for a better identification. The two reference strains S. epidermidis 
(RP62A), and S. hominis (SP2) gave the expected results. Among the 27 strains 
investigated, the classification was as follows: 9 very black with a dry crystalline 
consistency (P; strong producer), 7 black (P; moderate producer), 7 almost black (WP; 
weak producer) and 4 red with the absence of a dry crystalline colonial morphology (non 
slime producer). The seven bacterial isolates that only partially stained by the Congo red 
dye (almost black) were considered as weak slime producers. Overall, 18 (≈ 67%) out of 
the 27 S.uberis isolates were shown to be slime producers. In general, the morphology on 
CRA matched the results of the microtitre plate assay; however the CRA assay identified 
more slime producers than the microtitre plate assay evaluation of biofilm. All isolates 
identified as producers (P) or weak producers (WP) by the microtitre plate assay (n = 13) 
produced black colony with a dry crystalline colonies on CRA, indicating slime 
production. Ten isolates were classified as non-producers by the microtitre plate assay, and 
weak producers (n = 6) or producers (n = 4) of slime according to their morphology on 
CRA. The remaining four isolates were identified as non-producers by both methods 
(Table 4-2 and Table 4-7). 
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Fig. 4-10. Colony morphologies of S. uberis on CRA. Different isolates were cultivated 
on CRABHI. Biofilm-positive isolates showed the typical dry crystalline morphology as 
seen in (RP62A, 3133.3, 3885 (1), 5851 (1), and 5851 (2)).  Other morphologies of 
biofilm-negative S. hominis strains (SP2) or intermediate morphologies (2917.2, and 
3551(2)). The digital images of colonies do not always perfectly correspond the closely 
matching appearance as per direct eye observation. 
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     Table 4-7. Phenotype characterisation by polystyrene microtitre plate assay (THB) and 
CRA of   biofilm formation by S. uberis isolates.  
Mastitis Isolates 
Microtitre Plate     
(biofilm production) 
CRA                                                                                          
(slime production) 
THB Results 48 h Results 
L
o
w
 C
el
l 
C
o
u
n
t 
2917.2 ‒ NP       Black with a dry crystalline morphology P 
2945.3 ‒ NP Black with a dry crystalline morphology P 
3068.2 ‒ NP Black with a dry crystalline morphology P 
3133.3 ± WP Very Black with a dry crystalline morphology P 
3147.1 ± WP Black with a dry crystalline morphology P 
3147.5 ‒ NP Black with a dry crystalline morphology P 
3217.2 ± WP Almost Black WP 
3217.3 ± WP Very Black with a dry crystalline morphology P 
3217.5 + P Very Black with a dry crystalline morphology P 
S
u
b
 C
li
n
ic
al
 
684.6 ‒ NP Red with no dry crystalline morphology  NP 
686.5 ± WP Black with a dry crystalline morphology P 
796.2 ‒ NP Almost Black WP 
796.3 ‒ NP Red with no dry crystalline morphology NP 
816.2 ‒ NP Almost Black WP 
868.4 ‒ NP Almost Black WP 
2407.7 ‒ NP Almost Black WP 
2581.2 ‒ NP Almost Black WP 
2655.5 ± WP Black with a dry crystalline morphology P 
2690.2 ‒ NP Red with no dry crystalline morphology NP 
C
li
n
ic
al
 
3551(1) ‒ NP Red with no dry crystalline morphology  NP 
3551(2) ‒ NP Almost Black WP 
3668(1) ± WP Very Black with a dry crystalline morphology P 
3860(1) ± WP Very Black with a dry crystalline morphology P 
3860(2) ± WP Very Black with a dry crystalline morphology P 
3885(1) ± WP Very Black with a dry crystalline morphology P 
5851(1) ± WP Very Black with a dry crystalline morphology P 
5851(2) ± WP Very Black with a dry crystalline morphology P 
 
P: Producer 
WP: Weak Producer 
NP: Non Producer 
* The uncertain classification required further confirmation at 72 h of incubation. 
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4.4 Discussion and conclusion  
Biofilms are a sessile and attached form of bacterial growth that allows survival 
under environmental stresses, for instance, in the presence of host phagocytic cells or 
antibacterial agents. It was not until the last two decades that biofilms were studied in 
connection with chronic diseases. Staphylococci isolated from milk form biofilms more 
frequently than isolates from extramammary sources (e.g., teat skin and milking unit 
liners) (Fox et al., 2005). Thus, this study attempted to investigate if S. uberis isolates from 
milk are able to produce biofilm. Twenty nine S. uberis isolates were tested for their ability 
to form biofilms on a polystyrene surface. The biofilm forming ability of these isolates was 
compared with that of the S. epidermidis strains RP62A and S. hominis strains SP2 (Gill et 
al., 2005). It has been reported that biofilm-positive strain (RP62A) is able to form a thick 
and multi-layered biofilm which results in colonisation of the polymer surface 
(Christensen et al., 1985; Gill et al., 2005), whereas SP2 is a non-biofilm forming strain 
(Christensen et al., 1985; Zhang et al., 2003). To detect bacterial biofilms, the relative 
amount of attached bacteria onto the microtiter plate was determined using crystal violet, 
which stains bacterial cell walls. The ability of the isolates to produce extracellular 
polysaccharide was assessed by Congo red agar. This study looked into the role of factors 
involved in biofilm production by bacteria isolates. 
Biofilm production by S. uberis occurred in most isolates from cows with or 
without mastitis and within the same time frame as S. epidermidis RP62A. Most isolates 
produced lower amounts of biofilm than the control RP62A. Biofilm production has been 
associated with pathogenicity in S. aureus isolates associated with mastitis in the bovine 
(Vasudevan et al., 2003), therefore, the ability of S. uberis to produce biofilm might be a 
desirable virulence factor during colonization of the udder.  
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The addition of milk markedly increased the amount of biofilm formation of S. uberis 
isolates. The effect of added milk on enhancement of biofilm formation by S. uberis in 
THB containing milk was statistically significant (p = 0.001, Table 4-3 and Appendix 1 
and 2). Pairwise comparison revealed that the effect 50 % milk in THB differed from the 
effect of the other treatments (12.5% and 25%). A milk concentration as low as 12.5 % 
was sufficient to stimulate biofilm formation by some isolates (Fig. A2-2 in Appendix 2). 
These results suggest that milk or its components could contribute to the pathogenesis of S. 
uberis mastitis by assisting in biofilm production. These findings are similar to those of 
Varhimo et al., (2010), who reported that skim milk (0.1% and 0.5% w/v) significantly 
enhanced biofilm formation by S. uberis in THB supplemented with yeast extract.   
In the presence of raw milk, S. uberis did not reliably produce stable biofilms, since 
biofilms were easily removed as large clumps observed during washing. No simple 
explanation can be offered for this. One possibility is that a component in raw milk (but 
not pasteurised milk) inhibited or reduced the initial attachment of S. uberis to the surface. 
Raw milk contains various components which enhance bacterial attachment; but there was 
no evidence that this occurred, in fact raw milk appeared to inhibit attachment. This effect 
of raw milk on biofilm formation could be related to natural antimicrobial agents in milk 
or associated with attachment of the bacteria to fat globules resulting in decreasing 
bacterial numbers for adhesion. Immunoglobulins present in cow’s milk can flocculate 
‘‘particles’’ including bacteria and even fat globules. In this way, bacteria can also be 
flocculated on fat globules and accumulate in the cream layer. Heat treatment of milk such 
as pasteurisation may inactivate the agglutinins and reducing the possibility of flocculation 
(Bylund, 2003). Another possibility is that very large amounts of biofilm were produced in 
the presence of raw milk, and these large adherent films were easily lost by the washing 
steps in the microtitre assay.  
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The finding that isolates from uninfected cows grown in THB supplemented with 
milk produced significantly more biofilm than isolates from cows with either subclinical or 
clinical infection differs from findings of two other studies (Varhimo et al., 2010; Crowley 
at al., 2011), that examined biofilm production in different media and used fewer isolates.  
If confirmed, our results could be explained if S. uberis growing within a biofilm attached 
to epithelial surfaces did not attract the attention of the immune system and thus failed to 
elicit a polymorph response. 
 Because milk is a protein-rich exosecretion, it is important to determine what roles 
the different milk components have on biofilm formation. Polystyrene microtitre plate 
assay systems showed that the individual milk proteins, casein and β-lactoglobulin over a 
range of concentrations found in vivo, did not enhance biofilm formation by S. uberis. 
Other studies have shown that individual milk proteins, in particular, β-casein, failed to 
enhance biofilm production by S. uberis (Almeida et al., 2003). Moreover, Fletcher (1976) 
showed that preadsorbed serum albumin and other proteins inhibited bacterial attachment 
to petri dishes. 
Bovine casein or a hydrolysed and partly dephosphorylated product in THB at 
concentrations ranging from 0.2 to 5 mg/mL did not enhance biofilm production by S. 
uberis under the experimental conditions of this study. In contrast, another study (Varhimo 
et al., 2010) showed that casein hydrolysate, α casein, β casein but not  casein 
significantly enhanced biofilm formation by S. uberis. Moreover, degradation of casein by 
a serine protease further enhanced biofilm density, leading the authors to suggest that 
proteases of S. uberis might contribute to biofilm formation. The reasons for the different 
findings in the two studies are unclear. The hydrolysed product used in the present study, 
which contained a mixture of mixture α, β  and  casein, may differ from the product used 
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by Varhimo et al. (2010). Casein is a major protein constituent in bovine milk, 
representing almost 80% of the total protein content. Due to genotypic differences, the 
casein levels in milk are believed to vary between cattle (Varhimo et al., 2011). Thus, the 
conditions used in this study may not represent levels of casein in the milk of all cows. The 
milk protein composition of different cows might affect the growth mode of S. uberis and 
the development of biofilm-related infection. 
It should be taken into account that during mammary gland infection, the response 
of the endogenous proteolytic system present in milk can increase the concentrations of 
collagenase, plasmin from plasminogen, polymorphonuclear (PMN) elastase and some 
cathepsins. The endogenous milk protease plasmin, a serine protease, contributes to 
primary proteolysis of caseins (Melchior, 2011). The continued presence of bacteria in the 
bovine mammary gland epithelial cells or encased in biofilmcould result in the continued 
recruitment of PMNs, and consequently proteolytic activity in milk. Although casein did 
not enhance biofilm production by S. uberis, it is still possible that proteolysis of casein or 
other milk proteins may contribute to biofilm formation.    
Biofilm formation by S. uberis was influenced by the concentration of fructose, 
glucose and sucrose as the carbohydrate source, all of which increased biofilm production. 
However, when lactose was used as the carbohydrate source, the biofilm produced by S. 
uberis was significantly decreased, although the growth was unaffected. This suggests that 
lactose may not be an appropriate carbohydrate source for extracellular matrix production 
by these isolates. This finding could explain the detachment of S. uberis biofilms in the 
presence of raw milk, if lactose affected the attachment process. 
Despite it being well known that iron plays a major role in the virulence of many 
bacterial pathogens, the interaction between iron physiology or virulence of streptococci is 
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still a mystery and not many studies have been done in this area. In addition to regulating 
genes required for iron acquisition, the concentration of iron often regulates virulence 
genes that are not directly involved in its uptake (Eichenbaum et al., 1996). This study 
examined the effects of iron deprivation on biofilm production by S. uberis especially, 
limiting the amount of available iron. Interestingly the results reveal that iron stress 
reduced the amount of biofilm produced by S. uberis.  
Addition of iron chelators to the assay medium at levels that did not inhibit 
planktonic growth led to a concentration-dependent reduction in biofilm formation in the 
clinical isolates. Further, complementation with FeCl3 restored the ability to produce 
biofilm, although not to the original levels. The depression of biofilm by iron depletion is 
in contrast to biofilm production by S. epidermidis which is enhanced by iron depletion 
(Deighton and Borland, 1993), but in agreement with other studies (Weinberg et al., 2004). 
One possible reason for the lack of a positive response of S. uberis to iron depletion is that 
streptococci, unlike staphylococci require very little iron for growth and therefore are not 
stressed by iron depletion (Patel et al., 2009; Weinberg et al., 1978). 
Other streptococci also require very little iron to support their metabolism. These 
include S. suis (Niven et al., 1999) and the human oral pathogen S. mutans (Martin et al., 
1984). However, acquisition of significant amounts of iron has been demonstrated for 
other streptococcal species such as human pathogens S. pyogenes (GAS) (Janulczyk et al., 
2003) and S. pneumoniae (Brown et al., 2001), indicating that requirements of streptococci 
for iron may vary between species.  
Although biofilms of both low cell counts isolates and clinical isolates were 
effectively inhibited by EDDA at concentration of 50 and 100 µl/mL, supplementing the 
medium with FeCl3 did not consistently reverse this inhibitory effect especially for isolates 
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from low cell counts (Fig. 4-4, Fig. 4-5 and Fig. 4-6). It is likely that EDDA chelated some 
divalent ions other than iron essential for growth of S. uberis. These may be essential for 
growth of S. uberis and cannot be replaced by addition of FeCl3 (Fig. 4-4, Fig. 4-5 and Fig. 
4-6). This is in agreement with observations that often iron can be replaced by other metals 
to support streptococcal metabolism. One example might be manganese, as was shown in 
the case of S. mutans (Martin et al., 1984; Smith et al., 2003).  
Another aim of this work was to define the affect of Lf on biofilm production of S. 
uberis. It has been reported by Almeida and Oliver (2006) and Fang et al. (2000) that S. 
uberis adhesion to mammary gland epithelium cells (Mac-T cells) was enhanced by Lf, 
which acts as bridging molecule. Three strains of S. uberis were capable of binding Lf; 
however purified Lf did not increase the attachment in one strain to the epithelial cells. A 
previous report (Moshynskyy et al., 2003) showed that addition of Lf has no effect on 
attachment of S. uberis to the mammary gland cells. Given that Lf promotes adhesion of 
some strains, it was hypothesised that Lf might also promote biofilm production. However, 
this study did not demonstrate any enhancement of biofilm following growth of most 
isolates in medium containing Lf at levels similar to those found in vivo. Lf did, however, 
contribute to an increase in biofilm formation by three isolates, all from cows with low cell 
counts (Fig. 4-7). This could be due to individual strain behaviour. It is likely that different 
surface components of individual strains of S. uberis promote attachment to polystyrene, 
teat skin and Mac-T cells in the presence of Lf. Strains used in the  studies by (Fang et al., 
2000; Moshynskyy et al., 2003; Patel et al., 2009) were probably phenotypically different 
with different surface adhesions. Based on the present study Lf does not appear to play a 
major role in biofilm formation by most isolates of S. uberis; however, it is still possible 
that Lf promotes biofilm formation in vivo. This result is consistent with previous studies 
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showing milk protein, particularly β-casein alone, had no effect on enhancement the 
biofilm formation by S. uberis (Almeida et al., 2003).  
This study showed that S. uberis isolates are capable of forming a dense biofilm 
under certaim conditions in the presence of milk. Biofilms depend on the production of an 
extracellular matrix-containing secreted polysaccharides or protein. Most S. uberis isolates 
produced extracellular matrix as indicated by their growth characteristics on CRA. 
It is possible that various proteins in milk (but not β-lactoglobulin, Lf) destroy the 
bridge between milk components and plastic surfaces, and therefore release the biofilm 
from the plastic. As limited amounts of biofilm were produced when indigenous flora were 
removed from milk and since the amount of biofilm produced by some isolates in 50% raw 
milk was not increased by adding S. uberis, it is likely that indigenous flora contribute to 
biofilm formation acting together with various milk components. Since biofilm production 
in raw milk decreased in the presence of some isolates, S. uberis may contain some 
extracellular product that detaches the indigenous flora or the milk or both. After 
detachment of the milk and indigenous flora, attachment sites might be free for S. uberis. 
In conclusion, results from this investigation indicate that the ability of S. uberis 
to produce biofilms can be enhanced by the addition of milk or individual milk 
components to the growth medium. Lipids in milk are unlikely to contribute to biofilm 
formation as skim milk and whole milk behaved is a similar way, although there was much 
individual variation and clinical isolates generally produced less biofilm in the presence of 
skim milk than other isolates. In addition, in the presence of raw milk, large amounts of 
biofilm were produced but were lost during washing steps; it is unknown whether this was 
a consequence of using microtitre plate assay or whether heavy biofilms also detach from 
mucosal surfaces in vivo.  
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This study throws some light on the interactions that occur between S. uberis, 
milk components and indigenous flora. Biofilm formation in S. uberis is a very complex 
process, which appears to be strain dependent, being promoted by milk and Lf (some 
isolates) and by the pre-existing flora in milk, but not by milk lipids or lactose.  The role of 
casein and its degradation products on biofilm formation requires further investigation.  
The attachment mechanisms may be different in vivo; for example, it is known that S.uberis can 
attach to mammary epithelial cells via S. uberis adhesion molecule (SUAM) and Lf. 
Given the economic impact of mastitis on the dairy industry, continued research 
into understanding the factors that influence the ability of S. uberis to colonize and 
maintain infections is critical for appropriate prevention and treatment. 
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Chapter 5: Virulence associated genes in Streptococcus uberis 
5.1 Introduction 
The rates of mastitis caused by S. agalactiae and S. aureus have been reduced 
significantly due to enhancement of milk hygiene, routine dry cow therapy and 
treatment of infected cows, however infection caused by bacteria from environmental 
reservoirs such as E. coli and S. uberis have not decreased in prevalence (Neave et al., 
1969). Lack of success in controlling bovine mastitis due to S. uberis is associated 
with the route of infection which is not well understood and there is inadequate 
information on pathogenesis of S. uberis (Mathews et al., 1994; Ward et al., 2003). 
Therefore, understanding virulence factors involved in invasion of the mammary 
gland may lead to development of strategies to control this important mastitis 
pathogen (Oliver et al., 1998). The influence of S. uberis virulence factors on host 
defence mechanisms and mammary gland physiology is poorly defined and has not 
received adequate research attention. However, several possible virulence factors of S. 
uberis have been proposed. Among these, hyaluronic acid capsule (Ward et al., 2001), 
the plasminogen activator such as PauA (Field et al., 1993; Rosey et al., 1999), 
lactoferrin binding protein (Lbp) (Moshynskyy et al., 2003), adherence to and 
invasion of epithelial cells mediated by SUAM (Almeida et al., 2006), Opp proteins 
involved in the active transport of solutes essential for the growth in milk (Reinoso et 
al., 2011; Smith et al., 2002), CAMP factor (Hassan et al., 2000; Jiang et al., 1996; 
Skalka et al., 1980), and hyaluronidase (Khan et al., 2003; Schaufuss et al., 1989), 
have been proposed. 
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5.1.1 Hyaluronic acid capsule  
It has been established that microorganisms may become more resistant to 
phagocytosis when the binding of antibody or complement to the bacterial cell is 
prevented by the capsule or by blocking the receptors on the phagocytic cells. Due to 
its role against phagocytic cells, the bacterial capsule is considered a virulence factor 
of some bacterial species (Ward et al., 2001). Phagocytosis and killing of bacteria by 
neutrophils is a major defence mechanism of the bovine mammary gland during 
lactation, and is responsible for controlling infections caused by S. aureus and 
eliminating infections caused by E. coli. The same is not the case for infection caused 
by S. uberis and the role of phagocytic cells in mastitis due to S. uberis appears less 
clear (Field et al., 2003).  
Leigh and Field (1994) reported that the production of hyaluronic acid 
capsule by S. uberis correlated with the ability to resist phagocytosis. The author 
showed also the ability of S. uberis to resist phagocytosis was significantly reduced 
when the capsule was removed by treatment with hyaluronidase. Furthermore, studies 
conducted by Field et al. (2003) and Ward et al. (2009) comparing a capsulated strain 
and a non-capsulated strain of S. uberis, showed that the capsulated strain was more 
capable of establishing infection in the lactating mammary gland. However, Leigh et 
al. (2004) reported that the ability of both organisms to resist phagocytosis was equal 
especially when the release of an effector molecule on cultivation of S. uberis in 
bovine milk resulted in the inhibition of neutrophil function. Capsule production is 
dependent on the Has operon, which is a cluster consisting of the hasAB gene and the 
hasC genes (Ward et al., 2001). In a study of isolates from New Zealand and the 
United Kingdom, Pullinger et al. (2006) showed that encapsulated bacteria were 
associated with sub-clinical mastitis. In contrast, studies in Denmark showed that 
carriage of the gene essential for capsule production (hasA) correlated with clinical 
Chapter 5. Virulence associated genes in S. uberis 
Page 142 
 
infection, however bacterial pathogenicity was not affected by mutation of hasA. Field 
et al. (2003) and Reinoso et al. (2011) reported that hasABC genes occurred at a 
higher frequency in the isolates associated with mastitis than is isolates not associated 
with mastitis. Their results indicated that these genes are the only ones required for 
capsule production, suggesting that the capsule is required for some cases of bovine 
mastitis and pathogenesis. In spite of numerous studies, the role of capsule in the 
pathogenesis of clinical mastitis is still a mystery.  
5.1.2 Plasminogen activator proteins (PauA & PauB)  
The presence of the caseinolytic enzyme plasmin improves bacterial growth 
in milk from infected cows (Mills and Thomas, 1981). Plasminogen activators present 
in blood plasma and animal tissue play a major role in generating plasmin from 
plasminogen (Collen, 1980; Leigh and Lincoln, 1997; Zhang et al., 2012). Some 
streptococcal species are capable of producing plasminogen activators, such as the 
enzyme streptokinase while S. aureus produces the enzyme staphylokinase. During 
the very early stages of bovine mastitis, the activation of plasminogen by streptokinase 
could facilitate the bacterial colonization in the lactating gland by increasing the 
release of nutrients (Leigh, 1993). 
In 1997, Leigh and Lincoln speculated that streptokinase, which activates 
bovine plasminogen, might be an essential virulence factor of S. uberis enhancing its 
ability to grow in the mammary gland. The streptokinase secreted from S. uberis 
activates bovine and ovine plasminogen (Kliem and Hillerton, 2002; Rosey et al., 
1999) whereas S. pyogenes (Lancefield group A) and S. equisimilis (Lancefield group 
C) activate both feline and human plasminogen. The Lancefield group E streptokinase 
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activity differs from other streptokinases by activating porcine plasminogen (Leigh, 
1993). 
It has been hypothesized that the capability of S. uberis to grow in mastitic 
milk could depend on the activation of plasminogen by the plasminogen activator 
PauA and this therefore could facilitate early mammary gland colonization prior to 
infection (Leigh, 1993; Leigh, 2000; Leigh et al., 1999; Rambeaud et al., 2004; Smith 
et al., 2002). However, Ward et al. (2003) showed that the activation of plasminogen 
by PauA has no effect on bacterial growth in milk or mammary gland inflammation. 
Nevertheless, vaccination with plasminogen activator, which induced a neutralizing 
antibody response, reduced the rate of colonization and decreased the incidence of the 
disease following experimental challenge with homologous and heterologous strains 
of S. uberis (Leigh et al., 1999).  
In a more recent study, Ward and Leigh (2002) identified a plasminogen 
activator which they have named PauB. Both native and recombinant forms of PauB 
displayed an unexpectedly broad specificity profile for bovine, ovine, equine, caprine, 
porcine, rabbit, and human plasminogen. However, there was no a single isolate found 
to encode the pauB gene when isolates from dairy cows in the United Kingdom and 
The Netherlands with clinical mastitis were screened for this plasminogen activator. 
Therefore, their finding suggested that the role of PauB in S. uberis pathogenesis is 
still unclear. It remains to be seen whether the abundance of PauB increases when 
other isolates of S. uberis are examined or whether indeed it is identified in other 
streptococci, resulting from the absence of species specificity displayed by PauB.    
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5.1.3 Lactoferrin binding protein (Lbp) 
Lactoferrin is an iron-binding glycoprotein found in bovine milk and 
depending on the severity of bovine mastitis, the concentration of Lf may increase up 
to 30-fold. The biological roles of Lf include amplification of the bovine mammary 
gland inflammatory response by promoting adhesion and aggregation of 
polymorphonuclear neutrophils (PMNs) to the endothelial surface, stimulating of 
macrophages and inhibiting granulocyte–monocyte colony-stimulating factor which 
lead to antibody production (Moshynskyy et al., 2003). According to the same author, 
Lf effects bacterial growth by iron limitation. However, certain Gram-negative 
bacteria such as Neisseria meningitidis and Haemophilus influenzae have surface 
receptors with specificity for LF and are able to use Lf as an iron sources. For this 
reason, it is believed that iron-binding receptors, which are named as Lf binding 
proteins (Lbp), are essential for bacterial pathogenesis and might be important 
virulence factors (Moshynskyy et al., 2003). Although, some Gram-positive pathogens 
including S. agalactiae, S. aureus and coagulase negative staphylococci possess Lf 
specific receptors on their surface, there is a lack of information regarding the role of 
Lf receptors of these pathogens and their possible role in pathogenesis (Moshynskyy 
et al., 2003; Patel et al., 2009).   
5.1.4 Streptococcus uberis adhesion molecule (SUAM) 
Streptococcus uberis adhesion molecule (SUAM) has been identified recently 
by studies conducted in vitro as a protein with an affinity for Lf, that plays a major 
role in the attachment of S. uberis to gland tissues particularly in the first stages of 
bovine mastitis and colonisation (Patel et al., 2009). This finding agreed with a study 
by Almedia et al. (2006), who reported that adherence and internalization was 
inhibited when S. uberis was pre-treated with antibodies to SUAM. However, the 
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internalization of S. uberis into mammary epithelial cells was significantly increased 
when the colonization assays were performed using cell growth medium containing 
bovine Lf. Their results supported the hypothesis that the interaction between SUAM, 
bovine Lf, and a putative Lf receptor on the bovine mammary epithelial cell surface 
could serve as a bridging molecule for internalization of S. uberis into mammary 
epithelial cells. Therefore, they indicated that the SUAM is a potential virulence factor 
involved in the pathogenesis of S. uberis mastitis. 
5.1.5 Opp proteins and mtuA gene 
It has been reported that the ability of S. uberis to hydrolyse casein to release 
the free and peptide-associated amino acids is very poor and therefore the organism 
produces PauA which assists in hydrolysing casein (Kitt and Leigh, 1993; Leigh, 
1997). In this process, the essential amino acids are released which can be taken up by 
S. uberis through the oligopeptide ABC transporter encoded by the opp operon, 
another important factor playing a role in the growth of S. uberis in milk (Smith et al., 
2002; Taylor et al., 2003). 
In addition to amino acid uptake, a further study conducted by Smith et al. 
(2003) found that the metal transporter uberis A, a product of the mtuA gene, which is 
involved in uptake of manganese (Mn
2+
) to be essential for growth of S. uberis in 
bovine milk.  
5.1.6 CAMP factor 
Christie et al. (1944) first described and named the CAMP phenomenon after 
a streptococcal culture was streaked next to a haemolytic S. aureus culture on blood 
agar and incubated at 37
o
C overnight. A distinct zone of complete haemolysis was 
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produced by streptococci within the diffusion zone of S. aureus. The CAMP factor of 
S. agalactiae is an extracellular protein with a molecular weight of 23.5 kDa. In 
addition to the extensive study of the CAMP factor of S. agalactiae (Bernheimer et al., 
1979; Brown et al., 1974; Jurgens et al., 1985, 1987; Ruhlmann et al., 1988; Skalka et 
al., 1980), many other bacteria are known to produce a positive CAMP reaction, 
including Pasteurella haemolytica, Aeromonas spp. and S. uberis (Figura and 
Guglielmetti, 1987; Fraser, 1962; Frey et al., 1989; Jiang et al., 1996; Valanne et al., 
2005). The ability to demonstrate the CAMP phenomenon of S. agalactiae using the 
exotoxin of Corynebacterium pseudotuberclosis in place of the ß -toxin of S. aureus 
was examined. Both S. agalactiae and S. uberis were capable to hemolyse the  the ß –
toxin zone of the ß –toxin by their exosubstances while a clear hemolysis of the 
exotoxin zone of C. pseudotuberclosis caused only by S. agalactiae (Skalka et al., 
1980). Rabbits and mice were injected intraperitoneally by exosubstances of S. uberis 
and S. agalactiae. Different clinical signs appeared shortly after 2 mins mainly on 
rabbits such as; dyspnoea, stomach pain and muscles spasm. Later on 1996 Jiang et al. 
have determined the nucleotide sequence of the S. uberis CAMP factor gene. 
However, the role of CAMP factor in S. uberis virulence and pathogenesis is still 
uncertain. In a recent study of Australian isolates of S. uberis, 15 of 31 (48%) 
possessed the hasA gene whereas none of nine (0%) possessed the gene (Tomitta, PhD 
thesis, RMIT University, 2008).   
5.1.7 Hyaluronidase 
Hyaluronidase is a general term used to describe enzymes that are capable of 
degrading the hyaluronic acid component of connective tissue and therefore facilitate 
the spread bacteria through tissues. Bacterial hyaluronidase acts as endo-N-
acetylhexosaminidases by elimination across the L-1-4 linkage (Hynes and Walton, 
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2000). Gram positive bacteria able to produce this enzyme include S. aureus, S. 
dysgalactiae, and S. uberis (Calvinho et al., 1998; Schaufuss et al., 1989; Skalka, 
1985). Specific bacteriophages from S. pyogenes and S. equi, encode hyaluronidases. 
The host cells of both of these phages were surrounded by the hyaluronic acid capsule, 
and therefore the bacteriophages encode hyaluronidase produced by the host cell to 
penetrate capsular material. No hyaluronidase activity was detected in the extracellular 
milieu of either S. pyogenes or S. equi infected with the temperate bacteriophages 
(Hynes and Walton, 2000; Hynes et al., 1995; Timoney et al., 1982). The results 
indicate that it is most likely the hyaluronidase component of streptococci that is 
encoded by bacteriophage (Ward et al., 2009).  It has not been established whether the 
hyaluronidase produced by S. uberis enhances virulence by aiding spread through host 
tissues.   
5.1.8 Comparison of virulent and non-virulent strains of S. uberis  
Over a number of years, development of vaccines against bovine mastitis due 
to S .uberis has been a major focus of scientific research, and a number of specialized 
techniques have been developed to this purpose, however, there was no great success 
and many potential vaccines failed (Hill et al., 1994; Leigh, 1999; Leigh et al., 2010). 
For instance, antigens derived from potential virulence associated genes such as PauA 
have been used in vaccine trials but cows remained infected, indicating that these 
vaccines do not provide a full protection towards S. uberis mastitis (Leigh et al., 1999; 
Leigh and Lincoln, 1997). The main key to S. uberis virulence factors is still unclear 
and should be investigated. Understanding of the genes associated with virulence of S. 
uberis is essential for successful vaccine production.  
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Genome comparisons between virulent and non-virulent strains within a 
species are useful for the identification of determinants which are essential for 
transmission, host specificity and virulence.   
In a previous study conducted by Tomita et al. (2008), multi locus sequence 
typing (MLST) was used to characterise Australian S. uberis isolates. Global clonal 
complexes (GCCs) that were highly-associated with clinical and subclinical mastitis in 
the S. uberis population were identified. Potentially virulent isolates from cows with 
clinical mastitis mainly belonged to GCC ST143 and GCC ST5, whereas potentially 
non-virulent isolates from cows with a low somatic cell count mainly belonged to 
ST86.  In a subsequent study (Tomita, PhD thesis, RMIT University, 2008) one isolate 
from GCC ST143 and one from GCC ST86 were selected as tester and driver 
respectively and analysed by subtractive hybridization. After identification of clones 
associated with disease, a collection of disease and commensal isolates was examined 
by Southern blot analysis for the presence of twenty tester-specific sequences or 
potential virulence associated genes. Of these, HasA gene and sequences aligning with 
ribos5-phosphate isomerase, RpiB, tagatose-6-phosphate kinase, putative acyl-CoA 
synthetase, and collagen-like surface protein demonstrated a statistically significant 
linkage relationship between their occurrence and both disease status and GCC type. 
Microarray techniques have quickly become powerful tools for bacterial 
transcriptome analysis (DeRisi et al., 2000; Khodursky et al., 2000) and genetic 
diversity analysis (Garaizar et al., 2006; Hacia, 1999). In contrast to Southern blotting, 
where a limited number of probes are transferred onto nitrocellulose or nylon 
membranes, a microarray includes tens of thousands of probes arrayed directly on the 
support and it therefore constitutes a high-throughput genotyping method (Li et al., 
2009). Moreover, microarray offers the latest technological advancement for multi-
Chapter 5. Virulence associated genes in S. uberis 
Page 149 
 
gene detection and diagnostics. It has been applied to investigate global changes in 
gene expression of cells and tissues, DNA sequence analysis and immunology. 
Microarray techniques are useful for distinguishing between DNA sequences which 
could have just single nucleotide polymorphisms (SNP) (Call, 2001). When a given 
gene sequence is found in virulent isolates but not in non-virulent isolates, this 
suggests that the gene sequence could be associated with virulence (Brown et al., 
2000; Dorrell et al., 2005).   
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5.1.9 Objectives 
The aim of this study was to investigate the virulence factors of S. uberis 
using comparative genome analyses using isolates from cows with clinical mastitis 
and isolates from cows with a low cell count in their milk using a Subtracted Diversity 
Array (SDA). In addition, the current research focused on fingerprinting the virulent 
and non-virulent isolates using the SDA technique. A pool of isolates belonging to 
GCC ST143/GCC ST5 and GCC ST86 was used as tester and driver pools 
respectively. A set of twenty-nine S. uberis isolates was fingerprinted to evaluate the 
potential of the SDA to discriminate virulent strains from non-virulent, establish 
genetic relationships between these genotypes, and to identify possible virulence 
determinants.  
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5.2 Materials and methods 
5.2.1 Selection of S. uberis isolates for microarray analysis 
In order to obtain a DNA representation for the subtraction a total of 29 S. 
uberis isolates consisting of isolates from cows with low cell counts and isolates from 
cows with clinical infection were sourced (Table 5-1). All isolates were sourced from 
farms in Gippsland, Victoria State, Australia. Nine isolates were selected from cows 
with low somatic cell counts (assumed to be pathogenic) while twenty isolates were 
from cows with clinical mastitis (assumed to be pathogens). Twelve isolates were 
collected for a previous study conducted at RMIT laboratory by Tomita et al. (2008). 
Eight isolates were collected as part of an investigation of an internal teat sealant 
(Runciman et al., 2010). These eight isolates were used in the PFGE study (Chapter 
3). The identification of all isolates was confirmed biochemically and by molecular 
methods (details in section 2.5.4). 
5.2.2 DNA extraction  
Genomic DNA was extracted from the different S. uberis strains using a 
Wizard® Genomic DNA Purification Kit in accordance with the manufacturer’s 
instructions (Promega, 1999). Briefly, cells from 10 mL of an overnight culture in 
THB, incubated at 37 
o
C were harvested by centrifugation at 3382 × g and 4 
o
C. The 
pellet was resuspended in 1 mL of 50 mM EDTA and transferred to a new centrifuge 
tube. The pellet was centrifuged at 16,100 × g for 3 min, again resuspended in 1 ml of 
50 mM EDTA and centrifuged at 16,100 × g for 3 min. The resultant pellet was 
resuspended in 380 μl of 50 mM EDTA. Bacterial cells of each sample were lysed by 
the addition of 60 μL of 10 mg/ml lysozyme and the bacterial suspensions gently 
mixed. The samples were then incubated at 37°C for one hour then 600 μl of Nuclei 
Lysis Solution was added and incubated at 80°C for 5 min. The tubes were cooled to 
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room temperature before each cell lysate was treated with 1.5 μl of RNase solution (10 
mg/ml) and mixed by inverting several times then incubated at 37°C for 30 min. The 
samples were then cooled to room temperature before the addition of 200 μl of Protein 
Precipitation Solution. The samples were vortexed vigorously for 20 s and incubated 
on ice for 5 min prior to centrifugation at 16,100 x g for 3 min. The supernatant 
containing the DNA was carefully removed and transferred to a clean 1.5 ml 
microcentrifuge tube containing 600 μl of room temperature isopropanol. The samples 
were gently mixed by inversion prior to incubation at room temperature for 15 min 
then centrifuged at 16,100 x g for 10 min. The supernatant was carefully decanted 
prior to the addition of 600 μl of 70% cold ethanol then the tubes were gently inverted 
several times to wash the DNA before centrifugation at 16,100 x g for 10 min. The 
supernatants were carefully aspirated, and the DNA pellets air dried for 15 min. 100 μl 
of DNA Rehydration Solution was added and the DNA was rehydrated by incubating 
at 65°C for one hour, or overnight at 4°C. The resuspended genomic DNA was 
purified and subsequent clean up was performed using the DNeasy® column of the 
DNeasy
®
 Blood & Tissue Mini Kit (Qiagen) following the protocol in the user 
manual. The genomic DNA was stored at -20°C for long-term. 
5.2.3 Development of tester and driver pools 
Streptococcus uberis isolates from cows with clinical mastitis and belonging to 
MLST types associated with virulence were selected as the source of genomic tester 
DNA. Isolates from cows with low cell counts and thought to represent possible non-
virulent isolates were selected as the source of genomic driver DNA for suppression 
subtractive hybridization (Table 5-2). All the isolates were collected during a previous 
study conducted at RMIT laboratory by Tomita et al. (2008). The tester pool consisted 
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of six isolates belonging to GCC ST5 and GCC ST143, while the driver pool 
consisted of six isolates belonging to GCC ST86s.  
5.2.4 Determination of genomic DNA concentration 
The concentration and purity of the genomic DNA pools were evaluated 
spectrophotometrically by measuring the absorbance (A) at 260 nm (A260nm) and 280 
nm (A280nm). DNA which had an A260nm/A280nm ratio of 1.8 to 2.0 was considered to be 
pure according to (Qiagen).   
 
. 
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   Table 5-1. Streptococcus uberis isolates selected for suppression subtractive hybridization  
   Disease              
status
i
 
Farm  
location 
  Isolate  
ID
ii
 
PFGE type      Source 
 
C Timboon      883-4                         Tomita et al. 2008  
C Newry 2169-2      11b          Tomita et al. 2008  
C Newry 2285-1 5a Tomita et al. 2008 
C Newry 2530-2 10b Tomita et al. 2008 
C Newry 2565-2 29 Tomita et al. 2008 
C Newry 2730-5 25 Tomita et al. 2008 
C Newry 2874-4 31a Tomita et al. 2008 
C Newry 2988-1 5d Tomita et al. 2008 
C Newry 3064-1 12 Tomita et al. 2008 
C Korumburra 5838-3 24 Tomita et al. 2008 
C Maffra 6093 34 Tomita et al. 2008 
C Maffra 6104 35 Tomita et al. 2008 
C D   2905(1)* 12 Runciman et al. 2010 
C T   3531(1)* 26 Runciman et al. 2010 
C M   3571(1)* 10 Runciman et al. 2010 
C M   3599(1)* 13 Runciman et al. 2010 
C P   3885(1)* 45a Runciman et al. 2010 
C J   4707(2)* 35a Runciman et al. 2010 
C R   6232(1)* 16 Runciman et al. 2010 
C J   7218(1)* 25 Runciman et al. 2010 
L Newry     2917-2** L31 Tomita et al. 2008 
L Newry     2945-3** L35 Tomita et al. 2008 
L Newry     3068-2** L55 Tomita et al. 2008 
L Newry 3133-3 17 Tomita et al. 2008 
L Newry 3147.5 16 Tomita et al. 2008 
L Newry 3147-1 21 Tomita et al. 2008 
L Newry 3217-1 15 Tomita et al. 2008 
L Newry 3217-3 19 Tomita et al. 2008 
L Newry 3333-3 20 Tomita et al. 2008 
 
i. Disease status is represented as follows: C, clinical mastitis; L, low cell count. 
ii. Isolate identification; suffixes -1, -2, -3, -4 refers to the colony number 
when several colonies were examined from a single plate. Suffixes (1), (2) 
refers to the episode number in cows with more than one episode of 
clinical mastitis.  
  * These isolates were part of the PFGE study (Chapter 3). 
** Unpublished data. 
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Table 5-2. Streptococcus uberis isolates selected as tester and driver for suppression 
subtractive hybridization  
Disease status  Farm location 
 
 Isolate ID     
 
PFGE type 
 
Global clonal  
     complex (GCC) 
C Newry 2893-1 28 143 
C Newry 2520-1 26 143 
C Moe 5851 33 5 
C Newry 2481-1 5b 5 
C Newry 2907-1 3 5 
C Newry 2956-4 5c 5 
L Newry 2655-5 22 86 
L Newry 3217-5 31b 86 
L Newry 3327-3 32 86 
L Newry 3217-2 18 86 
L Newry 2690-2 27 - 
L Newry 3147-4 11a - 
 
Disease status is represented as follows: C, clinical mastitis which was 
used as tester; L, low cell count which was used as driver. GCC has been 
assigned by the S. uberis MLST database (Tomita et al., 2008). -, goes not 
belong to any GCC. 
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5.2.5 Suppression subtractive hybridization (SSH) 
The gDNA subtraction, library and microarray construction were 
performed according to the procedure described by Jayasinghe et al. (2007). 
Subtraction was conducted on the basis of manufacturer’s instructions (Clontech, 
2008) described in the PCR-Select™ cDNA Subtraction Kit. Equal amounts of DNA 
extracted from six clinical mastitis isolates represented the tester pool while the driver 
pool was represented by equal amounts of DNA extracted from six low cell counts 
isolates (Table 5-2). Fig. 5-1 and Fig. 5-3 are present the steps in Rsa I digestion and 
Adaptor ligation of tester DNA, a two-round subtractive hybridization and PCR 
enrichment using Rsa I digested driver DNA.  
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Fig 5-1. Subtractive hybridization and PCRs chart adapted from PCR-Select™ 
Bacterial Genome Subtraction Kit (Clontech, 2008). 
Subtracted 
tester-specific 
DNA sequences 
Unsubtracted 
tester-specific 
DNA sequences 
Control primary PCR 
with primer 1 
Primary PCR 
with primer 1 
Control secondary 
PCR with nested 
primer 1 and 2R 
Secondary PCR 
with nested 
primer 1 and 2R 
pGEM
®
-T Easy vector 
Construction of 
clone library  
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5.2.5.1 Restriction digestion  
Due to its importance for subtraction and ligation, 4 µg of both tester and 
driver pools were digested overnight at 37
o
C using the tetra-nucleotide restriction 
endonuclease Rsa I and mixed with 6 µL of 10X Rsa 1 Restriction Buffer in a final 
reaction volume of 60 µL containing 20 U of the enzyme. The final volume was made 
up with molecular grade water. Purification of digested DNA was performed using 
phenol: chloroform extraction and the DNA was precipitated using ethanol-
ammonium acetate before being resuspended in 5.5 µL of water. 
5.2.5.2 Adaptor ligation  
The digested and purified tester DNA pool was aliquotted into two separate 
tubes (tester 1-1 and tester 1-2) and ligated to Adaptor 1 or Adaptor 2R (Fig. 5-1). The 
ligation reactions were set up as shown in (Table 5-2). 1.5 μL of each tester DNA pool 
ligation reaction (tester 1-1 and 1-2) were combined before overnight ligation, ligated 
for use as a control for unsubtracted hybridization (tester control 1-c). After ligation 
was complete at 16 
o
C overnight, the ligation reaction was stopped by adding 1 µL of 
0.2 M EDTA then the ligase was inactivated by heating the samples to 72 
o
C for 5 
min. 1 µL of unsubtracted tester (tester control 1-c) was removed and diluted into 1 
mL of molecular grade water and stored at -20 
o
C until use. 
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           Table 5-3. Setting up the ligation reactions  
Component Tester 1-1 (µL) Tester 1-2 (µL) 
 
Digested tester DNA pool (120 ng)        1          1 
 
T4 DNA ligase (400 units/µL)        1          1 
 
5X ligation buffer        2          2 
 
Adaptor 1 (10µM)        2          - 
 
Adaptor 2R (10µM)        -          2 
 
Sterile H2O 
 
       4 
 
         4 
 
 
Total volume        10         10 
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                                                                                                 Nested PCR primer 1  
Adaptor 1             5'-CTA ATA CGA CTC ACT ATA GGG CTC GAG CGG CCG CCC GGG CAG GT-3' 
         
         
         PCR Primer 1      5'-CTA ATA CGA CTC ACT ATA GGG C-3' 
   
         
         
       
Nested PCR primer 2R 
 Adaptor 2R           5'-CTA ATA CGA CTC ACT ATA GGG CAG CGT GGT CGC GGC CGA GGT-3' 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5-2. Sequences of adaptors and PCR primer, when: 
 PCR primer 1 was binding to adaptor 1 and 2R, and used for Primary PCR. 
    Nested PCR primer 1 was ligated to adaptor 1 and 2R, and used for Secondary PCR.  
 Nested PCR primer 2R was ligated to adaptor 1 and 2R, and used for Secondary PCR. 
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5.2.5.3 First subtractive hybridization   
In order to perform subtraction, 2 µL of an excess of driver DNA was added 
to 1 µL of each adaptor-ligated tester DNA (tester 1-1 and tester 1-2) before the 4X 
Hybridization buffer (1 µL) was added. During the first hybridization the final volume 
(4 µL) of each sample was heat denatured at 98 
o
C for 90 sec using PCR machine heat 
block. The samples then were allowed to anneal at 60 
o
C for 1.5 hr. This temperature 
was chosen because the hybridization temperature for subtractive hybridization 
depends on the GC content of a particular genome. A review by Hacker et al. (1997) 
showed that the optimal hybridization temperature for genomic DNA with an average 
GC content 40-51%, for instance, (S. typhimurium, D. nodosus, E. coli, and Y. 
enterocolitica) is 63°C. However, in the case of C. perfringens (26.5%) or S. uberis 
(36.63%), the hybridization temperature might be reduced to 60°C as the GC value of 
the genomic DNA is low. In this step the homologous sequences between the driver 
and tester were hybridized, leaving almost all of the tester specific DNA single 
stranded (Fig. 5-3). 
5.2.5.4 Second subtractive hybridization   
After the first hybridization, the two samples (adaptor-ligated tester 1-1 and 
1-2) were combined together in one tube, and fresh denatured driver DNA was added 
to further enrich for tester-specific sequences. The entire mixture was incubated at 60 
o
C overnight prior to adding 200 µL of dilution buffer and mixed well by pipetting. 
During the two hybridizations, tester : driver  ratio was 1 : 30, and at the end of the 
second hybridization, tester specific DNA should be the only double stranded DNA 
with a different adapter sequence at the 5’-ends (Fig. 5-3). The resultant double-
stranded Type e molecules contained tester-specific sequences with two different 
annealing sites for nested PCR primers 1 and 2R at their 5´ and 3´ ends which 
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contributed subsequent selective amplification following a two-step nested PCR 
(Clontech, 2008). 
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Fig. 5-3. Schematic diagram of PCR-Select bacterial genome subtractive hybridization protocol. 
Type e molecules are formed only if the sequence is present in the tester DNA, but absent in 
the driver DNA. Solid lines represent the Rsa I-digested DNAs. Solid boxes represent the 
outer part of the Adaptor 1 and 2R overhanging strands and the corresponding PCR Primer 1 
sequence. Clear boxes represent the inner part of Adaptor 1 and the corresponding Nested 
Primer 1 sequence. Shaded boxes represent the inner part of Adaptor 2R and the 
corresponding Nested Primer 2R sequence (Clontech, 2008). 
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5.2.6 PCR Amplification of subtracted DNA 
5.2.6.1 Primary PCR  
Primary PCR and secondary PCR were performed in a Perkin-Elmer Gene 
Amp PCR System 2400 with hot start to amplify exponentially tester specific DNA. 
According to the manufacturer’s instructions (Clontech, 2008), the primary PCR was 
performed with a PCR master mix containing 10X PCR buffer, 0.2 mM dNTP, 0.4 
µM of primer 1, and 1 µL of the diluted subtracted tester-specific DNA fragments. 
The reaction mix then was incubated at 75
o
C for 60 sec to fill in the missing strands of 
the adaptors, creating the binding sites for PCR Primer 1 before adding 2 U of Taq 
DNA polymerase to each tube in a final reaction volume of 25 µL. The reaction was 
incubated for a further 5 min at 75
o
C. The samples were not removed from the thermal 
cycler; the thermal cycling was immediately commenced using 94
o
C, 2 min followed 
by 32 cycles of: 94°C, 30 s; 65°C, 45 s; 72°C, 90 sec, and a final extension step at 
72°C for 5 min.   
5.2.6.2 Secondary PCR  
After amplification, the secondary PCR was commenced by diluting 1 µL 
of the primary PCR amplicons in 39 µL molecular grade water. Afterwards, the 
secondary PCR was performed using 10X PCR buffer, 0.2 mM dNTP, 0.4 µM of 
Nested PCR primer 1 and Nested PCR primer 2R, and 1 µL of the diluted primary 
PCR product. The reaction mix then was incubated at 75
o
C for 3 min before adding 2 
U of Taq DNA polymerase to each tube in a final reaction volume of 25 µL. The 
reaction was incubated for a further 3 min at 80
o
C. The samples were not removed 
from the thermal cycler; the thermal cycling was immediately commenced using 23 
cycles of: 94°C, 33 s; 65°C, 45 s; 72°C, 90 sec, and a final extension step at 72°C for 
5 min.   
Chapter 5. Virulence associated genes in S. uberis 
Page 165 
 
5.2.7 Cloning of the subtracted sequences  
Amplified products of the nested PCR by the secondary PCR were cloned 
into the pGEM
®
-T Easy vector according to the manufacturer’s instructions. In brief, 
after purification of PCR product using the QIAquick PCR Purification Kit, 
approximately 100 ng of tester specific DNA (≈ 2µL) was ligated in reactions 
containing 5 µL of 2X Rapid Ligase Buffer, 1 µL pGEM
®
-T Easy vector, 1 µL of T4 
DNA Ligase and molecular grade water to a final volume of 10 µL. The reactions 
were mixed by pipetting prior to incubation overnight at 4
o
C. Then 2 µL of ligation 
reaction was added to a sterile microcentrifuge tube on ice, 50 µL of competent E. coli 
JM109 cells were added, the tube was gently mixed prior to incubation on ice for 20 
min. The cells were then heat-shocked for 50 s at 42°C and immediately returned to 
ice for 2 min prior to the addition of 950 μl of room temperature SOC medium and 
incubated for 2 hr at 37°C with shaking at 175 rpm. Approximately 80 µL of each 
transformation culture was plated onto LB agar supplemented with ampicillin (100 
µg/mL), X-Gal and IPTG (80 µg/mL), then the plates were incubated overnight at 
37
o
C. White colonies were then sub-cultured in 3 mL LB broth containing ampicillin 
and grown overnight at 37
o
C with shaking.    
5.2.8 Nested PCR for insert amplification   
Positive transformation was determined by PCR amplification of the cloned 
insert using the nested primers from the subtraction kit. Cloned inserts which showed 
a single band were isolated with the plasmid from subcultured transformed cells using 
DirectPrep 96 Miniprep Kit. Sub-cultured transformed cells were then diluted in one 
volume of sterile glycerol and stored at -80
0
C. The cloned inserts were PCR amplified 
from the corresponding plasmid using nested primers 1 and 2R. The master mix 
contained 10X PCR buffer, a final concentration 1.5 mM MgCl2, 0.2 mM of each 
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dNTP, 0.1 µM of nested PCR primer 1 and 2R, 1.25 U of Taq DNA polymerase, 2 µL 
of purified plasmid using PCR cycling conditions 94
o
C, 5 min followed by 30 cycles 
of: 94°C, 10 s; 68°C, 30 s; 72°C, 90 sec, and a final extension step at 72°C for 5 min.   
5.2.9 Precipitation and purification of plasmid DNA  
Following the PCR amplification, approximately 80 µL of PCR products 
were transferred to V-bottom polypropylene 96-well plates. Using a multichannel 
pipette 96% of ethanol was added to a final concentration of 59% and 3M sodium 
acetate (pH 5.2) to a final concentration of 90 mM and the plasmid DNA was 
precipitated overnight at – 20oC. The plates were then centrifuged at 3000 rpm for 1.5 
hr at 4
o
C. The supernatant was decanted using a pipette and the plates were inverted 
briefly to drain. The plasmid DNA pellet was washed with 70% ethanol prior of 
centrifugation and draining with the same conditions, the pellets air dried at room 
temperature for ≈2 hr. The plasmid DNAs were then resuspended in 50% dimethyl 
sulfoxide (DMSO) and stored at 4
o
C until use.  
5.2.10 Microarray construction and printing 
A total of 280 clones with inserts ranging from 250 bp to 750 bp, were 
transferred into a 384-well plate including the positive and negative controls. The 
control spots on the SDA included printing control (Cy-3) and negative controls; 
printing buffer (50% DMSO), nested PCR primers 1 and 2R, and pGEM
®
-T Easy 
vector. The positive controls consisted of three housekeeping genes; hasA, hasC, and 
pauA. The 280 clones together with the controls were printed on aminosilane-coated 
slides using a BioRobotics
®
 MicroGrid II Compact arrayer (Genomic Solutions). Six 
subarrays were gridded on a Corning® GAPS II coated slide and each subarray was 
composed of 280 features including controls. Therefore, two hybridization 
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experiments could be performed with a single printed slide, where each hybridization 
reaction was tested with six subarrays. The spotted DNA was then rehydrated by 
steaming the printed slide surface for 7 sec, and slides with the printed side up were 
dried over 100
o
C heating block for 7 sec. The slides were then placed with the printed 
side up in ultraviolet radiation for 7 min and heated at 80
0
C in an incubator for 3 hr.  
5.2.11 Validation of the array 
The DNA fragments from both the tester and driver pool were hybridized 
separately to validate the SDA. In addition, the array was tested for the ability to 
differentiate between 29 S. uberis strains representing 20 isolates from cows with 
clinical mastitis and 9 isolates from cows with low cell count.     
 5.2.11.1 Labeling of target DNA 
The pooled tester and driver (Target DNA) as well as the 29 S. uberis 
strains were digested with Rsa 1 and subsequently purification on a column using 
QIAquick PCR Purification Kit. Approximately 200 ng of restriction digested gDNA 
fragments were then labeled with Biotin-11-dUTP using the Biotin DecaLabel
TM
 
DNA Labeling Kit in accordance with manufacturer’s instructions. Briefly, 10 µL of 
purified DNA (200 ng) was mixed with 10 µL of Decanuleotide 5X buffer and made 
up to a final reaction volume of 44 µL with Nuclease free water. The reaction mixture 
was spun for 5 sec before incubated in a boiling water bath for 10 min, and 
immediately cooled on ice for 2 min then the mixture was spun for 5 sec and returned 
to ice. 5 µL of biotin labeling mix and 1 µL of Klenow fragment were quickly added 
to the mixture prior to a gentle flick and spin for 5 sec. The reaction was then 
incubated at 37
o
C for 20 h, and stopped with 1 µL of 0.5M EDTA, pH 8.0 and no 
further purification was performed.  
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5.2.11.2 Hybridization of the SDA 
The hybridization of microarray slides was performed as described by 
Jayasinghe et al., (2007) with a slight modification in the amount of biotin-labelled 
sample used. Briefly, microarray slides were pre-hybridized at 42
o
C for 45 min in a 
solution containing 5X standard saline citrate (SSC), 0.1% sodium dodecyl sulphate 
(SDS), 1% bovine serum albumin (BSA) and 25% formamide. The slides were then 
rinsed with deionized water and immediately dried by an air gun. Approximately 30 
ng of biotin-labelled sample (dried to 16 µL) was mixed with 17 µL of 2X fresh 
hybridization buffer (500 µL of formamide, 250 µL of 20X SSC, 20 µL of 10% SDS 
and the mixture was made up to a final volume of 1000 µL by sterile MilliQ water), 
0.5 µL of 1 mg/mL Human Cot1 DNA, and 0.5 µL of 10 mg/mL of salmon sperm 
DNA. The mixture was then denatured at 100
0
C for 2 min and applied to the array 
under a 22x22-mm lifter slip and the slides were subsequently placed in a waterproof 
and humidified hybridization chamber and incubated overnight in a water bath at 
42
o
C. All hybridizations were performed with six technical replicates (six sub-arrays) 
and three biological replicates, leading to a total of eighteen data points per array 
feature.  
Post hybridization, the slides were removed from the hybridization 
chambers with care taken not to disturb the lifter slips and the slides were washed 
twice for 8 min with agitation in 500 mL 40
o
C Wash buffer (1X SSC and 0.1% SDS) 
and the lifter slips were gently removed while the slides were in the buffer, once for 8 
min with agitation in 500 mL 40
o
C Wash buffer (0.1X SSC and 0.1% SDS) and once 
for 5 min in 500 mL Wash buffer (0.1X SSC) at room temperature with agitation. The 
protocol of detection of the biotinylated DNA targets bound on the array was 
performed with modification from Mirus Label IT
® 
µArray
® 
Biotin Labelling Kit 
(Mantri et al., 2012). Briefly, the slides were transferred and washed once in 500 mL 
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6X SSPE-T buffer containing (0.9 M NaCl, 0.06 M NaH2PO4.H2O, 0.006 M EDTA, 
0.005% Triton X-100, pH 7.4) with care taken not to allow the slides to dry. 
Immediately after the wash with 6 x SSPE-T buffer, 200 µL of the detection solution 
(0.8 µl of 25 µg/uL of BSA and 0.5 µl of streptavidin-labelled Cy
TM
3 dye and made 
up to 200 µL with 6X SSPE-T) was applied on the wet surface of the slide and 
covered by a 25x60-mm lifter slip to evenly distribute the solution on the array. The 
slides were then placed in hybridization chambers and wrapped in aluminum foil 
before being incubated at 37
o
C for 40 min in the dark. The slides were finally washed 
three times for 5 min in 500 mL Wash buffer (6X SSPE-T) at room temperature with 
agitation and rinsed with deionized water before being dried with an air gun. 
5.2.12 Scanning and data analysis 
5.2.12.1 Scanning and quantitation of spot intensities  
Slides were scanned with a ScanArray Gx (PerkinElmer Life and Analytical 
Sciences, Downers Grove, IL) microarray scanner in conjunction with the supplied 
software. The slides were scanned at 10 μm resolutions at 532 nm (Cy3, green laser) 
and 50% photomultiplicator (PMT) gain to keep background noise low. The 
quantitation of scanned array was performed using PerkinElmer ScanArray Express 
software v 2.0. The designed grid which was provided with the program was fully 
adjusted to match and fit all the printed spots on the array image, and the signal 
intensities were quantified using the adaptive circle and LOWESS functions. During 
the quantitation low background was subtracted. The scanning software flagged 
Probes which did not hybridize automatically and labelled as ‘bad’ while some other 
abnormal spots were flagged manually. ‘Good’ probes were accepted as having a 
mean ‘signal to noise ratio’ (SNR) value of a minimum 5, all the quantified data was 
then exported to Microsoft Excel Sheet.  
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5.2.12.2 Data analysis  
The signal-to-noise ratio, defined as Mean Foreground - Mean 
Background/Standard deviation of Background, was obtained for each spot by 
ScanArray Express
®
. Since the signal value accounts for variations in background 
intensity over the array, it is considered to have a very high level of accuracy in the 
correction of background.  
Data analysis included subtracting the background from median signal 
intensity for each feature, logarithmic transformation and combining and technical 
biological replicates by taking the average to produce a single value for each feature 
for a particular S. uberis strain. Therefore, signal intensities and flag values of the 
three biological replicates were first compared before calculating the average of signal 
intensities for only those features that were flagged ‘Good’ in all three replicates. The 
values of features were converted to zero when even just one of the replicates had a 
‘Bad’ flag.  
5.2.13 Statistical analysis  
5.2.13.1 Principal component analysis (PCA)  
The data of the 280 features across the twenty nine genotypes was used to 
perform PCA (MINITAB
®
 version 16). This analysis was able to distinguish the 
features that accounted for most of the variability found across the isolates and to 
identify the probes that show maximum differentiation among the S. uberis strains 
assessed. 
5.2.13.2 Hierarchical cluster analysis   
The mean signal values which resulted from combining the biological 
replicates were transferred to PSAW Statistics 18 to perform a hierarchical cluster 
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analysis. This software was used to examine relationships between the 29 S. uberis 
strains by generating the dissimilarity dendogram using hierarchical cluster analysis 
with Euclidean distance and between-groups linkage.  
5.2.14 Sequencing of selected probes 
Twelve of the strain-specific features together with the fourteen features 
chosen by PCA were selected for sequencing. The PCR products were sequenced by 
Macrogen Inc. (Seoul, Korea). The sequences were then edited using Bioedit software 
and the primer sequences were removed before being analysed through the National 
Center of Biotechnology Information blast (www.ncbi.nlm.nih.gov/BLAST) using 
different databates (Nucleotide collection, Chromosome, Expressed sequence tags and 
Genomic survey sequences.  
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5.3 Results 
5.3.1 Restriction digestion  
Approximately 0.2 µg of undigested genomic DNA and 5 µL of Rsa 1 
digested genomic DNA were analysed using agarose gel electrophoresis. A high 
molecular weight band of the undigested DNA appeared on the top of the gel while 
the Rsa 1 digested DNA had decreased greatly in size and appeared as a smear (Fig. 5-
4).    
5.3.2 Analysis of suppressive subtractive hybridization (SSH) 
The six S. uberis isolates from cows with clinical mastitis which represent 
the tester and the other six isolates from cows with low cell count in their milk as the 
driver were used for subtractive hybridization. The secondary PCR results are 
presented in Fig. 5-5. The unsubtracted genomic DNA control generated the most 
intense bands on agarose gel electrophoresis during secondary PCR while the 
subtracted genomic DNA demonstrated weaker bands than those observed in the 
unsubtracted genomic DNA control (Fig. 5-5). 
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  Fig 5-4. An example of S. uberis genomic DNA, Lane 1 (before) and Lane 2 
(after) Rsa 1 digestion, Lane M (DNA size marker).  
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Fig 5-5. Secondary PCR products generated following tester-specific and 
control suppression subtractive hybridization (SSH). 
  M. 1 kp DNA ladder (molecular weight rang 250 to 10000 bp). 
1. Secondary PCR product generated from the tester 1-1. 
2. Secondary PCR product generated from the tester 1-c (unsubtracted control) 
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5.3.3 The pGEM
®
-T Easy vector cloning 
Post suppression subtractive hybridization and amplification of subtracted 
tester-specific sequences, a library of S. uberis tester-specific sequences was obtained 
following cloning of the secondary PCR products into the pGEM
®
-T Easy vector. 
Approximately 363 E. coli transformants (Fig. 5-6) were obtained from a total of five 
(W1-W5) independent cloning experiments generating the tester-specific S. uberis 
libraries W1 (Clones W1; 1-41); W2 (W2; Clones 1-117); W3 (W3; Clones 1-73); W4 
(W4; Clones 1-76) and W5 (W5; Clones 1-56). Two hundred and seventy two of the 
recombinants from the libraries W1-W5 were chosen based on their generation of a 
clear and single band ranging in size from 250 to 1000 bp (Fig. 5-7). 
5.3.4 Subtraction efficiency and validation of the microarray  
In order to determine the efficiency of the tester-specific gDNA subtraction, 
the gDNA pool of 6 S. uberis isolates representing the tester (virulent isolates) and the 
other gDNA pool of 6 S. uberis isolates representing the driver (non-virulent isolates) 
were hybridized on the SDA. Sixty-five (23%) positive spots were observed after 
hybridizing the driver target with the array. Theoretically, the absence of hybridization 
of the driver pool should be obtained from a perfect subtraction as all driver sequences 
are supposed to be eliminated; thus, these features that gave signal on both driver and 
tester represent the sequences that were not fully subtracted. Accordingly, the 
subtraction was able to isolate tester-specific DNA sequences with 77% efficiency and 
the 23% of the features may represent non-subtracted sequences. 
 
 
 
Chapter 5. Virulence associated genes in S. uberis 
        Page 176 
 
 
 
 
 
 
 
Fig. 5-6. An example of transformation of E. coli using pGEM
®
-T Easy vector 
following selection on plates of LB agar supplemented with ampicillin using X-Gal / 
IPTG selection for the generation of tester-specific plasmid libraries. White colonies 
represent transformed E. coli containing tester-specific DNA inserts while blue 
colonies have no insert in the plasmid. 
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Fig 5-7. An example of positive transformation determined by PCR 
amplification of the cloned insert using the nested primers 1 and 2R. 
The empty lanes indicate missing white colonies. 
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5.3.5 Capacity of the SDA to fingerprint various S. uberis strains 
The potential of SDA for genotyping was tested by performing independent 
hybridisations for 29 S. uberis isolates representing 20 isolates from cows with clinical 
mastitis and nine isolates from cows with low cell counts.  All the 29 S. uberis isolates 
generated different hybridization patterns allowing discrimination (Fig. 5-8 and 
Appendix 3). 
A hierarchical cluster dendogram was constructed based on the 215 features, 
after 65 positive spots of driver target (un-subtracted sequences) were eliminated. The 
29 genotypes grouped into clusters that clearly differentiated between isolates from 
cows with clinical mastitis and uninfected cows (Fig. 5-9). The cluster on the top of 
the dendogram contained the majority of the isolates from cows with low cell counts 
while the clusters on the bottom grouped only isolates from cows with clinical 
mastitis. The clusters in the middle of the dendogram grouped three low cell count 
isolates together with three isolates from cows with clinical infection. Specifically, 
there were five clusters in the range 7 to 9 distance coefficients. Cluster 1 contained 
seven isolates of which six were from cows with low cell counts. Cluster 2 contained 
both clinical isolates and low cell counts, while clusters 3, 4 and 5 contained 
exclusively clinical isolates.      
All the 29 S. uberis isolates tested using this array generated different 
hybridization patterns allowing discrimination (refer to Appendix 3). Interestingly, 
strain (7218 (1)) hybridized to the least number of probes (21/215) while isolate 
5838.3 hybridized to most probes (106/215). Strain 5838.3 was expected to hybridize 
to large number of probes as it belongs to the clinical group of isolates.  
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B) A) 
Fig 5-8. An example of S. uberis isolates generated different hybridization patterns onto six 
sub-arrays grided on coated slides, each subarray composed of 280 samples. Image (A) 
represents isolate from cow with clinical mastitis (5838.3) whereas image (B) represents 
isolate from cow with low cell count (3147.1).  
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Fig 5-9. Dissimilarity dendogram for the 29 S. uberis isolates genotypes: 9 isolates from 
cows with low cell count and 20 isolates from cows with clinical mastitis; first infection is 
denoted by number (1), (2) next to the isolates which obtained from recurrent clinical 
mastitis cases, constructed using Squared Euclidean distance and between groups linkage 
on signal-to-noise ratio of the 215 subtracted fragments. The steps of the dendogram show 
the combined clusters and the values of the distance coefficients at each step; the values 
have been rescaled to numbers between 0 and 25, preserving the ratio of the distances 
between the steps. 
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In order to identify the DNA fragments that caused the majority of variance in 
the data, a principal components analysis (PCA) was performed. The analysis 
extracted six different components with significant Eigen values. The first and second 
principal components explained the majority of the variation (58.4%) of the data (Fig. 
5-10). The probes that explained the maximum variance hybridized to the DNA from 
most of the 29 S. uberis strains examined. The variance was explained by the 
difference in signal intensities (median log2 values) for the particular probe. Therefore, 
these two dimensions could have most of the variability, in other words, a high 
positive values on the X axis of certain features explain a large proportion of the total 
variance found with the full set of features. The most distant features from the cluster 
and/or closer to zero were then chosen as these features accounting for most of the 
variability found across the genotypes, implying that these were the only features that 
had higher variance and higher mean across the fingerprints.  
In addition to the PCA analysis of probes that showed most variance between 
the S. uberis isolates, the hybridization patterns of all the 29 S. uberis isolates were 
compared to distinguish important spots/probes. The identification of the probes was 
based on probes that specifically hybridized to a particular isolates or isolates from the 
same farm. These probes along with their importance are listed in Table 5-4. A 
number of isolate-specific probes were identified, for instance, the probe W4-24 was 
found to be specific for two isolates from cows with clinical mastitis (2988.1 and 3599 
(1)). Another important observation was that probe W4-81 hybridized specifically to 
both locations (Newry district of Gippsland and R farm). The strain-specific features 
together with the fourteen features chosen by PCA were selected for sequencing. 
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Table 5-4. Important probes selected after comparing hybridization patterns of the 29 
S. uberis isolates. 
Clone ID* Significance 
W3-72, W1-28, W4-20, W3-57, W4-9, 
W1-31, W4-65, W3-23, W5-38, W2-
16, W2-1, W3-73, W5-20, W2-18. 
Probes from PCA analysis revealing 
maximum amount of variation. These 
probes hybridized with most of the S. uberis 
isolates. 
W4-24 Specifically hybridized to clinical isolates 
(2988.1 and 3599 (1)). 
W4-13 
Hybridized only to clinical isolates (2730.5, 
2874.4, 3531 (1) and 6232 (1)). 
W4-5 
Hybridized only to clinical isolates (2730.5, 
3531 (1), 4707 (2) and 6232 (1)). 
W3-21 
Specifically hybridized to clinical isolates 
(2565.2, 2730.5, 3571 (1) and 3599 (1)). 
W3-30 
Hybridized only to clinical isolates (2169.2, 
2285.1, 2874.4, 3531 (1) and 6232 (1)). 
W5-31 
Specifically hybridized to clinical isolates 
(2169.2, 2285.1, 3531 (1), 3599 (1) and 
6232 (1)). 
W4-81 
Specifically hybridized to isolates located in 
the Newry district of Gippsland and R farm. 
W2-17 
Hybridized only to isolates located in the 
Newry district of Gippsland, R and Maffra 
farms. 
W4-80 
Specifically hybridized to certain clinical 
isolates located in the Newry district of 
Gippsland, T and Maffra farms. 
W4-64 
Hybridized only to isolates located in the 
Newry district of Gippsland, R and J farms. 
W4-15 
Specifically hybridized to certain clinical 
isolates. 
W2-38 
Specifically hybridized to certain clinical 
isolates. 
*Clone identification 
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Fig 5-10. Principal component analysis (PCA) of the 215 subtracted fragments using signal-
to-noise ratio for the 29 S. uberis isolates genotypes. The first principal component accounts 
for 34.9% of variation and the second component explained only 23.5% of variation. The 
ovals indicate features that account for the variability found across the genotypes, i.e only 
the fourteen most distant features from zero on the X axis were chosen and therefore they 
are the only features had a high variance and a high mean across the fingerprints. 
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5.3.6 Sequencing of selected features 
The strain-specific features together with the fourteen features chosen by PCA 
listed in Table 5-4 were selected for sequencing. Comparative genomic analysis with 
other streptococci by NCBI BLASTN presented in Table 5-5. The comparison of each 
of the sequenced spots identified the probes that hybridized to most of the S. uberis 
isolates tested (from PCA analysis) had matches in the streptococcal genomes 
compared. Four of these probes; W2-1, W4-65, W1-31 and W4-9 were 98-99% 
identical to putative microcin immunity protein of S. uberis 0104J genome (Ward et 
al., 2009). The feature W4-20 was 92% identical to copper importing ATPase of S. 
parauberis. Also, the sequences of the probes W2-16 and W3-73 were 77-78% 
identical to homologues in S. parauberis (fatty oxidation complex protein and 4-
hydroxybutyrate CoA-transferase) and S. iniae genome (3-hydroxyacyl-CoA 
dehydrogenase and Glutaryl-CoA dehydrogenase). Additionally, the probe of 
sequence W1-28 that hybridized to the most S. uberis strains tested (from PCA 
analysis) was 83% identical to membrane protein of S. macedonicus sequence. This 
probe was also 81% identical to sugar transporter of S. equines genome while the 
feature W5-20 had 74% matches to glycosyl transferase of the same organism. 
 
Among the probes that were specific for S. uberis clinical isolates, 50% 
sequence of W3-30 and W2-38 was 74% identical to putative transposase of S. 
salivarius gene and both having E value of 2e-20 and 6e-20 respectively. 43% 
sequence of the probe W5-31 was 95% identical to Integrase of Facklamia hominis. 
The probe W4-24 exhited 97% protein sequence identity with the putative mannitol-1-
phosphate 5-dehydrogenase and sugar phosphotransferase system (PTS), ІІA 
component in the reference S. uberis strain 0104J genome available in the Sanger S. 
uberis database (Table 5-5). Furthermore, 61% sequence of W3-21 was 71% identical 
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to hypothetical protein of E. faecalis. Interestingly, the sequence of the probe W2-17 
that specific for S. uberis clinical isolates did not have any significant match in the 
database.   
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                Table 5-5. Sequence characterization of probes selected after comparing hybridization patterns of the 29 S. uberis isolates. 
Clone 
ID
a
 
Putative protein CDS Organism Identity  E Value  
W2-16b 3-hydroxyacyl-CoA dehydrogenase 
Fatty oxidation complex protein 
A0G_0277 
STP_1025 
NZ_JH930418.1 S. iniae  
NC_015558.1 S. parauberis 
78%   
77% 
5e-98 
1e-86  
W3-73b Glutaryl-CoA dehydrogenase 
4-hydroxybutyrate CoA-transferase 
A0G_0275 
STP_1026 
NZ_JH930418.1 S. iniae  
NC_015558.1 S. parauberis 
78%    
 77% 
5e-98 
1e-86  
W2-1b Microcin immunity protein SUB0175 NC_012004.1 S. uberis 98% 0.0 
W4-65b Putative microcin immunity protein SUB0175 AM946015.1 S. uberis 98% 0.0 
W5-20b Glycosyl transferase HMPREF0819_0729 NZ_GL698429.1 S. equinus 74% 2e-97 
W1-31b Putative microcin immunity protein SUB0175 AM946015.1 S. uberis 99% 0.0 
W4-9b Putative microcin immunity protein SUB0175 AM946015.1 S. uberis 99% 0.0 
W4-20b Copper importing ATPase STP_1455 NC_015558.1 S. parauberis 92% 0.0 
W1-28b Membrane protein 
Sugar transporter 
SMA_1309 
HMPREF0819_0731 
NC_016749.1 S. macedonicus                    
NZ_Gl698429.1 S. equinus 
83%                            
81% 
2e-81 
2e-74  
W4-24c Putative mannitol-1-phosphate 5-dehydrogenase   
Sugar phosphotransferase system (PTS), ІІA component 
SUB0287 & SUB0288  AM946015.1 S. uberis 97% 0.0 
 W5-31c Integrase HMPREF9706_00867 43% sequence is identical to NZ_ 
JH932292.1 Facklamia hominis  
95% 4e-67 
W3-21c Hypothetical protein EFKG_00175 61% sequence is identical to 
NZ_GG692670.1 E. faecalis 
71% 1e-15 
W3-30c Putative transposase SALIVB_0679 50% sequence is identical to 
NC_015760.1 S. salivarius 
74% 2e-20 
W2-17
c
 Non  NA
d
 Non No significant 
 match  
found at all 
NA
d
 
W4-15c 4-hydroxybutyrate CoA-transferase A0G_0276 
STP_1026 
NZ_JH930418.1 S. iniae  
NC_015558.1 S. parauberis 
78%                            
77% 
5e-98 
1e-86  
W2-38c Putative transposase SALIVB_0679 50% sequence is identical to 
NC_015760.1 S. salivarius 
74% 6e-20 
      
a
Clone identification;  
b
Hybridized to most of the S. uberis isolates from PCA;  
      
c
Specifically hybridized to certain clinical isolates; 
d
NA, not applicable
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5.4 Discussion and conclusion  
5.4.1 Subtraction efficiency  
The subtraction technique was able to eliminate about 77% of common DNA 
sequences between the pool of S. uberis isolates from cows with clinical mastitis 
which were thought to represent virulent isolates and the pool of S. uberis strains from 
cows with low cell counts and could be non-virulent strains. No study has previously 
investigated or compared virulence genes of S. uberis using hybridization-based 
microarray innovative technique (SDA) of features constructed from pooled genomic 
DNA. The SDA technique used in this study was developed by Jayasinghe et al., 
(2007) who performed a very broad subtraction by subtracting pooled non-angiosperm 
gDNA from pooled angiosperm gDNA. This array when validated had 97% 
subtraction efficiency. Subsequently, a narrower subtraction was performed between 
pooled Asterids and non-Asterids gDNA (Mantri et al., 2012) which resulted in 99% 
subtraction efficiency. In comparison, a SSH microarray developed by close 
subtraction between 2 Dendrobium species had only 76% efficiency which is 
comparable to the 77% efficiency found in this study (Li et al., 2006). As a 
consequence, 23% of the positive spots observed during hybridization of non-virulent 
target to the SDA could resemble non-subtracted sequences. Nevertheless, the 
subtraction method was effective in eliminating the common sequences, although a 
100% subtraction was not achieved.  
In addition, failure to totally remove driver sequences by the subtraction 
could be due to several reasons. The quantity of the driver pool used might be slightly 
lower than required. This problem could be overcome if the 30-fold excess of driver 
which was used in this study according to the Clontech instructions, was increased 
giving a greater excess of driver. This strategy would subtract sequences that are 
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partially homologous between the tester and driver, enriching for those highly tester-
specific DNA sequences (Diatchenko et al., 1996). Temperature may also play a role 
in imperfect subtraction. Subtraction hybridization was performed at 68
0
C; this is a 
high temperature and only the highly similar sequences between the driver and tester 
would be hybridized and subtracted, while for the less similar sequences single-
stranded DNA would remain unhybridized to be amplified by PCR, and then printed 
on the array. Therefore, reducing the temperature of the two rounds of subtraction 
hybridization may improve SDA techniques and elevate the percentage of  the 
sequences that are partially homologous between the pools to be subtracted (Gadgil et 
al., 2002). The most interesting reason for sub-optimal subtraction could be the 
presence of bacteriophage-related genes in the S. uberis isolates. It has been observed 
that phage-related genes are present in bovine isolates of S. dysgalactiae and S. uberis, 
suggesting that bacteriophages may also play a role in the genetic plasticity and 
virulence of bovine mastitis (Rato et al., 2011). Moreover, T4-19 transposase-like 
gene and three additional clones (T1-16; T4-01 and T4-17) related to known 
bacteriophage and transposon sequences have been identified by Tomita, PhD thesis 
RMIT (2008). The authors suggested that the occurrence of such bacteriophage, 
transposon and transposase-like sequences are indicative of their possible role in 
horizontal gene transfer and account for the substantial recombination observed in the 
S. uberis population. 
5.4.2 Differentiation between isolates 
Given the importance of virulence factors for pathogenesis, this study 
developed a microarray to analyse the putative virulence factors among different S. 
uberis isolates. As shown in Fig. 5-9 and Appendix 3, the array was able to 
differentiate between the 29 genotypes based on the prevalence and virulence 
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specificity for each S. uberis tested strain. The results suggest genetic variability 
among strains. This variability makes the array of this experiment a potential tool for 
strain and virulence typing, since each strain tested may have a certain distribution of 
putative virulence factors. Other studies have used microarray technology to 
distinguish between closely related species or detect virulence-associated genes 
expressed by some members of the species. For example, since members of the 
Bacillus cereus group are closely related, the similarity between the genomes of 
different isolates is considerably high and it is hard to distinguish between isolates. 
Moreover, several microarrays have been developed to analyse B. cereus and B. 
anthracis virulence factors (Sergeev et al., 2006).   
5.4.3 Clustering of clinical and low cell count S. uberis 
The dendogram analysing the microarray patterns of 20 clinical isolates and 9 
low cell counts shows five major clusters. The first cluster contains seven S. uberis 
isolates; among them just one isolate from a cow with clinical mastitis. The 
hybridization of the isolate 7218 (1) to least number of probes may be attributed to its 
shorter or smaller genome size (Baack et al., 2005). This clearly indicated that these 
isolates lack statistically significant linkage with disease status and makes them 
unlikely candidates for S. uberis to have virulence-associated factors. The second 
cluster is mixed, consisting of seven isolates; four (883.4, 2565.2, 3885(1) and 6093) 
from cows with clinical mastitis and three (2945.3, 2917.2 and 3333.3) from cows 
with low cell counts. These S. uberis isolates may represent opportunistic pathogens, 
possibly able to cause infections in particular groups of cows with increased 
susceptibility to infection, for example heifers or older animals. No information was 
available on the age of cows or their health status, however, the only isolate in this 
group for which further infection history was available (3885(1)) had a second 
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infection with a new strain three weeks after the first infection (Fig. 5-8). It is 
interesting that only one of these seven isolates was from a cow in the study of 
repeated episodes of clinical mastitis (Chapter 3). Another reason for the clustering of 
clinical and commensal isolates is related to their geographical location as all were 
isolated from the Newry district of Gippsland. It is noteworthy that all other 15 S. 
uberis isolates from cows with clinical infection, grouped together in the third, fourth 
or fifth cluster and are suspected of carrying potential virulence associated genes. The 
subtracted sequences might include the housekeeping genes used in the MLST 
analysis, since most of the clinical isolates belong to GCC 143 or GCC 5 while the 
low cell counts belonged to GCC 86. However, it is likely that other differences exist.  
Of the 15 isolates in this group, six were in from cows with repeated episodes of 
clinical mastitis and all subsequently had recurrences with the same strain (Chapter 3).   
The PCA analysis showed that most of the features clustered around zero 
with only a small number of features forming a loose cluster along the first component 
axis. Based on this analysis, only the fourteen most distant features from the X axis 
were chosen for further study since the first component explains most of the variation. 
Upon examination of these fourteen features (Table 5-4) it was observed that they 
were the only features that had higher variance and higher mean across the 
fingerprints; therefore, they could be highly informative. However none of them 
showed any specificity to a particular group of isolates.  
Arrays were further examined visually to detect potentially important spots 
that were present mainly in clinical isolates. Ten group-specific features were 
identified which were not previously detected by PCA since they had lower means 
across the fingerprints (Table 5-4). These results imply that the PCA alone was not 
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able to detect all the polymorphic sequences in the dataset since high variances were 
found for features with high and low mean signal intensity among the fingerprinted 
samples, and the PCA was only able to detect the features with high variance and high 
mean.   
Many methods exist for identification of microbial pathogens and their 
virulence factors. For instance, SSH is a method designed to identify sequences 
present in one strain used as a tester but not present in the driver and was used 
previously for identification of genetic differences among two human isolates of C. 
jejuni (Hepworth et al., 2007). Moreover, representational difference analysis (RDA) 
of cDNA (cDNA RDA) has been applied previously to identify putative virulence 
associated genes in a S. uberis isolate from a cow with clinical infection. The authors 
found oppA genes encoding oligopeptide binding proteins may play a certain role in 
nutrient acquisition for S. uberis, and delay or stop the bacterial growth in milk. The 
results suggested OppA2 could be a virulence factor by binding small peptides 
involved in quorum sensing (Taylor et al., 2003). The method described here, the 
SDA, can be applied to fingerprint species related to the ‘tester’ group that were not 
used in initial gDNA subtraction. This ability of the SDA has significant advantages 
over the other methods such as (SSH) based arrays that employ pair-wise subtraction 
and can only discriminate the isolates used to construct the array. SDA is efficient, 
economical, and less labour intensive than other DNA based fingerprinting methods 
(Mantri et al., 2012). In addition, microarray analysis is a powerful technology that 
allows global comparative analysis of the gene content between different isolates in a 
given species and even between species in a genus. 
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5.4.4 Sequencing of selected probes 
Comparing the sequenced probes revealed the spots from PCA analysis; which 
hybridized to most of the S. uberis isolates tested, had matches in the streptococcal 
genomes compared. Four out of nine were 98-99% identical to putative microcin 
immunity protein of S. uberis 0104J genome (SUB0175). Whilst this protein could be 
S. uberis virulence-associated genes, it is highly likely to be present in all S. uberis 
isolates including isolates associated with cows with low cell counts. This hypothesis 
was supported by a study reported that this gene is conserved in the global S. uberis 
population (Ward et al., 2009), and as a consequence reduces the probability of this 
gene is associated with S. uberis strain-specific virulence. Since the sequences of 
features W4-20, W2-16, W3-73, W1-28 and W5-20 exhibited extensive protein 
sequence identity to genes involved in carbohydrate and lipid metabolism, the 
correlation between the distributions of these DNA sequences and disease status could 
indicate their essential role in the growth or survival of S. uberis in diverse 
environments rather than their possible roles as virulence factors. 
For the clinical sequences specific to clinical isolates, 50% sequence of W3-30 
and W2-38 was 74% identical to Putative transposase virulence factor in S. salivarius. 
This result suggests that the S. uberis W3-30 and W2-38 represent part of an insertion 
sequence most likely acquired via horizontal gene transfer from other Streptococcus 
spp. (Franken et al., 2001). 43% sequence of the probe W5-31 was 95% identical to 
integrase of Facklamia hominis; which is a rare causative organism of infective 
endocarditis in humans. The majority cases of this heart disease are caused by 
streptococci (Ananthakrishna et al., 2012). The itegrase was listed as a pseudogene in 
additional file 1 of study conducted by (Ward et al., 2009). It is believed that 
pseudogenes are over-represented in genomes of bacteria experiencing new 
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environmental niches or those becoming equipped to live in a diversity of habitats 
(Lerat and Ochman, 2005). Since there were no intensive studies on F. hominis, the 
paucity of virulence determinants in this species, and consequently identified by 
comparison with S. uberis, reflects this.  
The probe W4-24 exhited 97% protein sequence identity with; the putative 
mannitol-1-phosphate 5-dehydrogenase and sugar phosphotransferase system (PTS), 
ІІA component in the reference S. uberis strain 0104J genome. This family of proteins 
did not have orthologous matches in the other streptococci. The high prevalence of 
these sequences may reflect the importance of these metabolic genes in S. uberis 
pathogenesis. This supports the hypothesis that the W4-24 sequence present in isolates 
from cows with clinical mastitis and not associated with low cell counts (Table 5-5). 
This finding could indicate their essential role of S. uberis to grow or survive in new 
environmental niches with possible roles as virulence factors. Additionally, 61% 
sequence of W3-21 had 71% matches to a hypothetical protein in E. faecalis, and it 
could make it a candidate for S. uberis virulence-associated factors. 
Finally and more importantly, the sequence of the probe W2-17 that was 
specific for S. uberis clinical isolates did not have any significant matches in the 
database, and it may be a novel virulence associated gene.   
This is the first genotyping array for S. uberis isolates. By using this array it 
was possible to fingerprint 29 S. uberis genotypes and to construct a hierarchical 
cluster which was able to differentiate clinical and commensal isolates of S. uberis.  
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Chapter 6: Final discussion 
For many years, S. uberis has been regarded as an important cause of 
bovine mastitis despite the widespread implementation of mastitis control strategies. It 
has been established that well managed herds and improved husbandry led to a 
reduction in the amount of contagious mastitis but not environmental infections which 
increased in prevalence (Bradley, 2002). Controlling bovine mastits due to contagious 
pathogens has lead to protection from intramammary infection and to reduced 
transmission among herds. The combination of proper hygiene systems with 
appropriate treatment has reduced the duration of infection and the number of new 
infections by more than half (Neave et al., 1969). This phenomenon raises many 
questions; (i) what is the relative importance of environmental transmission and cow-
to-cow transmission for cows with clinical mastitis, (ii) what virulence factors does S. 
uberis possess, e.g. biofilm production and (iii) do clinical isolates and low cell count 
differ in their genetic makeup?  
Numerous studies conducted in different countries have demonstrated 
genetically diverse populations of S. uberis. None of these studies have exclusively 
examined the transmission patterns of S. uberis for cows with repeated episodes of 
clinical mastitis. In this study, 60 Australian S. uberis isolates from cows with more 
than one episode of clinical mastitis were examined by PFGE, to look for evidence of 
cow-to-cow transmission and the occurrence of reactivating infection versus re-
infection. Although a large number of different PFGE patterns was identified, there 
were some examples of identical PFGE types being isolated from different cows in the 
same herd. Possibly these isolates were widespread in the environment and relatively 
stable over time or, alternatively, they were transmitted between cows at milking. In 
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some cases strains persisted between lactations in a chronically infected quarter. The 
transmission of these isolates causing recurrent infections within a herd might be 
influenced by management factors, in particular milking management. It could also be 
that these isolates have higher transmission ability or are more capable of becoming 
established in the host epithelial cells by attachment, than the other isolates. 
Alternatively the isolates causing recurrent clinical mastitis may be more resistant to 
dry cow therapy than other isolates, or able to persist intra-cellularly, where it is not 
easy for the antimicrobial agents to reach effective concentrations. Finally, these 
isolates could cause more severe mammary gland infection and fibrosis, preventing 
the antimicrobial agents from accessing infected gland (McDougall et al., 2004). 
Another possibility is that cows with reactivating infections were unable to eradicate 
the initial infection due to age or some other underlying factor. This study of PFGE 
profiles of isolates from recurrent infections indicated that the epidemiology of 
recurrent mastitis is similar to that of mastitis in general; however, the PFGE analysis 
did not provide insight into the virulence mechanisms of S. uberis. 
At the time this study was initiated, very little was known about S. uberis 
biofilm formation. This part of the dissertation initially focused on the ability of S. 
uberis to produce biofilms on abiotic surface such as polystyrene plastic, mainly to 
address the hypothesis that attachment and biofilm production on such surfaces may 
help to explain the pathogenesis of S. uberis mastitis. The results showed that most S. 
uberis produced small amounts of biofilm in vitro. The amount of biofilm produced 
increased in the presence of milk, but was not affected by milk components such as 
carbohydrate, protein, Lf and lipid. 
Iron limitation reduced the amount of biofilm produced by clinical isolates 
as did lactose at concentrations of 1% and 2%. The indigenous flora present in raw 
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milk appeared to enhance biofilm production by S. uberis. Although this study was 
conducted in vitro, it has some implication for the growth of S. uberis in vivo. It is 
possible that the presence of indigenous flora in milk helps establish infection and 
prevents S. uberis being removed by the flow of milk. This could happen in vivo as the 
milk and indigenous flora present in the teat canal might provide an opportunity for S. 
uberis to attach to the mammary gland epithelium cells and then to form biofilm. The 
interaction of the different components of milk is likely to be complex, for instance, 
lactose inhibited biofilm formation, whereas iron limitation at some levels enhanced 
biofilm formation. Nevertheless, biofilm formation might explain the S. uberis 
resistance towards antimicrobial agents, since bacterial growing within biofilms are 
well known to re more resistant to antimicrobiaql agents than their planktonic 
counterparts (Lewis, 2001).    
This work has provided further evidence that strains of S. uberis causing 
clinical mastitis differ from strains colonizing the teat skin and teat canal of dairy 
cattle. In a previous study by Tomita (PhD thesis, RMIT University, 2008), a 
collection of disease and commensal isolates was examined by Southern blot analysis 
for the presence of potential virulence associated genes or sequences associated with 
clinical mastitis isolates. Of these, hasA gene as well as several putative virulence 
associated sequences demonstrated a statistically significant linkage relationship 
between their occurrence and disease status. The microarray analysis described in this 
thesis clearly differentiated low cell counts from clinical isolates. This suggests 
clinical isolates may carry specific genes that could be associated with their 
transmissibility or capacity to infect and invade the bovine udder.   
Further work was performed to sequence clones of interest that were present 
mainly in clinical isolates and to identify and characterise potential virulence 
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determinants. Putative S. uberis virulence factors were identified using subtractive 
hybridization. First, sequences that encoded proteins involved in metabolism which 
may have a major role in the growth and survival of S. uberis in different 
environments were compared. The probe, W4-24 for instance, exhibited a sequence 
that matched a sequence in the genome of the reference S. uberis strain 0104J. This 
family of proteins does not have orthologous matches in the other streptococci. The 
high prevalence of these sequences among clinical isolates may reflect the importance 
of these metabolic genes in S. uberis pathogenesis with possible roles as virulence 
factors. Furthermore, the W3-21 sequence was analogous to a hypothetical sequence 
in E. faecalis. This protein has been identified and recognized as a virulence factor in 
a range of Gram positive bacteria including E. faecalis (Rozdzinski et al., 2001). 
Although the function of this protein is not clear, it could be necessary for virulence 
factors. Interestingly, the sequence of the probe W2-17 that was highly associated 
with S. uberis clinical mastitis had no matches in the databases, and it could be a novel 
virulence gene. 
In conclusion, the results obtained throughout the course of this dissertation 
have confirmed that the transmission of strains causing recurrent mastitis is similar to 
other types of mastitis. Some of the factors involved in the formation of biofilm by S. 
uberis have been identified and the work has established a number of novel 
approaches for studying this veterinary-dairy relevant condition. This study has 
evaluated a genotyping method, microarray, as a useful tool with high discriminatory 
power, capable of differentiating unrelated isolates and detecting potential virulence 
factors. Microarray is coming to diagnostic microbiology; this work may lead to the 
development of diagnostic tests for detection of virulent strains of S. uberis with a 
greater potential to cause clinical mastitis. Moreover, since understanding of the genes 
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associated with virulence of S. uberis is essential for successful vaccine production; 
this work could lead to the discovery of potential new vaccine candidates for S. uberis 
mastitis.   
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Appendices 
 
Appendix 1: 
Table. A1-1. Biofilm formation by S. uberis for milk type, percentage and mastitis 
types. 
 
Control – milk without S. uberis  
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 1.50 (0.02) 2.70 (0.02)  3.78 (0.03)  32594.799**  12.5 < 25 < 50 
Whole 0.14 (0.008)  0.22 (0.009)  0.57 (0.01)  5393.772**  12.5 < 25 < 50  
Skim 0.11 (0.005) 0.13 (0.01) 0.20 (0.005) 477.796** 12.5 < 25 < 50 
Note. **p < 0.001. 
 
 
Cow ID (3217.5) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 2.20 (0.02) 3.06 (0.03)  3.89 (0.03)  10792.814**  12.5 < 25 < 50 
Whole 1.55 (0.02)  2.59 (0.02)  3.57 (0.03)  19475.963**  12.5 < 25 < 50  
Skim 1.54 (0.02) 2.64 (0.05) 3.65 (0.06) 6371.999** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID (3217.2) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 1.39 (0.02) 2.90 (0.04)  3.97 (0.04)  15724.608**  12.5 < 25 < 50 
Whole 0.31 (0.02)  0.89 (0.02)  3.62 (0.04)  42476.705**  12.5 < 25 < 50  
Skim 0.29 (0.02) 0.70 (0.03) 3.49 (0.01) 71364.437** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (3217.3) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 2.19 (0.01) 3.30 (0.02)  3.61 (0.33)  184.906**  12.5 < 25 < 50 
Whole 1.19 (0.01)  2.65 (0.03)  3.57 (0.02)  43070.063**  12.5 < 25 < 50  
Skim 1.16 (0.03) 2.83 (0.02) 3.64 (0.03) 21447.529** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (3147.5) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 1.29 (0.01) 1.88 (0.02)  3.07 (0.03)  70497.007**  12.5 < 25 < 50 
Whole 0.24 (0.03)  0.58 (0.03)  3.47 (0.01)  70178.838**  12.5 < 25 < 50  
Skim 0.30 (0.02) 0.64 (0.03) 3.44 (0.04) 33217.617** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID (3147.1) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 1.29 (0.01) 2.58 (0.03)  3.79 (0.01)  98316.396**  12.5 < 25 < 50 
Whole 0.75 (0.03)  0.76 (0.03)  3.56 (0.03)  51769.501**  12.5 < 25 < 50  
Skim 0.25 (0.03) 0.36 (0.03) 2.20 (0.14) 1647.091** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (3068.2) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 1.39 (0.01) 2.05 (0.02)  3.89 (0.02)  140551.679**  
12.5 < 25 < 
50 
Whole 0.88 (0.02)  1.76 (0.02)  3.66 (0.03)  44221.451**  
12.5 < 25 < 
50  
Skim 0.82 (0.02) 1.96 (0.03) 3.14 (0.02) 49156.924** 
12.5 < 25 < 
50  
Note. **p < 0.001. 
Cow ID (2945.3) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 1.29 (0.02) 2.79 (0.02)  3.88 (0.02)  51712.414**  12.5 < 25 < 50 
Whole 0.65 (0.03)  2.68 (0.01)  3.58 (0.01)  86605.442**  12.5 < 25 < 50  
Skim 0.85 (0.15) 2.76 (0.03) 3.60 (0.04) 1318.082** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID (2917.2) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.29 (0.01) 0.72 (0.01)  1.20 (0.02)  8179.497**  12.5 < 25 < 50 
Whole 0.77 (0.02)  1.05 (0.03)  3.67 (0.02)  44506.338**  12.5 < 25 < 50  
Skim 0.45 (0.03) 0.75 (0.03) 3.63 (0.03) 45531.503** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (3133.3) – low cell count mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.37 (0.01) 0.68 (0.02)  1.17 (0.02)  5528.093**  12.5 < 25 < 50 
Whole 0.26 (0.02)  0.65 (0.03)  3.35 (0.03)  49676.293**  12.5 < 25 < 50  
Skim 0.35 (0.03) 0.85 (0.03) 3.66 (0.03) 37173.231** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (2581.2) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.20 (0.08) 0.54 (0.08)  0.84 (0.13)  393.630**  12.5 < 25 < 50 
Whole 0.19 (0.04)  0.22 (0.06)  0.39 (0.06)  15306.736**  12.5 < 25 < 50  
Skim 0.25 (0.04) 0.33 (0.04) 0.22 (0.04) 347.201** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID (2655.5) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.29 (0.09) 0.65 (0.05)  1.79 (0.07)  7517.596**  12.5 < 25 < 50 
Whole 0.57 (0.04)  0.99 (0.04)  3.59 (0.05)  21318.056**  12.5 < 25 < 50  
Skim 0.43 (0.06) 0.92 (0.06) 2.75 (0.05) 159.377** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (2690.2) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.27 (0.06) 0.51 (0.09)  0.86 (0.06)  1534.820**  12.5 < 25 < 50 
Whole 0.19 (0.03)  0.28 (0.01)  1.59 (0.03)  45039.925**  12.5 < 25 < 50  
Skim 0.31 (0.06) 0.48 (0.10) 1.5 (0.07) 40.842** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (2407.7) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 1.21 (0.08) 2.68 (0.08)  3.69 (0.04)  3719.579**  12.5 < 25 < 50 
Whole 0.28 (0.03)  0.59 (0.03)  2.69 (0.03)  25149.716**  12.5 < 25 < 50  
Skim 0.40 (0.06) 0.92 (0.08) 2.73 (0.05) 7877.058** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID (868.4) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.40 (0.03) 1.69 (0.08)  3.80 (0.09)  188.099**  12.5 < 25 < 50 
Whole 0.31 (0.03)  0.99 (0.03)  3.59 (0.03)  8265.935**  12.5 < 25 < 50  
Skim 0.31 (0.05) 1.09 (0.01) 2.50 (0.05) 2915.023** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (816.2) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.69 (0.06) 1.59 (0.09)  3.70 (0.08)  107.227**  12.5 < 25 < 50 
Whole 0.79 (0.01)  0.99 (0.01)  3.61 (0.02)  585.497**  12.5 < 25 < 50  
Skim 0.87 (0.04) 1.09 (0.01) 2.33 (0.05) 26.217** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (796.3) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.56 (0.04) 3.71 (0.03)  3.89 (0.06)  201.868**  12.5 < 25 < 50 
Whole 0.17 (0.01)  1.5 (0.01)  3.59 (0.03)  101096.421**  
12.5 < 25 < 
50  
Skim 0.29 (0.04) 1.69 (0.13) 1.91 (0.08) 2363.526** 
12.5 < 25 < 
50  
Note. **p < 0.001. 
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Cow ID (796.2) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.38 (0.05) 1.69 (0.05)  3.28 (0.07)  7981.879**  12.5 < 25 < 50 
Whole 0.18 (0.004)  0.48 (0.03)  3.56 (0.05)  11960.207**  12.5 < 25 < 50  
Skim 0.28 (0.07) 0.69 (0.05) 2.81 (0.08) 5383.084** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (686.5) – sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.23 (0.03) 0.38 (0.04)  0.60 (0.02)  36183.907**  12.5 < 25 < 50 
Whole 0.27 (0.01)  0.39 (0.01)  3.58 (0.01)  33159.398**  12.5 < 25 < 50  
Skim 0.30 (0.06) 0.61 (0.06) 3.44 (0.14) 3616.214** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID (684.6) – Sub-clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.28 (0.01) 0.40 (0.02)  1.32 (0.02)  97910.782**  12.5 < 25 < 50 
Whole 0.19 (0.01)  0.30 (0.02)  3.49 (0.01)  2222.296**  12.5 < 25 < 50  
Skim 0.21 (0.05) 0.33 (0.06) 1.81 (0.06) 9965.845** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID 3885(1) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.33 (0.01) 0.95 (0.03)  3.84 (0.03)  58921.752**  12.5 < 25 < 50 
Whole 0.69 (0.02)  1.27 (0.03)  3.02 (0.01)  36924.693**  12.5 < 25 < 50  
Skim 0.78 (0.01) 1.3 (0.03) 1.59 (0.02) 18033.460** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID 3885(2) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.45 (0.03) 2.85 (0.03)  3.84 (0.03)  47598.448**  12.5 < 25 < 50 
Whole 0.31 (0.01)  0.77 (0.02)  3.73 (0.02)  172957.742**  12.5 < 25 < 50  
Skim 0.53 (0.01) 0.89 (0.01) 3.69 (0.02) 305974.781** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID 5851(1) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.25 (0.03) 0.35 (0.03)  1.61 (0.02)  3454.472**  12.5 < 25 < 50 
Whole 0.25 (0.02)  0.59 (0.02)  1.09 (0.02)  5557.965**  12.5 < 25 < 50  
Skim 0.98 (0.004) 1.67 (0.01) 3.40 (0.03) 90690.406** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID 5851(2) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.24 (0.04) 2.75 (0.03)  3.96 (0.03)  48376.257**  12.5 < 25 < 50 
Whole 0.97 (0.03)  1.62 (0.004)  3.59 (0.01)  88404.280**  12.5 < 25 < 50  
Skim 1.16 (0.03) 1.85 (0.03) 3.70 (0.03) 44683.856** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID 3551(1) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.25 (0.02) 0.95 (0.02)  3.66 (0.02)  97392.188**  12.5 < 25 < 50 
Whole 0.35 (0.02)  0.56 (0.01)  1.45 (0.02)  16308.214**  12.5 < 25 < 50  
Skim 0.53 (0.02) 0.75 (0.03) 2.20 (0.03) 1417.656** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID 3551(2) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.34 (0.03) 0.64 (0.01)  3.55 (0.03)  54856.710**  12.5 < 25 < 50 
Whole 0.35 (0.02)  0.60 (0.02)  0.96 (0.01)  3290.174**  12.5 < 25 < 50  
Skim 0.54 (0.03) 0.85 (0.02) 2.00 (0.02) 6807.907** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID 3668(1) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.56 (0.03) 0.66 (0.02)  3.76 (0.02)  59360.335**  12.5 < 25 < 50 
Whole 0.36 (0.02)  0.45 (0.02)  1.56 (0.02)  10382.114**  12.5 < 25 < 50  
Skim 0.52 (0.01) 0.64 (0.04) 3.40 (0.02) 25743.154** 12.5 < 25 < 50  
Note. **p < 0.001. 
Cow ID 3668(2) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.24 (0.02) 0.45 (0.02) 0.95 (0.03) 2352.958** 12.5 < 25 < 50 
Whole 0.33 (0.01) 0.54 (0.01) 1.73 (0.02) 34043.107** 12.5 < 25 < 50 
Skim 0.54 (0.03) 0.77 (0.03) 1.60 (0.01) 415.360** 12.5 < 25 < 50 
Note. **p < 0.001. 
Cow ID 3860(1) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.25 (0.03) 0.96 (0.03)  2.76 (0.02)  28137.128**  12.5 < 25 < 50 
Whole 0.33 (0.03)  0.76 (0.02)  1.35 (0.02)  4904.265**  12.5 < 25 < 50  
Skim 0.47 (0.04) 0.91 (0.03) 3.40 (0.03) 16453.670** 12.5 < 25 < 50  
Note. **p < 0.001. 
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Cow ID 3860(2) – clinical mastitis 
Milk 
Type 
12.5% (n = 12) 25% (n = 12) 50% (n = 12) 
F(df = 2, 33) 
Post-hoc 
comparisons
1
 M (SD) M (SD) M (SD) 
Raw 0.25 (0.02) 0.86 (0.03)  2.43 (0.03)  23944.226**  12.5 < 25 < 50 
Whole 0.77 (0.02)  1.58 (0.02)  2.45 (0.03)  19710.177**  12.5 < 25 < 50  
Skim 0.84 (0.02) 1.71 (0.04) 1.49 (0.01) 1229.894** 12.5 < 25 < 50  
Note. **p < 0.001. 
 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:Value 
Source 
Type III Sum 
of Squares 
df 
Mean 
Square 
F Sig. 
Partial Eta 
Squared 
Corrected Model 2836.561
a
 26 109.098 179.848 0.00 0.618 
Intercept 6772.902 1 6772.902 11165.075 0.00 0.794 
MilkType 34.341 2 17.170 28.305 0.00 0.019 
Percentage 2367.700 2 1183.850 1951.567 0.00 0.575 
Mastitis 259.976 2 129.988 214.284 0.00 0.129 
MilkType * Percentage 10.087 4 2.522 4.157 0.00 0.006 
MilkType * Mastitis 18.766 4 4.692 7.734 0.00 0.011 
Percentage * Mastitis 49.790 4 12.448 20.520 0.00 0.028 
MilkType * Percentage 
* Mastitis 
91.772 8 11.472 18.911 0.00 0.050 
Error 1752.511 2889 0.607    
Total 11387.184 2916     
Corrected Total 4589.072 2915     
a. R Squared = 0.618 (Adjusted R Squared = 0.615) 
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Univariate Tests 
Dependent Variable:Value 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial Eta 
Squared 
Contrast 34.341 2 17.170 28.305 0.000 0.019 
Error 1752.511 2889 0.607    
The F tests the effect of Milk Type. This test is based on the linearly independent 
pairwise comparisons among the estimated marginal means. 
 
Univariate Tests 
Dependent Variable:Value 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial Eta 
Squared 
Contrast 2367.700 2 1183.850 1951.567 0.000 0.575 
Error 1752.511 2889 0.607    
The F tests the effect of Percentage. This test is based on the linearly independent 
pairwise comparisons among the estimated marginal means. 
 
Univariate Tests 
Dependent Variable:Value 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial Eta 
Squared 
Contrast 259.976 2 129.988 214.284 0.000 0.129 
Error 1752.511 2889 0.607    
The F tests the effect of Mastitis. This test is based on the linearly independent 
pairwise comparisons among the estimated marginal means. 
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Appendix 2: 
 
 
 
Fig. A2-1. The effect of milk type on biofilm formation by S. uberis determined by the 
polystyrene microtitre plate assay. 
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Fig. A2-2. Three way ANOVA represents the effect of milk type on biofilm 
formation by S. uberis in media containing milk with different percentage 
determined by the polystyrene microtitre plate assay.  
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Fig. A2-3. The effect of milk type on biofilm formation by S. uberis in media 
containing milk with different percentage determined by the polystyrene microtitre plate 
assay. Data points are represent the average of three biological replicates and the error 
bars show standard deviation for each isolate tested. 
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Appendix 3: 
Fig. A3-1. Streptococcus uberis isolates generated different hybridization patterns onto 
six sub-arrays grided on coated slides, each subarray composed of 280 samples. Images 
represent isolates from cows with clinical mastitis and isolates from cows with low cell 
count in their milk.     
 
 
Tester                                                                Driver 
          
 
Isolate 7218 (1) (clinical)                                 Isolate 2917.2 (commensal) 
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Isolate 883.4 (clinical)                                Isolate 3133.3 (commensal) 
   
                             Isolate 2565.2 (clinical)                               Isolate 3217.3 (commensal)                                                   
   
Isolate 3885 (1) (clinical)                              Isolate 3068.2 (commensal 
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Isolate 6093 (clinical)                                  Isolate 3217.1 (commensal) 
     
Isolate 2874.4 (clinical)                                Isolate 3147.5 (commensal) 
   
 
Isolate 4707 (2) (clinical)                             Isolate 2945.3 (commensal) 
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Isolate 3571 (1) (clinical)                              Isolate 3333.3 (commensal) 
   
Isolate 6104 (clinical)                                Isolate 2285.1 (clinical) 
   
Isolate 6232 (1) (clinical)                                      Isolate 2169.2 (clinical) 
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Isolate 2988.1 (clinical)                               Isolate 2730.5 (clinical) 
   
Isolate 3531 (1) (clinical)                                             Isolate 2530.2 (clinical) 
   
Isolate 2905 (1) (clinical)                             Isolate 3064.1 (clinical) 
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Isolate 3599 (1) (clinical) 
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